
<html lang="en"     class="pb-page"  data-request-id="5c4766a7-51b2-4d50-b42e-d9c162cee06f"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";article:article:10.1021/jm201258k;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2012.55.issue-2;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Structure–Activity Relationship (SAR) Development and Discovery of Potent Indole-Based Inhibitors of the Hepatitis C Virus (HCV) NS5B Polymerase" /></meta><meta name="dc.Creator" content="Kevin X.  Chen" /></meta><meta name="dc.Creator" content="Bancha  Vibulbhan" /></meta><meta name="dc.Creator" content="Weiying  Yang" /></meta><meta name="dc.Creator" content="Mousumi  Sannigrahi" /></meta><meta name="dc.Creator" content="Francisco  Velazquez" /></meta><meta name="dc.Creator" content="Tin-Yau  Chan" /></meta><meta name="dc.Creator" content="Srikanth  Venkatraman" /></meta><meta name="dc.Creator" content="Gopinadhan N.  Anilkumar" /></meta><meta name="dc.Creator" content="Qingbei  Zeng" /></meta><meta name="dc.Creator" content="Frank  Bennet" /></meta><meta name="dc.Creator" content="Yueheng  Jiang" /></meta><meta name="dc.Creator" content="Charles A.  Lesburg" /></meta><meta name="dc.Creator" content="Jose  Duca" /></meta><meta name="dc.Creator" content="Patrick  Pinto" /></meta><meta name="dc.Creator" content="Stephen  Gavalas" /></meta><meta name="dc.Creator" content="Yuhua  Huang" /></meta><meta name="dc.Creator" content="Wanli  Wu" /></meta><meta name="dc.Creator" content="Oleg  Selyutin" /></meta><meta name="dc.Creator" content="Sony  Agrawal" /></meta><meta name="dc.Creator" content="Boris  Feld" /></meta><meta name="dc.Creator" content="Hsueh-Cheng  Huang" /></meta><meta name="dc.Creator" content="Cheng  Li" /></meta><meta name="dc.Creator" content="Kuo-Chi  Cheng" /></meta><meta name="dc.Creator" content="Neng-Yang  Shih" /></meta><meta name="dc.Creator" content="Joseph A.  Kozlowski" /></meta><meta name="dc.Creator" content="Stuart B.  Rosenblum" /></meta><meta name="dc.Creator" content="F. George  Njoroge" /></meta><meta name="dc.Description" content="Starting with the indole-based C-3 pyridone lead HCV polymerase inhibitor 2, extensive SAR studies were performed at different positions of the indole core. The best C-5 groups were found to be com..." /></meta><meta name="Description" content="Starting with the indole-based C-3 pyridone lead HCV polymerase inhibitor 2, extensive SAR studies were performed at different positions of the indole core. The best C-5 groups were found to be com..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="January 6, 2012" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm201258k" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2011 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm201258k" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm201258k" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm201258k" /></link>
        
    
    

<title>Structure–Activity Relationship (SAR) Development and Discovery of Potent Indole-Based Inhibitors of the Hepatitis C Virus (HCV) NS5B Polymerase | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm201258k" /></meta><meta property="og:title" content="Structure–Activity Relationship (SAR) Development and Discovery of Potent Indole-Based Inhibitors of the Hepatitis C Virus (HCV) NS5B Polymerase" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-2/jm201258k/production/images/large/jm-2011-01258k_0005.jpeg" /></meta><meta property="og:description" content="Starting with the indole-based C-3 pyridone lead HCV polymerase inhibitor 2, extensive SAR studies were performed at different positions of the indole core. The best C-5 groups were found to be compact and nonpolar moieties and that the C-6 attachments were not affecting potency. Limited N-1 benzyl-type substituent studies indicated that the best substitutions were fluoro or methyl groups at 2′ or 5′ positions of the benzyl group. To improve pharmacokinetic (PK) properties, acylsulfonamides were incorporated as acid isosteres at the C-2 position. Further optimization of the combination at N-1, C-2, C-5, and C-6 resulted in the identification of compound 56, which had an excellent potency in both NS5B enzyme (IC50 = 0.008 μM) and cell-based replicon (EC50 = 0.02 μM) assays and a good oral PK profile with area-under-the curve (AUC) of 14 and 8 μM·h in rats and dogs, respectively. X-ray structure of inhibitor 56 bound to the enzyme was also reported." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm201258k"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm201258k">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm201258k&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm201258k&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm201258k&amp;href=/doi/10.1021/jm201258k" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2012</span><span class="cit-fg-volume">, 55</span><span class="cit-fg-issue">, 2</span><span class="cit-fg-pageRange">, 754-765</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/55/2" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm201243p" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm201284m" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Structure–Activity Relationship (SAR) Development and Discovery of Potent Indole-Based Inhibitors of the Hepatitis C Virus (HCV) NS5B Polymerase</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kevin+X.++Chen">Kevin X. Chen</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Bancha++Vibulbhan">Bancha Vibulbhan</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Weiying++Yang">Weiying Yang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mousumi++Sannigrahi">Mousumi Sannigrahi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Francisco++Velazquez">Francisco Velazquez</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Tin-Yau++Chan">Tin-Yau Chan</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Srikanth++Venkatraman">Srikanth Venkatraman</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gopinadhan+N.++Anilkumar">Gopinadhan N. Anilkumar</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Qingbei++Zeng">Qingbei Zeng</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Frank++Bennet">Frank Bennet</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yueheng++Jiang">Yueheng Jiang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Charles+A.++Lesburg">Charles A. Lesburg</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jose++Duca">Jose Duca</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Patrick++Pinto">Patrick Pinto</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Stephen++Gavalas">Stephen Gavalas</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yuhua++Huang">Yuhua Huang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Wanli++Wu">Wanli Wu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Oleg++Selyutin">Oleg Selyutin</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sony++Agrawal">Sony Agrawal</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Boris++Feld">Boris Feld</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hsueh-Cheng++Huang">Hsueh-Cheng Huang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Cheng++Li">Cheng Li</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kuo-Chi++Cheng">Kuo-Chi Cheng</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Neng-Yang++Shih">Neng-Yang Shih</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Joseph+A.++Kozlowski">Joseph A. Kozlowski</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Stuart+B.++Rosenblum">Stuart B. Rosenblum</a></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=F.+George++Njoroge">F. George Njoroge</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff2"><span class="aff-symbol">†</span> <span class="aff-text">Merck Research Laboratories, 2015 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div><div class="aff-info" id="aff4"><span class="aff-symbol">‡</span> <span class="aff-text">Drug Design, Merck Research Laboratories, 2015 Galloping Hill Road, Kenilworth, NJ 07033, United States</span></div><div class="corresp-info"><strong>*</strong>Phone: 732-662-1333. Fax: 908-740-7152. E-mail: <a href="/cdn-cgi/l/email-protection#e18a99828fa19880898e8ecf828e8c"><span class="__cf_email__" data-cfemail="8ce7f4efe2ccf5ede4e3e3a2efe3e1">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm201258k&amp;href=/doi/10.1021%2Fjm201258k" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2012</span></span><span class="cit-volume">, 55</span><span class="cit-issue">, 2</span><span class="cit-pageRange">, 754–765</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">December 13, 2011</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>20 September 2011</li><li><span class="item_label"><b>Published</b> online</span>6 January 2012</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 26 January 2012</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm201258k" title="DOI URL">https://doi.org/10.1021/jm201258k</a></div><div class="article_header-article-copyright"><strong>Copyright © 2011 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D754%26pageCount%3D12%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DKevin%2BX.%2BChen%252C%2BBancha%2BVibulbhan%252C%2BWeiying%2BYang%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D55%26issueNum%3D2%26contentID%3Djm201258k%26title%3DStructure%25E2%2580%2593Activity%2BRelationship%2B%2528SAR%2529%2BDevelopment%2Band%2BDiscovery%2Bof%2BPotent%2BIndole-Based%2BInhibitors%2Bof%2Bthe%2BHepatitis%2BC%2BVirus%2B%2528HCV%2529%2BNS5B%2BPolymerase%26numPages%3D12%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D765%26publicationDate%3DJanuary%2B2012">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm201258k"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2631</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">26</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm201258k" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Structure–Activity Relationship (SAR) Development and Discovery of Potent Indole-Based Inhibitors of the Hepatitis C Virus (HCV) NS5B Polymerase&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Kevin&quot;,&quot;last_name&quot;:&quot;X. Chen&quot;},{&quot;first_name&quot;:&quot;Bancha&quot;,&quot;last_name&quot;:&quot;Vibulbhan&quot;},{&quot;first_name&quot;:&quot;Weiying&quot;,&quot;last_name&quot;:&quot;Yang&quot;},{&quot;first_name&quot;:&quot;Mousumi&quot;,&quot;last_name&quot;:&quot;Sannigrahi&quot;},{&quot;first_name&quot;:&quot;Francisco&quot;,&quot;last_name&quot;:&quot;Velazquez&quot;},{&quot;first_name&quot;:&quot;Tin-Yau&quot;,&quot;last_name&quot;:&quot;Chan&quot;},{&quot;first_name&quot;:&quot;Srikanth&quot;,&quot;last_name&quot;:&quot;Venkatraman&quot;},{&quot;first_name&quot;:&quot;Gopinadhan&quot;,&quot;last_name&quot;:&quot;N. Anilkumar&quot;},{&quot;first_name&quot;:&quot;Qingbei&quot;,&quot;last_name&quot;:&quot;Zeng&quot;},{&quot;first_name&quot;:&quot;Frank&quot;,&quot;last_name&quot;:&quot;Bennet&quot;},{&quot;first_name&quot;:&quot;Yueheng&quot;,&quot;last_name&quot;:&quot;Jiang&quot;},{&quot;first_name&quot;:&quot;Charles&quot;,&quot;last_name&quot;:&quot;A. Lesburg&quot;},{&quot;first_name&quot;:&quot;Jose&quot;,&quot;last_name&quot;:&quot;Duca&quot;},{&quot;first_name&quot;:&quot;Patrick&quot;,&quot;last_name&quot;:&quot;Pinto&quot;},{&quot;first_name&quot;:&quot;Stephen&quot;,&quot;last_name&quot;:&quot;Gavalas&quot;},{&quot;first_name&quot;:&quot;Yuhua&quot;,&quot;last_name&quot;:&quot;Huang&quot;},{&quot;first_name&quot;:&quot;Wanli&quot;,&quot;last_name&quot;:&quot;Wu&quot;},{&quot;first_name&quot;:&quot;Oleg&quot;,&quot;last_name&quot;:&quot;Selyutin&quot;},{&quot;first_name&quot;:&quot;Sony&quot;,&quot;last_name&quot;:&quot;Agrawal&quot;},{&quot;first_name&quot;:&quot;Boris&quot;,&quot;last_name&quot;:&quot;Feld&quot;},{&quot;first_name&quot;:&quot;Hsueh-Cheng&quot;,&quot;last_name&quot;:&quot;Huang&quot;},{&quot;first_name&quot;:&quot;Cheng&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Kuo-Chi&quot;,&quot;last_name&quot;:&quot;Cheng&quot;},{&quot;first_name&quot;:&quot;Neng-Yang&quot;,&quot;last_name&quot;:&quot;Shih&quot;},{&quot;first_name&quot;:&quot;Joseph&quot;,&quot;last_name&quot;:&quot;A. Kozlowski&quot;},{&quot;first_name&quot;:&quot;Stuart&quot;,&quot;last_name&quot;:&quot;B. Rosenblum&quot;},{&quot;first_name&quot;:&quot;F.&quot;,&quot;last_name&quot;:&quot;George Njoroge&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2012&quot;,&quot;month&quot;:&quot;01&quot;,&quot;day&quot;:&quot;06&quot;,&quot;issue&quot;:&quot;2&quot;,&quot;volume&quot;:&quot;55&quot;,&quot;pages&quot;:&quot;754-765&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm201258k&quot;},&quot;abstract&quot;:&quot;Starting with the indole-based C-3 pyridone lead HCV polymerase inhibitor 2, extensive SAR studies were performed at different positions of the indole core. The best C-5 groups were found to be compact and nonpolar moieties and that the C-6 attachments were not affecting potency. Limited N-1 benzyl-type substituent studies indicated that the best substitutions were fluoro or methyl groups at 2′ or 5′ positions of the benzyl group. To improve pharmacokinetic (PK) properties, acylsulfonamides were incorporated as acid isosteres at the C-2 position. Further optimization of the combination at N-1, C-2, C-5, and C-6 resulted in the identification of compound 56, which had an excellent potency in both NS5B enzyme (IC50 = 0.008 μM) and cell-based replicon (EC50 = 0.02 μM) assays and a good oral PK profile with area-under-the curve (AUC) of 14 and 8 μM·h in rats and dogs, respectively. X-ray structure of inhibitor 56 bound to the enzyme was also reported.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm201258k&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm201258k" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm201258k&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm201258k" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm201258k&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm201258k" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm201258k&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm201258k&amp;href=/doi/10.1021/jm201258k" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm201258k" /></input><a href="/doi/pdf/10.1021/jm201258k" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (1 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm201258k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm201258k%26sid%3Dliteratum%253Aachs%26pmid%3D22148957%26genre%3Darticle%26aulast%3DChen%26date%3D2012%26atitle%3DStructure%25E2%2580%2593Activity%2BRelationship%2B%2528SAR%2529%2BDevelopment%2Band%2BDiscovery%2Bof%2BPotent%2BIndole-Based%2BInhibitors%2Bof%2Bthe%2BHepatitis%2BC%2BVirus%2B%2528HCV%2529%2BNS5B%2BPolymerase%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D55%26issue%3D2%26spage%3D754%26epage%3D765%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291465" title="Structure activity relationship">Structure activity relationship</a>,</li><li><a href="/action/doSearch?ConceptID=290676" title="Substituents">Substituents</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/55/2" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-2/jmcmar.2012.55.issue-2/production/jmcmar.2012.55.issue-2.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-2/jm201258k/production/images/medium/jm-2011-01258k_0005.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-2/jm201258k/production/images/large/jm-2011-01258k_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201258k&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Starting with the indole-based C-3 pyridone lead HCV polymerase inhibitor <b>2</b>, extensive SAR studies were performed at different positions of the indole core. The best C-5 groups were found to be compact and nonpolar moieties and that the C-6 attachments were not affecting potency. Limited <i>N</i>-1 benzyl-type substituent studies indicated that the best substitutions were fluoro or methyl groups at 2′ or 5′ positions of the benzyl group. To improve pharmacokinetic (PK) properties, acylsulfonamides were incorporated as acid isosteres at the C-2 position. Further optimization of the combination at <i>N</i>-1, C-2, C-5, and C-6 resulted in the identification of compound <b>56</b>, which had an excellent potency in both NS5B enzyme (IC<sub>50</sub> = 0.008 μM) and cell-based replicon (EC<sub>50</sub> = 0.02 μM) assays and a good oral PK profile with area-under-the curve (AUC) of 14 and 8 μM·h in rats and dogs, respectively. X-ray structure of inhibitor <b>56</b> bound to the enzyme was also reported.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div class="extra-info-sec articleNote withdrawn"><h4><span></span> Accession Codes</h4><p class="last">Protein Data Bank ID <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3TYV">3TYV</a>.</p></div><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_07410" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_07410" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Hepatitis C virus (HCV) has infected an estimated 3% of the world’s population (over 170 million people).<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> The slow progression and mild symptoms of the HCV infection make it a stealth epidemic. Most infections progress to a chronic state that persists for decades and eventually lead to cirrhosis, liver failure, or liver cancer.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Currently, there is no anti-HCV vaccine available. The new standard of care (SOC) after recent protease inhibitor approval involves the combination of a protease inhibitor with pegylated α-interferon and the oral nucleoside antiviral agent ribavirin.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> The outcome of the treatment is defined by the sustained virologic response (SVR) or undetectable HCV RNA in serum at the end of treatment and six months post treatment. The SVR rate for patients with the most difficult to treat genotype-1 HCV is about 70% with the new current therapy.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Large pill burden (750–800 mg 3-times a day), relapse (mutations), and discontinuation due to the presence of side effects with these therapies necessitates the need for new and more effective HCV treatments.</div><div class="NLM_p">Hepatitis C virus was identified more than two decades ago.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> It belongs to the Flaviviridae family of enveloped viruses. It is a positive-sense single-stranded RNA virus with a single open frame of ∼9600 nucleosides. The viral genome encodes a polyprotein of more than 3000 amino acids. The polyprotein is divided into structural and nonstructural precursor regions. The structural protein contains the nucleocapsid core protein (C) and two glycoproteins E1 and E2 (NS1). The nonstructural proteins located downstream are: NS2, NS3, NS4A, NS4B, NS5A, and NS5B. Because of their essential role in the replication of HCV virus, intensive research has been focused on finding drugs directly targeting these nonstructural proteins, and exciting progress has been made in these endeavors.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Clinical trials have demonstrated dramatic improvements in SVR rate in patients treated with a direct acting agent in combination with pegylated interferon and ribavirin.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Recent approval of the two HCV NS3 protease inhibitors boceprevir<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> (Merck & Co.) and telaprevir<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> (Vertex Pharmaceuticals) by the FDA have generated great excitement for the new treatments of HCV infection. Several other NS3 protease inhibitors and a number of candidates targeting other nonstructural enzymes are also under development.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a></div><div class="NLM_p">The HCV NS5B gene encodes an RNA-dependent RNA polymerase (RdRp) whose enzymatic activity is critical to the replication of the viral RNA genome.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Replication of the plus-strand RNA viral genome consists of two steps: synthesis of the complementary negative-strand RNA using the positive-strand RNA as a template, and the subsequent synthesis of multiple positive-strand RNA genome using the minus-strand RNA as a template. Besides its direct role in the replication of viral RNA genome, the HCV NS5B polymerase is potentially associated with a number of other important functions. It forms a replicase complex (RC) with other HCV nonstructural proteins (NS3, NS4A, NS4B, and NS5A) and a number of cellular cofactors during replication.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> It was also suggested that NS5B might regulate the function of other HCV enzymes. The crystal structure of the catalytic domain of N5SB has revealed several significant features.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> The polymerase shares many common features of other polymerases with characteristic thumb, finger, and palm domains analogous with a right hand. In addition to a well-conserved active site (located in the palm domain) for nucleoside binding, mechanistic and structural studies have revealed the existence of multiple allosteric inhibitor binding sites. Binding to these sites interferes with conformational changes required during RNA synthesis. Thumb pockets I and II are two allosteric sites that are located in thumb domain, while palm site I and II are two pockets located adjacent to the active site. These thumb and palm region sites have been popular targets for drug development, which makes the NS5B a particularly druggable target.<a onclick="showRef(event, 'ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref12 ref13">(12, 13)</a></div><div class="NLM_p">Extensive efforts directed at inhibiting HCV NS5B polymerase have resulted in numerous drug candidates. They belong to two distinctive classes of inhibitors: nucleoside active site inhibitors (NIs) and non-nucleoside allosteric inhibitors (NNIs).<a onclick="showRef(event, 'ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref12 ref13">(12, 13)</a> They target different stages of RNA synthesis.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> NNIs were shown to interfere with steps prior to or during the initiation of RNA synthesis. In contrast, the triphosphate form of NIs binds to the active site during elongation. NIs are analogues of natural substrates of the polymerase that are incorporated into the growing RNA chain leading to chain termination. These agents require phosphorylation before being active. Because NS5B is a highly conserved region of the HCV genome, NIs have similar activity against all genotypes and a high genetic barrier to resistance.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Several NIs have advanced into clinical trials, including prodrugs valopicitabine (Idenix), R1626 (Roche), RG-7128 (Pharmasset/Roche), PSI-7977 (Pharmasset), PSI-352938 (Pharmasset), IDX-184 (Idenix), and INX-189 (Inhibitex).<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> NNIs, on the other hand, achieve NS5B inhibition by binding to one of at least five allosteric enzyme sites resulting in conformational changes which alter the protein-inhibiting catalytic activity of polymerase. A number of clinical candidates have been identified,<a onclick="showRef(event, 'ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref12 ref13">(12, 13)</a> among them, HCV-796 (Wyeth/Viropharma),<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> filibuvir (Pfizer),<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> VX-222 (Vertex/Virochem),<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> ANA598 (Anadys),<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> BI207127 (Boehringer Ingelheim),<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> and BMS-791325 (Bristol-Myers Squibb)<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> have been progressed to phase II clinical trials. The rapid development of resistant mutants has been observed with NNIs because they bind distantly to the active center of NS5B and mutations at the NNI binding site may not necessary lead to impairment of the enzyme function.</div><div class="NLM_p">The indole-based lead compound, <b>1</b>, was discovered through screening effort at Schering-Plough Research Institute. It had only moderate binding activity (IC<sub>50</sub> = 0.9 μM) in an RdRp enzyme binding assay.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> It was inactive in the cell-based replicon assay<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> (EC<sub>50</sub> > 100 μM). The X-ray structure of <b>1</b> in complex with NS5B indicated that it bound to a NS5B apoprotein cavity adjacent to the active site at the “palm” site of the protein.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> There was an unusual F···H–N hydrogen bonding between the C-3 fluorophenyl and tyrosine-448. Starting from this lead compound, extensive SAR investigations were conducted to improve potency of the indole-based inhibitors. A breakthrough was achieved when C-3 2-fluorophenyl group was replaced with a 3-pyridone moiety, and the benzene ring at <i>N</i>-1 substituent was replaced with 4-(2-amino)pyridine, as shown in structure <b>2</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>).<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> The pyridone carbonyl and N–H formed strong hydrogen bonds with backbone isoleucine-447 residue, and the amino-pyridine moiety had a hydrogen bonding interaction with serine-367. As a result of the additional interactions, there was a near 20-fold improvement in enzyme potency. More importantly, <b>2</b> demonstrated activity in the cellular replicon assay with an EC<sub>50</sub> of 4.8 μM. Starting from this new lead compound <b>2</b>, our task was to develop inhibitors with potency and PK properties desirable in a drug candidate. Herein, we report the SAR development and the discovery of a potent HCV NS5B polymerase inhibitor which exhibited a good PK profile in rats.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-2/jm201258k/production/images/medium/jm-2011-01258k_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-2/jm201258k/production/images/large/jm-2011-01258k_0007.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. HCV NS5B polymerase inhibitors early lead structures.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-2/jm201258k/production/images/large/jm-2011-01258k_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201258k&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div id="sec1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Synthesis of HCV NS5B Polymerase Inhibitors</h3><div class="NLM_p">The general synthesis of HCV NS5B polymerase inhibitors is outlined in Schemes <a class="ref internalNav" href="#sch1" aria-label="1">1</a> and <a class="ref internalNav" href="#sch2" aria-label="2">2</a>. The ethyl indole-2-carboxylate <b>3</b>, with desired substituents at 4,5,6-positions, was either commercially available or could be prepared via known procedures. Intermediate <b>3</b> was iodinated at C-3 with <i>N</i>-iodosuccinimide (NIS) to give compound <b>4</b>. The Suzuki–Miyaura cross-coupling reaction<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> between <b>4</b> and 2-methoxy-3-pyridine boronic acid <b>5</b> in the presence of a palladium catalyst afforded product <b>6</b> in 50–85% yields from <b>3</b>. The indole nitrogen was then alkylated to provide compound <b>7</b> in 40–90% yields through alkylation with a benzylic halide. The methoxypyridine in <b>7</b> was then converted to pyridone product <b>8</b> upon treatment with hydrochloric acid. The ethyl ester was finally hydrolyzed to carboxylic acid <b>9</b> with yields of 30–60% in two steps, which was tested in RdRp enzyme assay and replicon cell-based assay.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-2/jm201258k/production/images/medium/jm-2011-01258k_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-2/jm201258k/production/images/large/jm-2011-01258k_0009.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-2/jm201258k/production/images/large/jm-2011-01258k_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201258k&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NIS, acetone, quant; (b) PdCl<sub>2</sub>(dppf)<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, 1,2-dimethoxyethane, 50–85%; (c) ArCH<sub>2</sub>Br or ArCH<sub>2</sub>Cl, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 40–90%; (d) 4 M HCl, <i>p</i>-dioxane; (e) LiOH, THF/H<sub>2</sub>O 30–60% (2 steps).</p></p></figure><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-2/jm201258k/production/images/medium/jm-2011-01258k_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-2/jm201258k/production/images/large/jm-2011-01258k_0010.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-2/jm201258k/production/images/large/jm-2011-01258k_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201258k&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) LiOH, THF/H<sub>2</sub>O; (b) CDI, then RSO<sub>2</sub>NH<sub>2</sub>, DBU, THF, 50–80% (2 steps); (c) 4 M HCl, <i>p</i>-dioxane, 30–50%.</p></p></figure><div class="NLM_p last">The indole-2-acylsulfonamide series of polymerase inhibitors were prepared according to the procedures shown in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>. Compound <b>7</b> was hydrolyzed to its corresponding carboxylic acid <b>10</b>. The acid was activated with carbonyl diimidazole (CDI) and then reacted with a sulfonamide in the presence of diazabicyclicunderdecane (DBU)<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> to give desired acylsulfonamide <b>11</b> in 50–80% yields from <b>7</b>. Product <b>11</b> was then treated with hydrochloric acid to provide pyridone final product <b>12</b> in 30–50% purified yields. The inhibitors were evaluated in enzyme and replicon assays to determine their biological activities.</div></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Results and Discussions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_62646" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_62646" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Preliminary SAR at Indole C-4, C-5, and C-6 Positions</h3><div class="NLM_p">With the lead compound <b>2</b> exhibiting interesting biological activity, an effort was taken to improve the potency via optimization of various substituents at different positions of the indole core. First, the effect of additional substitution at C-4 and C-6 positions was examined and the SAR is summarized in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> (compounds <b>13</b>–<b>15</b>). Starting from compound <b>2</b>, a second chloro substituent was introduced at C-4. Unfortunately, the resulting inhibitor <b>13</b> had an IC<sub>50</sub> of 0.75 μM in an RdRp enzyme binding assay,<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> a 14-fold decrease in activity. The removal of the C-5 chloro group and introduction of a larger bromo atom at C-4 gave <b>14</b> (IC<sub>50</sub> = 4.0 μM) with a 75-fold loss in activity compared to <b>2</b>. The detrimental effect of the C-4 substituents was probably caused by its intervention of proper orientation of the C-3 pyridone ring for optimal hydrogen bonding. The investigation was then focused on C-6 modifications. An additional chloro group was introduced to C-6 of compound <b>2</b> to give inhibitor <b>15</b>. The potency of this compound remained essentially unchanged at approximately 0.05 μM (IC<sub>50</sub>). It appeared that the C-6 substituent did not adversely affect the potency.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Modifications at C-4, C-5, and C-6 of Indole Core</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-2/jm201258k/production/images/medium/jm-2011-01258k_0011.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-2/jm201258k/production/images/medium/jm-2011-01258k_0012.gif" alt="" id="fx2" /></img><div></div></div><div class="NLM_p last">The effort was next focused on C-5 optimization (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Groups were introduced at this position to evaluate the SAR effect of the size, polarity, and H-bonding ability of the substituents. Replacing the chloro atom in <b>2</b> with a larger bromo atom gave rise to compound <b>16</b>, which had similar activity (IC<sub>50</sub> = 0.047 μM). A large six-membered pyridone analogue (<b>17</b>) was clearly not tolerated with significantly decreased activity (IC<sub>50</sub> of 7.0 μM). Similar effects were observed for inhibitors (<b>19</b>, <b>20</b>, and <b>22</b>) with other polar substituents, from the larger methyl sulfone in <b>19</b>, to medium sized acetyl group in <b>20</b>, and to small hydroxyl in <b>22</b>. The complete lack of activity of <b>22</b> was quite striking. These results point to the conclusion that the enzyme surface near the C-5 substituent was highly hydrophobic and that polar functionalities were not tolerated. Further evidence of a hydrophobic pocket was provided by the good activity observed with the cyclopropyl analogue <b>18</b> and acetylene analogue <b>21</b>. Both <b>18</b> and <b>21</b> had similar potency to that of compound <b>2</b>. The breakthrough came from trifluoromethyl and trifluoromethoxy substituted compounds <b>23</b> and <b>24</b>. These two inhibitors were three times more potent than the lead compound <b>2</b> and served as the basis for further optimization at other positions of the indole ring.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> SAR Studies of <i>N</i>-1 Aromatic Substituents</h3><div class="NLM_p">Although compound <b>24</b> had improved binding (IC<sub>50</sub>), it did not possess a desirable PK profile in rats as exemplified by its negligible oral AUC value (<0.1 μM·h). Most other compounds with the 2-aminopyridinemethyl substituent at indole nitrogen (<i>N</i>-1) also displayed poor PK. This structure element was presumably responsible for the lack of exposure of these compounds in vivo. A metabolically more stable moiety was clearly desirable at the <i>N</i>-1 position. Thus, a number of <i>N</i>-1 benzyl-based substituents were investigated. Because anilines are known to have potential toxicity concerns, we decided to screen benzyl groups with substituents other than a primary amino group. The results of this SAR study are shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a> with representative compounds.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. SAR at Indole Core <i>N</i>-1 Aromatic Substituent</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-2/jm201258k/production/images/medium/jm-2011-01258k_0013.gif" alt="" id="fx3" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-2/jm201258k/production/images/medium/jm-2011-01258k_0014.gif" alt="" id="fx4" /></img><div></div></div><div class="NLM_p last">Substitution at different positions of the benzene ring was explored. The <i>para</i>-methoxy substituted benzyl analogue <b>25</b> was almost equally potent (IC<sub>50</sub> = 0.025 μM) to compound <b>24</b>, while difluoromethoxy analogue <b>26</b> was about 3-fold less active. However, simple <i>ortho</i>-methyl or fluoro substituted benzyl groups provided more potent compounds <b>27</b> and <b>28</b>, both with an IC<sub>50</sub> of 0.009 μM. Additional methyl or fluoro groups at the <i>para</i>-position in <b>29</b> or <b>30</b> caused a small drop in activity (IC<sub>50</sub> = 0.016 and 0.025 μM, respectively). In contrast, the additional substitution at either <i>meta</i>-position enhanced the potency as evidenced in compounds <b>31</b> and <b>32</b>. Both 2′-fluoro-3′-methyl substituted analogue <b>31</b> and the 2′,5′-difluoro structure <b>32</b> had excellent activities (IC<sub>50</sub> = 0.005 and 0.004 μM, respectively). Some polar functionalities such as a primary amide at the 5′-position (<b>33</b>) were not only tolerated but improved the potency (IC<sub>50</sub> = 0.007 μM) compared to <b>24</b>. Overall, the <i>N</i>-1 substituent SAR exercise improved the potency by 3–4-fold, and more importantly, several aromatic moieties that were more likely to demonstrate good PK properties were discovered. The 2′,5′-difluorobenzyl group in compound <b>32</b> was selected for further SAR investigations.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Further Optimization of C-5 Substitution</h3><div class="NLM_p">After the discovery of an <i>N</i>-1 benzyl group suitable for continued SAR development, we believed that it was necessary to re-examine C-5 substituents. We learned from earlier C-5 SAR studies (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>) that very polar substituents were not suitable for that position. Thus, a select group of nonpolar aliphatic structures were evaluated (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). The compounds bearing trifluoromethoxy (<b>23</b>) or trifluoromethyl (<b>24</b>) groups were found to be equally potent in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>. In contrast, the compound with a C-5 trifluoromethoxy group in the 2′,5′-difluorobenzyl series (<b>34</b>, IC<sub>50</sub> = 0.024 μM) was less active than the corresponding trifluoromethyl analogue (<b>32</b>, IC<sub>50</sub> = 0.004 μM). The methoxy substituted compound <b>35</b> fared slightly better (IC<sub>50</sub> = 0.015 μM), albeit slightly less active. Replacement with the larger ethoxy moiety caused a significant drop in activity in analogue <b>36</b> (IC<sub>50</sub> = 0.079 μM). The four-carbon chain 1-butenyl group, not surprisingly, gave rise to an even greater loss of potency in inhibitor <b>37</b> (IC<sub>50</sub> = 0.15 μM). A few smaller alkyl substituents, however, afforded interesting compounds with excellent IC<sub>50</sub> values. The 5-methyl analogue <b>38</b> had very good activity (IC<sub>50</sub> = 0.008 μM). The slightly larger ethyl and bromo substituents provided two inhibitors (<b>39</b>, <b>40</b>) with IC<sub>50</sub>s of 0.004 and 0.003 μM, respectively. Similar sized trifluoroethyl analogue <b>41</b> was also quite active, although with slight loss of potency compared to <b>32</b>. The bulkier <i>tert</i>-butyl and 1-methylcyclopropyl substitutions were tolerated (<b>42</b> and <b>43</b>) with IC<sub>50</sub>s of 0.008 and 0.009 μM, respectively, about 2-fold higher than that of <b>32</b>. On the basis of the overall profile of the compounds, the potential liability of the substituents and ease of synthesis, we decided to focus our future SAR studies on three small alkyl C-5 substituents that showed excellent potency: methyl, ethyl, and trifluoromethyl groups.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Optimization of C-5 Substituent</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-2/jm201258k/production/images/medium/jm-2011-01258k_0015.gif" alt="" id="fx5" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-2/jm201258k/production/images/medium/jm-2011-01258k_0016.gif" alt="" id="fx6" /></img><div></div></div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> C-2-Acylsulfonamide SAR Investigation</h3><div class="NLM_p">Although a number of C-2 carboxylic acid inhibitors examined in Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>, <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>, and <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a> demonstrated excellent potency in the enzyme assay, their activities in cellular replicon assay were much less impressive, with an EC<sub>50</sub> typically in the range of 0.1 μM to greater than 1.0 μM. For example, compound <b>38</b> had an EC<sub>50</sub> of 1.1 μM. The fact that these carboxylic acids were poorly soluble might be a factor in hindering them from cellular uptake because they existed as carboxylate salts under physiological pH. To improve replicon assay potency and solubility of these indole derivatives, the carboxylic acid moiety was replaced by an acylsulfonamide isostere. Thus, a set of simple alkyl acylsulfonamides were prepared (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>) and their potency in enzyme and cellular replicon assays was determined. Compounds <b>44</b>–<b>47</b> had a C-5 methyl substituent, while compounds <b>48</b>–<b>51</b> had a C-5 ethyl group. From the C-2 methyl acylsulfonamide (<b>44</b>) to ethyl, isopropyl, and cyclopropyl acylsulfonamides (<b>45</b>, <b>46</b>, and <b>47</b>, respectively), the potency against the enzyme remained approximately the same in a narrow range of 0.006–0.010 μM. The potency in cell-based replicon assay, however, varied significantly, but they were all better than the EC<sub>50</sub> of compound <b>38</b> (1.1 μM). The methyl sulfonamide analogue (<b>44</b>) was the least potent (EC<sub>50</sub> = 0.49 μM), but ethyl, isopropyl, and cyclopropyl sulfonamides became progressively more potent (EC<sub>50</sub> = 0.20, 0.09, 0.09 μM, for compounds <b>45</b>, <b>46</b>, and <b>47</b>, respectively). Similar trends were observed in the C-5-ethyl series. From compounds <b>48</b> to <b>51</b>, the enzyme assay activity IC<sub>50</sub> improved 2-fold from 0.006 (for <b>48</b>) to 0.003 μM (for <b>51</b>). More improvement was observed in replicon activity in this series from methyl acylsulfonamide <b>48</b> (EC<sub>50</sub> = 0.15 μM) to cyclopropyl acylsulfonamide <b>51</b> (EC<sub>50</sub> = 0.06 μM).</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. C-2-Acylsulfonamide Optimization</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-2/jm201258k/production/images/medium/jm-2011-01258k_0001.gif" alt="" id="fx7" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-2/jm201258k/production/images/medium/jm-2011-01258k_0002.gif" alt="" id="fx8" /></img><div></div></div><div class="NLM_p last">Along with the efforts to improve the enzyme and cellular assay potency, the PK profile of the compounds was evaluated and used as an important criterion to select the best compound for further investigation. The AUCs in rats after oral dosing (10 mg/kg) was measured to determine the exposure of the inhibitors in Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>. All four C-5 methyl acylsulfonamides (<b>44</b>–<b>47</b>) had good to excellent AUCs ranging from 6.8 to 22 μM·h. In the C-5-ethyl series (<b>48</b>–<b>51</b>), however, AUCs varied more significantly from extremely high for <b>48</b> (72 μM·h) to poor for <b>50</b> (0.8 μM·h). Among four more potent compounds with EC<sub>50</sub> < 0.1 μM in the table, a pair of cyclopropyl acylsulfonamides (<b>47</b> and <b>51</b>) demonstrated very good PK with AUCs of 9.1 and 12 μM·h, respectively. When both potency and PK factors were considered, the cyclopropyl acylsulfonamide was a better C-2 moiety in a given series with the same C-5 substituent and was used for further SAR studies.</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Reoptimization of C-5 and C-6 Substituents</h3><div class="NLM_p">With the <i>N</i>-1, C-2, and C-3 moieties optimized, the effects of C-5 and C-6 substituents were then revisited to determine the best combination for compounds with a C-2 acylsulfonamide. Preliminary SAR studies in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> indicated that only compact and nonpolar alkyl groups were tolerated at C-5 position, and C-6 substitution had little impact on potency. Several compact and nonpolar substituents were tested at the C-5 and C-6 (<b>51</b>–<b>60</b>, Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). They all had excellent activity against RdRp enzyme with an IC<sub>50</sub> between 0.003 and 0.008 μM. The difference in replicon assay potency, however, was significant, with EC<sub>50</sub> ranging from 0.02 μM (<b>56</b>) to 0.6 μM (<b>54</b>). Among the six compounds without C-6 substituents (R<sup>6</sup> = H), those with 1-methylcyclopropyl and trifluoroethyl at C-5 were less potent than others in the replicon assay (EC<sub>50</sub> = 0.6 μM for <b>54</b>, and EC<sub>50</sub> = 0.23 μM for <b>55</b>). Both inhibitors with trifluoromethyl and <i>tert</i>-butyl C-5 groups were slightly more active in cellular assay, with EC<sub>50</sub> values around 0.05 μM. Most compounds in this group demonstrated good PK in rats with AUCs at or above 5 μM·h, except <b>55</b>, which had a poor AUC of 0.67 μM·h.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Optimization of C-5 and C-6 Substituents</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-2/jm201258k/production/images/medium/jm-2011-01258k_0003.gif" alt="" id="fx9" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-2/jm201258k/production/images/medium/jm-2011-01258k_0004.gif" alt="" id="fx10" /></img><div></div></div><div class="NLM_p last">Five analogues with a C-6 substituent (<b>56</b>–<b>60</b>) were included in Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>. Among three compounds with a C-5-methyl group, 6-fluoro analogue <b>56</b> was much more potent (EC<sub>50</sub> = 0.02 μM) than 6-chloro and 6-trifluoromethyl analogues (EC<sub>50</sub> of 0.15 and 0.28 μM, respectively). If 6-F substitution was combined with 5-CF<sub>3</sub> or 5-ethyl groups (<b>59</b> and <b>60</b>), the results (EC<sub>50</sub> = 0.28 and 0.06 μM, respectively) were not as impressive as that of <b>56</b>. The rat oral AUC was poor for compound <b>58</b> (0.69 μM·h), good for compound <b>60</b> (6.4 μM·h), and excellent for compound <b>56</b> (14 μM·h). When the overall profiles of these compounds were evaluated, compound <b>56</b> had the best combination of potency and PK. It was selected as a potential candidate for further evaluation.</div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Profile of Compound <b>56</b></h3><div class="NLM_p last">With a calculated cLogP of 3.8 and polar-surface-area (PSA) of 100, it is not surprising to observe that compound <b>56</b> has only moderate permeability of 35 nm/s (apical to basolateral) in a Caco-2 cell permeability assay. When dosed orally in rats at 10 mg/kg, compound <b>56</b> had an excellent AUC<sub>0–24h</sub> of 14 μM·h. It also had a very high concentration of 5850 ng/g in rat livers 6 h after oral dosing. The PK of compound <b>56</b> in dogs was also robust, with a good AUC<sub>0–24h</sub> of 8.0 μM·h in 24 h after 2 mg/kg oral dosing. The clearance of the compound in human hepatocytes was low at <1.0 μL/min/Mcells. The IC<sub>50</sub>s of compound <b>56</b> against the cytochrome P450 (CYP) 2D6, 3A4, 2C9, and 2C19 enzymes (concurrent/preincubation) were all greater than 20 μM. The compound had no P450 3A4 enzyme induction signal at 10 μM in a human PXR assay. There was also no signal at 10 μM in an hERG efflux assay. This compound was selected for more comprehensive studies because of its overall superior profile.</div></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> X-ray Structure of Compound <b>56</b>.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a></h3><div class="NLM_p">The X-ray crystal structure of inhibitor <b>56</b> bound to the HCV NS5B polymerase was solved (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>, Protein Data Bank access code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3TYV">3TYV</a>).<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Similar to the X-ray structure of compound <b>1</b> bound to the enzyme, <b>56</b> also binds to the “palm” site of NS5B apoprotein within the active site cavity. The indole core makes π-stacking interactions with the benzene ring of protein backbone Tyr-448. The <i>N</i>-1 benzyl moiety of the inhibitor stacks atop the thiol side chain of Cys-366. The C-2 acylsulfonamide motif does not have direct binding with the protein, but it interacts indirectly with protein residues Ser-556, Gly-449, and Ser-288 through the formation of a hydrogen bonding network with adjacent water molecules. The indole core and the C-3 pyridone ring have contacts with the side chain of Met-414. There is a pair of hydrogen bonding interaction between the pyridone and the protein backbone, one between the pyridone oxygen and the backbone N–H of Tyr-448, the other between the pyridone N–H and the backbone carbonyl of Ile-447. Because the dihedral angle between the pyridone ring and the indole was not big, any sizable substituent at C-4 position will change the orientation of the pyridone ring and thus disrupt the two hydrogen bonds. The indole C-5 methyl and C-6 fluoro groups reach into a constricted tunnel which extends to protein surface on the other side of the “thumb” subdomain.</div><figure id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-2/jm201258k/production/images/medium/jm-2011-01258k_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-2/jm201258k/production/images/large/jm-2011-01258k_0008.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. X-ray crystal structure of compound <b>56</b> bound to HCV NS5B polymerase.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-2/jm201258k/production/images/large/jm-2011-01258k_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201258k&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_53814" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_53814" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Starting from compound <b>2</b>, an indole-based early lead inhibitor of HCV NS5B polymerase, extensive SAR development on multiple positions of the indole core was performed. While the unique and optimized 3-pyridone moiety at C-3 position was kept constant, substituents at <i>N</i>-1, C-2, C-4, C-5, and C-6 positions were varied systemically to optimize potency in both enzyme assays and cell-based replicon assays and to improve PK properties. The C-4 SAR investigation demonstrated that no substitution was tolerated. The best C-5 groups were found to be compact and nonpolar moieties. The C-6 substituents, in general, did not provide potency enhancement except in the C-5 methyl and C-6 fluoro combination series. Limited benzyl-type <i>N</i>-1 substituent studies indicated that the best substitutions were fluoro or methyl groups at 2′ or 5′ positions. The incorporation of acylsulfonamides as carboxylic acid isosteres at C-2 position improved PK properties. Further optimization of the combination at <i>N</i>-1, C-2, C-5, and C-6 positions resulted in the identification of compound <b>56</b>, which had excellent enzymatic and cellular assay potencies (IC<sub>50</sub> = 0.008 μM, EC<sub>90</sub> = 0.02 μM, respectively) and an excellent PK profile in rats and dogs (AUC = 14 and 8 μM·h, respectively). An X-ray structure of inhibitor <b>56</b> bound to the enzyme was also reported. The indole core, C-3 pyridone, C-2 acylsulfonamide, C-5 methyl, and 6-F all contributed to the high potency of compound <b>56</b>. This work demonstrated the importance of reoptimization after significant changes were made to other positions of the molecule.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_48421" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_48421" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> General Methods</h3><div class="NLM_p">Reagents and solvents, including anhydrous solvents, such as THF, dichloromethane, and DMF, were purchased from Aldrich or other commercial sources and were used without further purification. Reactions that were moisture sensitive or using anhydrous solvents were performed under either a nitrogen or an argon atmosphere. Analytical thin layer chromatography (TLC) was performed on precoated silica gel plates obtained from Analtech. Visualization was accomplished with UV light or by staining with basic KMnO<sub>4</sub> solution, ethanolic H<sub>2</sub>SO<sub>4</sub>, or Vaughn’s reagent. Some compounds were purified by flash chromatography either on a glass column using Merck silica gel 60 (230–400 mesh) or on an ISCO RediSep disposable silica gel column. More polar compounds were purified by reverse phase HPLC on a Sunfire C18 preparative column (50 mm × 250 mm, 10 μm) running at 30 mL/min using 20–100% acetonitrile/water (both as a 0.1% trifluoroacetic acid solution) as eluent. NMR spectra were recorded at 400 or 500 MHz for <sup>1</sup> H and at 100 or 125 MHz for <sup>13</sup>C on a Bruker or Varian spectrometer with CDCl<sub>3</sub> or DMSO-<i>d</i><sub>6</sub> as solvent. The chemical shifts are given in ppm, referenced to the internal TMS or deuterated solvent signal. HPLC, LC-MS, and/or <sup>1</sup>H NMR methods were employed to determine the purity of the synthesized compounds. All new compounds tested had purity at or above 95%.</div><div class="NLM_p">General procedures for iodination of <b>3</b>: The solution of compound <b>3</b> (1 mmol) and <i>N</i>-iodosuccinimide (NIS) (1.05 mmol) in acetone (15 mL) was stirred at room temperature (rt) for 3 h (h). Saturated aqueous sodium thiosulfate (5 mL) was added. After stirring for 5 min (min), ethyl acetate (30 mL) and water (20 mL) were added. The layers were then separated. The aqueous solution was extracted with ethyl acetate (2 × 25 mL). The combined organic layer was washed with brine, dried over magnesium sulfate, and concentrated in vacuo to give the crude product, which was usually pure enough to be used in the next reaction.</div><div class="NLM_p">General procedures for Suzuki coupling between <b>4</b> and 2-methoxy-3-pyridine boronic acid (<b>5</b>): To the suspension of 3-iodoindole (<b>4</b>, 10.0 mmol) and [1,1′-bis(diphenylphosphino)ferrocene] dichloropalladium (PdCl<sub>2</sub>(dppf)<sub>2</sub>) (1.0 mmol) in dimethoxyethane (DME) (120 mL) at rt was added a solution of boronic acid (<b>5</b>) (12.0 mmol) and potassium carbonate (50 mmol) in water (30 mL). The mixture was bubbled with argon gas through a frit glass bubbler for 5 min before it was heated to 90 °C in an oil bath and stirred for 4 h. After cooling to rt, the mixture was diluted with water and ethyl acetate (300 mL each) and the two layers were separated. The aqueous solution was extracted with ethyl acetate (2 × 200 mL). The combined organic solution was washed with brine, dried over magnesium sulfate, and concentrated in vacuo to give the crude product, which was purified by silica gel flash chromatography using 0–50% ethyl acetate in hexanes as eluent to give the desired product (<b>6</b>) in 50–85% yield.</div><div class="NLM_p">General procedures for the preparation of <b>7</b>: The mixture of <b>6</b> (5.0 mmol), arylmethyl bromide (or arylmethyl chloride) (7.5 mmol), and cesium carbonate (7.5 mmol) in anhydrous dimethylformamide (DMF) (80 mL) was vigorously stirred at rt for 16 h. The solution was then diluted with water and ethyl acetate (200 mL each), and the two layers were separated. The aqueous solution was extracted with ethyl acetate (100 mL). The combined organic solution was washed with water (2 × 300 mL), brine, dried over magnesium sulfate, and concentrated in vacuo to give the crude product, which was purified by silica gel flash chromatography using 0–60% ethyl acetate in hexanes as eluent to give the desired product (<b>7</b>) in 40–90% yield.</div><div class="NLM_p">General procedures for the preparation of <b>8</b>: Compound <b>7</b> (1.0 mmol) was dissolved in a solution of 4 M hydrogen chloride in <i>p</i>-dioxane (50 mL) in a sealed tube. The solution was then heated to 90 °C in an oil bath and stirred for 3 h before it was cooled to rt. The solution was then concentrated in vacuo to give the crude product, which was usually pure enough to be used in the next reaction.</div><div class="NLM_p">General procedures for the preparation of <b>9</b>: Compound <b>8</b> (1.0 mmol) and lithium hydroxide (4.0 mmol) was dissolved in THF and water (10 mL each). The solution was then heated to 70 °C in an oil bath and stirred for 16 h before it was cooled to rt. The solution was then made acidic (pH ∼ 2) by addition of 1 N hydrochloric acid. Ethyl acetate was added (30 mL), and layers were separated. The aqueous solution was extracted with ethyl acetate (2 × 20 mL). The combined organic solution was washed with brine, dried over magnesium sulfate, and concentrated in vacuo to give the crude product, which was purified by reverse phase HPLC to give the desired product (<b>9</b>) in 30–60% yield (2 steps).</div><div class="NLM_p">General procedures for the preparation of <b>10</b>: Compound <b>10</b> was prepared from compound <b>7</b> according to the same procedures described above for the preparation of <b>9</b>. The crude product was usually pure enough to be used in the next reaction.</div><div class="NLM_p">General procedures for the preparation of <b>11</b>: The mixture of <b>10</b> (0.50 mmol) and carbonyl diimidazole (CDI) (0.60 mmol) in anhydrous THF (5 mL) was heated to 75 °C in an oil bath and stirred 1.5 h. The solution was then cooled to rt, alkyl sulfonamide and DBU (1.5 mmol each) were added, and the resulting mixture was stirred at rt for 18 h. It was then diluted with water and ethyl acetate (30 mL each), and the two layers were separated. The aqueous solution was extracted with ethyl acetate (2 × 15 mL). The combined organic solutions were washed with brine, dried over magnesium sulfate, and concentrated in vacuo to give the crude product, which was purified by silica gel flash chromatography using 0–80% acetone in dichloromethane as eluent to give the desired product (<b>11</b>) in 50–80% yield.</div><div class="NLM_p last">General procedures for the preparation of <b>12</b>: Compound <b>12</b> was prepared from compound <b>11</b> according to the same procedures described above for the preparation of <b>8</b>. The crude product was purified by reverse phase HPLC to give the desired product (<b>12</b>) in 30–50% yield.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> 1-[(2-Amino-4-pyridinyl)methyl]-4,5-dichloro-3-(1,2-dihydro-2-oxo-3-pyridinyl)-1<i>H</i>-indole-2-carboxylic Acid (<b>13</b>)</h3><div class="NLM_p last">Compound <b>13</b> was prepared according to the reaction sequence outlined in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a> and the general procedures described above for the preparation of generic compound <b>9</b>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>), 11.36 (s, 2 H), 7.76 (d, <i>J</i> = 5.2 Hz, 1 H), 7.36 (q, <i>J</i> = 1.9 Hz, 1 H), 7.27 (s, 2 H), 7.18 (q, 8.9 Hz, 2 H), 6.28 (d, <i>J</i> = 5.4 Hz, 1 H), 6.14 (s, 2 H), 5.79 (s, 2 H), 5.60 (d, <i>J =</i> 16.8 Hz, 1 H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>), 168.9, 163.8, 160.7, 148.5, 147.9, 145.0, 143.3, 135.6, 134.3, 127.5, 111.4, 111.1, 110.9, 110.0, 106.2, 98.7, 67.9, 47.4, 27.8, 19.2. HRMS calcd for C<sub>20</sub>H<sub>15</sub>Cl<sub>2</sub>N<sub>4</sub>O<sub>3</sub> (M + H)<sup>+</sup>, 429.0521; found, 429.0517.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> 1-[(2-Amino-4-pyridinyl)methyl]-4-bromo-3-(1,2-dihydro-2-oxo-3-pyridinyl)-1<i>H</i>-indole-2-carboxylic Acid (<b>14</b>)</h3><div class="NLM_p last">Compound <b>14</b> was prepared according to the reaction sequence outlined in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a> and the general procedures described above for the preparation of generic compound <b>9</b>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>), 13.44 (s, 1 H), 11.58 (s, 1 H), 7.90 (d, <i>J =</i> 6.0 Hz, 1 H), 7.76 (s, 2 H), 7.59 (d, <i>J =</i> 8.1 Hz, 1 H), 7.40–7.38 (m, 3 H), 7.24 (t, <i>J =</i> 7.9 Hz, 1 H), 6.58 (d, <i>J =</i> 5.8 Hz, 1 H), 6.30 (s, 1 H), 6.24 (t, <i>J =</i> 6.4 Hz, 1 H), 4.38 (q, <i>J =</i> 18.0 Hz, 2 H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>), 163.3, 163.0, 156.1, 155.7, 142.1, 139.7, 138.2, 135.3, 128.5, 127.1, 126.9, 126.3, 125.0, 120.8, 116.1, 111.5, 111.2, 109.0, 105.4, 48.2. HRMS calcd for C<sub>20</sub>H<sub>16</sub>N<sub>4</sub>O<sub>3</sub>Br (M + H)<sup>+</sup>, 439.0406; found LRMS, 439.0.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> 1-[(2-Amino-4-pyridinyl)methyl]-5-bromo-3-(1,2-dihydro-2-oxo-3-pyridinyl)-1<i>H</i>-indole-2-carboxylic Acid (<b>16</b>)</h3><div class="NLM_p last">Compound <b>16</b> was prepared according to the reaction sequence outlined in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a> and the general procedures described above for the preparation of generic compound <b>9</b>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>), 11.97 (s, 1 H), 8.44 (s, 1 H), 7.74 (s, 1 H), 7.58 (s, 1 H), 7.42 (s, 2 H), 7.18 (s, 2 H), 6.27 (s, 2 H), 6.20 (s, 1 H) 5.80 (s, 2 H), 5.59 (s, 2 H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>), 165.8, 162.9, 160.7, 149.3, 148.5, 141.6, 135.0, 129.7, 124.4, 123.8, 113.0, 112.4, 111.4, 109.7, 109.5, 106.4, 100.4, 97.0, 96.4, 93.5, 81.5, 74.3, 62.6, 52.1, 48.3, 47.4, 44.1. HRMS calcd for C<sub>20</sub>H<sub>16</sub>N<sub>4</sub>O<sub>3</sub>Br (M + H)<sup>+</sup>, 439.0406; found, 439.0398.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> 5-Acetyl-1-[(2-amino-4-pyridinyl)methyl]-3-(1,2-dihydro-2-oxo-3-pyridinyl)-1<i>H</i>-indole-2-carboxylic Acid (<b>20</b>)</h3><div class="NLM_p last">Compound <b>20</b> was prepared according to the reaction sequence outlined in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a> and the general procedures described above for the preparation of generic compound <b>9</b>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>), 11.96 (s, 2 H), 8.12 (s, 1 H), 8.00 (s, 2 H), 7.95–7.91 (m, 3 H), 7.66 (d, <i>J</i> = 8.9 Hz, 1 H), 7.57 (d, <i>J</i> = 7.8 Hz, 1 H), 6.56 (d, <i>J</i> = 6.0 Hz, 1 H), 6.40 (d, <i>J</i> = 6.6 Hz, 1 H), 6.36 (s, 1 H), 5.87 (s, 2 H), 2.59 (s, 3 H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>), 198.1, 163.5, 162.1, 156.4, 155.4, 141.5, 140.6, 137.4, 135.6, 131.5, 129.4, 126.5, 125.7, 125.5, 123.5, 120.3, 111.8, 111.2, 109.4, 106.1, 48.2, 27.6. LRMS calcd for C<sub>22</sub>H<sub>19</sub>N<sub>4</sub>O<sub>4</sub> (M + H)<sup>+</sup>, 403.1; found: 403.2.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> 1-[(2-Amino-4-pyridinyl)methyl]-3-(1,2-dihydro-2-oxo-3-pyridinyl)-5-(trifluoromethyl)-1<i>H</i>-indole-2-carboxylic Acid (<b>24</b>)</h3><div class="NLM_p last">Compound <b>24</b> was prepared according to the reaction sequence outlined in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a> and the general procedures described above for the preparation of generic compound <b>9</b>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>), 13.78 (s, 1 H), 11.90 (s, 1 H), 8.03 (s, 2 H), 7.92 (d, <i>J</i> = 6.7 Hz, 1 H), 7.82 (s, 1 H), 7.80 (s, 1 H), 7.66–7.61 (m, 2 H), 7.47 (q, <i>J</i> = 1.9 Hz,1 H), 6.63 (q, <i>J</i> = 1.3 Hz, 1 H), 6.38–6.35 (m, 2 H), 5.90 (s, 2 H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>), 163.4, 162.0, 156.8, 155.0, 141.7, 139.7, 136.9, 135.8, 129.7, 125.1, 124.8, 122.9, 122.6, 122.1, 119.7, 119.5, 119.4, 113.0, 111.2, 109.5, 106.0, 48.2. LRMS calcd for C<sub>21</sub>H<sub>16</sub>F<sub>3</sub>N<sub>4</sub>O<sub>3</sub> (M + H)<sup>+</sup>, 429.1; found, 429.0.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> 1-[(2,4-Difluorophenyl)methyl]-3-(1,2-dihydro-2-oxo-3-pyridinyl)-5-(trifluoromethyl)-1<i>H</i>-indole-2-carboxylic Acid (<b>30</b>)</h3><div class="NLM_p last">Compound <b>30</b> was prepared according to the reaction sequence outlined in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a> and the general procedures described above for the preparation of generic compound <b>9</b>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>), 13.25 (s, 1 H), 11.83 (s, 1 H), 7.84 (d, <i>J</i> = 8.8 Hz, 1 H), 7.75 (s, 1 H), 7.62–7.60 (m, 2 H), 7.44 (dd, <i>J</i> = 1.9, 1.5 Hz,1 H), 7.30–7.25 (m, 1 H), 7.00–6.96 (m, 1 H), 6.81–6.77 (m, 1 H), 6.34 (t, <i>J</i> = 6.6 Hz, 1 H), 5.91 (s, 2 H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>), 163.6, 162.1, 161.5, 161.4, 159.6, 159.5, 141.4, 139.6, 135.6, 130.3, 130.2, 130.1, 127.0, 126.1, 125.2, 124.8, 122.6, 122.4, 122.3, 122.2, 122.1, 121.7, 119.2, 119.1, 119.0, 113.0, 112.6, 112.5, 112.4, 106.0, 105.1, 104.9, 104.7, 42.4. LRMS calcd for C<sub>22</sub>H<sub>14</sub>F<sub>5</sub>N<sub>2</sub>O<sub>3</sub> (M + H)<sup>+</sup>, 449.1; found, 449.0.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> 1-[(2,5-Difluorophenyl)methyl]-3-(1,2-dihydro-2-oxo-3-pyridinyl)-5-(trifluoromethyl)-1<i>H</i>-indole-2-carboxylic Acid (<b>32</b>)</h3><div class="NLM_p last">Compound <b>32</b> was prepared according to the reaction sequence outlined in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a> and the general procedures described above for the preparation of generic compound <b>9</b>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>), 13.28 (s, 1 H), 11.83 (s, 1 H), 7.85 (d, <i>J</i> = 7.5 Hz, 1 H), 7.76 (s, 1 H), 7.64 (s, 2 H), 7.45 (s, 1 H), 7.32–7.38 (m, 1 H), 7.16 (d, <i>J</i> = 2.7 Hz, 1 H), 6.50 (s, 1 H), 6.35 (s, 1 H), 5.93 (s, 2 H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>), 163.6, 162.1, 159.9, 157.6, 141.4, 139.5, 135.6, 129.8, 128.0, 127.0, 126.1, 121.8, 119.3, 119.2, 118.0, 117.9, 116.6, 116.5, 115.4, 115.3, 115.2, 113.0, 106.0, 42.9. LRMS calcd for C<sub>22</sub>H<sub>14</sub>F<sub>5</sub>N<sub>2</sub>O<sub>3</sub> (M + H)<sup>+</sup>, 449.1; found, 449.1.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> 1-[(2,5-Difluorophenyl)methyl]-3-(1,2-dihydro-2-oxo-3-pyridinyl)-5-(trifluoromethoxy)-1<i>H</i>-indole-2-carboxylic Acid (<b>34</b>)</h3><div class="NLM_p last">Compound <b>34</b> was prepared according to the reaction sequence outlined in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a> and the general procedures described above for the preparation of generic compound <b>9</b>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>), 11.82 (s, 1 H), 7.72 (d, <i>J</i> = 9.2 Hz, 1 H), 7.59 (dd, <i>J</i> = 1.94, 1.77 Hz, 1 H), 7.43 (dd, <i>J</i> = 1.90, 1.54 Hz, 1 H), 7.36 (s, 1 H), 7.32–7.28 (m, 1 H), 7.18–7.14 (m, 1 H), 6.54–6.50 (m, 1 H), 6.34 (t, <i>J</i> = 6.6 Hz, 1 H), 5.88 (s, 2 H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>), 163.7, 162.1, 161.1, 159.1, 158.0, 150.7, 143.8, 141.2, 138.2, 137.2, 128.1, 127.0, 118.1, 118.0, 117.9, 117.8, 116.4, 115.3, 113.6, 113.3, 103.0, 94.5, 67.2, 42.7, 30.0, 24.2. HRMS calcd for C<sub>22</sub>H<sub>14</sub>F<sub>5</sub>N<sub>2</sub>O<sub>4</sub> (M + H)<sup>+</sup>, 465.0874; found, 465.0868.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> 1-[(2,5-Difluorophenyl)methyl]-3-(1,2-dihydro-2-oxo-3-pyridinyl)-5-(methoxy)-1<i>H</i>-indole-2-carboxylic Acid (<b>35</b>)</h3><div class="NLM_p last">Compound <b>35</b> was prepared according to the reaction sequence outlined in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a> and the general procedures described above for the preparation of generic compound <b>9</b>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>), 12.98 (s, 1 H), 11.79 (s, 1 H), 7.59 (q, <i>J</i> = 2.4 Hz, 1 H), 7.50 (d, <i>J</i> = 9.2 Hz, 1 H), 7.41 (q, <i>J</i> = 3.6 Hz, 1 H), 7.31–7.27 (m, 1 H), 7.16–7.11 (m, 1 H), 6.98 (q, <i>J</i> = 2.6 Hz, 1 H), 6.86 (d, <i>J</i> = 2.5 Hz, 1 H), 6.37–6.33 (m, 2 H), 5.83 (s, 2 H), 3.73 (s, 3 H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>), 174.4, 172.8, 166.0, 151.3, 145.4, 144.1, 138.8, 137.6, 137.0, 128.4, 128.2, 127.3, 126.7, 125.6, 125.4, 123.2, 120.8, 116.6, 112.4, 66.7, 52.9. LRMS calcd for C<sub>22</sub>H<sub>17</sub>F<sub>2</sub>N<sub>2</sub>O<sub>4</sub> (M + H)<sup>+</sup>, 411.1; found, 411.2.</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> 1-[(2,5-Difluorophenyl)methyl]-3-(1,2-dihydro-2-oxo-3-pyridinyl)-5-ethoxy)-1<i>H</i>-indole-2-carboxylic Acid (<b>36</b>)</h3><div class="NLM_p last">Compound <b>36</b> was prepared according to the reaction sequence outlined in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a> and the general procedures described above for the preparation of generic compound <b>9</b>.<sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>), 11.76 (s, 1 H), 7.58 (q, <i>J</i> = 2.1 Hz, 1 H), 7.48 (d, <i>J</i> = 9.1 Hz, 1 H), 7.40 (q, <i>J</i> = 2.0 Hz, 1 H), 7.30–7.27 (m, 1 H), 7.15–7.11 (m, 1 H), 6.97 (q, <i>J</i> = 2.6 Hz, 1 H), 6.84 (d, <i>J</i> = 2.1 Hz, 1 H), 6.38–6.33 (m, 2 H), 5.82 (s, 2 H), 3.99–3.95 (m, 2 H), 1.30 (t, <i>J</i> = 6.9 Hz, 3 H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>), 174.4, 172.8, 170.4, 168.5, 167.9, 166.0, 165.2, 151.4, 145.4, 144.0, 139.2, 138.8, 137.7, 136.9, 128.4, 128.2, 127.6, 126.8, 126.7, 125.6, 125.4, 123.3, 123.1, 121.0, 120.8, 116.7, 113.4, 74.8, 52.9, 26.1. LRMS calcd for C<sub>23</sub>H<sub>19</sub>F<sub>2</sub>N<sub>2</sub>O<sub>4</sub> (M + H)<sup>+</sup>, 425.1; found, 425.1.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> 1-[(2,5-Difluorophenyl)methyl]-3-(1,2-dihydro-2-oxo-3-pyridinyl)-5-methyl-1<i>H</i>-indole-2-carboxylic Acid (<b>38</b>)</h3><div class="NLM_p last">Compound <b>38</b> was prepared according to the reaction sequence outlined in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a> and the general procedures described above for the preparation of generic compound <b>9</b>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>), 13.0 (s, 1 H), 11.8 (s, 1 H), 7.56 (dd, <i>J</i> = 2.2, 1.9 Hz, 1 H), 7.5 (d, <i>J</i> = 8.6 Hz, 1 H), 7.41 (d, <i>J</i> = 6.3 Hz, 1 H), 7.32–7.27 (m, 1 H), 7.24 (s, 1 H), 7.17–7.08 (m, 2 H), 6.37–6.33 (m, 2 H), 5.83 (s, 2 H), 2.36 (s, 3 H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>), 181.8, 181.4, 177.0, 174.5, 172.8, 152.8, 151.5, 147.3, 145.6, 141.2, 138.2, 137.5, 136.3, 131.2, 128.4, 121.9, 113.7, 113.1, 112.4, 78.4, 66.3, 59.9, 41.8, 36.6, 36.5, 32.4. LRMS calcd for C<sub>22</sub>H<sub>17</sub>F<sub>2</sub>N<sub>2</sub>O<sub>3</sub> (M + H)<sup>+</sup>, 395.1; found, 395.0.</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> 1-[(2,5-Difluorophenyl)methyl]-3-(1,2-dihydro-2-oxo-3-pyridinyl)-5-ethyl-1<i>H</i>-indole-2-carboxylic Acid (<b>39</b>)</h3><div class="NLM_p last">Compound <b>39</b> was prepared according to the reaction sequence outlined in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a> and the general procedures described above for the preparation of generic compound <b>9</b>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>), 12.97 (s, 1 H), 11.78 (s, 1 H), 7.58 (dd, <i>J</i> = 1.8, 2.2 Hz, 1 H), 7.49 (d, <i>J</i> = 8.5 Hz, 1 H), 7.42 (d, <i>J</i> = 4.8 Hz, 1 H), 7.32–7.27 (m, 1 H), 7.24 (s, 1 H), 7.20 (d, <i>J =</i>8.4 Hz, 1 H), 7.17–7.11 (m, 1 H), 1.18 (t, <i>J =</i>7.6 Hz, 3 H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>), 164.0, 162.3, 159.4, 158.0, 157.5, 155.6, 141.0, 137.4, 137.0, 135.0, 128.0, 127.0, 126.6, 119.5, 118.1, 118.0, 117.9, 117.8, 117.7, 116.4, 116.3, 116.2, 116.1, 115.2, 115.0, 106.1, 29.1, 17.1. HRMS calcd for C<sub>23</sub>H<sub>19</sub>F<sub>2</sub>N<sub>2</sub>O<sub>4</sub> (M + H)<sup>+</sup>, 409.1364; found, 409.1358.</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> 5-Bromo-1-[(2,5-difluorophenyl)methyl]-3-(1,2-dihydro-2-oxo-3-pyridinyl)-1<i>H</i>-indole-2-carboxylic Acid (<b>40</b>)</h3><div class="NLM_p last">Compound <b>40</b> was prepared according to the reaction sequence outlined in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a> and the general procedures described above for the preparation of generic compound <b>9</b>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>), 13.14 (s, 1 H), 11.80 (s, 1 H), 7.62–7.58 (m, 3 H), 7.45 (dd, <i>J</i> = 1.9, 1.9 Hz, 1 H), 7.42 (dd, <i>J</i> = 1.7, 1.9 Hz, 1 H), 7.32–7.27 (m, 1 H), 7.18–7.14 (m, 1 H), 6.45–6.41 (m, 1 H), 6.33 (t, <i>J</i> = 6.6 Hz, 1 H), 5.86 (s, 2 H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>), 163.6, 162.1, 160.5, 147.2, 141.4, 136.9, 129.2, 128.5, 128.3, 123.6, 119.3, 119.1, 117.9, 117.7, 115.3, 114.3, 114.0, 109.1, 106.2, 55.9, 48.8, 42.6. LRMS calcd for C<sub>21</sub>H<sub>14</sub>F<sub>2</sub>N<sub>2</sub>O<sub>3</sub>Br (M + H)<sup>+</sup>, 459.0, 461.0; found, 461.3.</div></div><div id="sec4_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> 1-[(2,5-Difluorophenyl)methyl]-3-(1,2-dihydro-2-oxo-3-pyridinyl)-5-(1,1-dimethylethyl)-1<i>H</i>-indole-2-carboxylic Acid (<b>42</b>)</h3><div class="NLM_p last">Compound <b>42</b> was prepared according to the reaction sequence outlined in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a> and the general procedures described above for the preparation of generic compound <b>9</b>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>), 12.99 (s, 1 H), 11.83 (s, 1 H), 7.58 (q, <i>J</i> = 1.9 Hz, 1 H), 7.50 (d, <i>J</i> = 8.8 Hz, 1 H), 7.45–7.41 (m, 2 H), 7.36 (s, 1 H), 7.32–7.29 (m, 1 H), 7.17–7.12 (m, 1 H), 6.44–6.40 (m, 1 H), 6.36 (t, <i>J</i> = 6.7 Hz, 1 H), 5.83 (s, 2 H), 1.29 (s, 9 H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>), 174.5, 172.8, 170.4, 168.5, 168.0. 166.1, 154.7, 151.5, 147.1, 145.5, 139.1, 138.4, 136.9, 135.0, 129.0, 128.5, 128.4, 128.3, 128.2, 126.9, 126.8, 126.7, 125.8, 125.7, 125.6, 125.5, 121.8, 116.6, 52.8, 45.7, 42.8. LRMS calcd for C<sub>25</sub>H<sub>23</sub>F<sub>2</sub>N<sub>2</sub>O<sub>3</sub> (M + H)<sup>+</sup>, 437.2; found, 437.3.</div></div><div id="sec4_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> 1-[(2,5-Difluorophenyl)methyl]-3-(1,2-dihydro-2-oxo-3-pyridinyl)-5-methyl-<i>N</i>-methylsulfonyl)-1<i>H</i>-indole-2-carboxamide (<b>44</b>)</h3><div class="NLM_p last">Compound <b>44</b> was prepared according to the reaction sequence outlined in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a> and the general procedures described above for the preparation of generic compound <b>12</b>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>), 12.77 (s, 1 H), 12.64 (s, 1 H), 7.82 (d, <i>J</i> = 9.7 Hz, 1 H), 7.66 (s, 1 H), 7.50 (d, <i>J</i> = 8.5 Hz, 1 H), 7.32–7.27 (m, 1 H), 7.23 (s, 1 H), 7.19 (d, <i>J</i> = 8.6 Hz, 1 H), 7.18–7.14 (m, 1 H), 6.60 (s, 2 H), 5.71 (s, 2 H), 3.25 (s, 3 H), 2.36 (s, 3 H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>), 159.9, 158.0, 157.6, 155.7, 136.9, 136.4, 131.2, 128.1, 127.2, 125.8, 120.7, 118.0, 117.9, 117.8, 117.7, 116.7, 116.6, 116.5, 116.4, 115.9, 115.7, 111.6, 108.2, 44.0, 42.5, 42.1, 41.0, 31.3, 21.9. HRMS calcd for C<sub>23</sub>H<sub>20</sub>F<sub>2</sub>N<sub>3</sub>O<sub>4</sub>S (M + H)<sup>+</sup>, 472.1143; found, 472.1137.</div></div><div id="sec4_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> 1-[(2,5-Difluorophenyl)methyl]-3-(1,2-dihydro-2-oxo-3-pyridinyl)-<i>N</i>-(ethylsulfonyl)-5-methyl-1<i>H</i>-indole-2-carboxamide (<b>45</b>)</h3><div class="NLM_p last">Compound <b>45</b> was prepared according to the reaction sequence outlined in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a> and the general procedures described above for the preparation of generic compound <b>12</b>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>), 12.73 (s, 1 H), 7.82 (d, <i>J</i> = 6.0 Hz, 1 H), 7.68 (s, 1 H), 7.54 (d, <i>J</i> = 9.5 Hz, 1 H), 7.32–7.27 (m, 1 H), 7.21 (s, 2 H), 7.18–7.13 (m, 1 H), 6.63 (t, <i>J</i> = 6.3 Hz, 1 H), 6.56- 6.52 (m, 1 H), 5.72 (s, 2 H), 3.35 (q, <i>J</i> = 7.3 Hz, 2 H), 2.36 (s, 3 H), 1.05 (t, <i>J</i> = 7.3 Hz, 3 H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>), 163.5, 162.0, 159.0, 158.0, 157.6, 155.7, 145.1, 140.1, 136.6, 131.3, 128.2, 127.9, 127.2, 120.7, 118.0, 117.9, 117.8, 117.7, 115.8, 115.5, 111.6, 108.3, 52.4, 47.7, 42.4, 31.3, 30.1, 21.9, 8.3. HRMS calcd for C<sub>24</sub>H<sub>22</sub>F<sub>2</sub>N<sub>3</sub>O<sub>4</sub>S (M + H)<sup>+</sup>, 486.1299; found, 486.1295.</div></div><div id="sec4_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> 1-[(2,5-Difluorophenyl)methyl]-3-(1,2-dihydro-2-oxo-3-pyridinyl)-5-methyl-<i>N</i>-[(1-methylethyl)sulfonyl)-1<i>H</i>-indole-2-carboxamide (<b>46</b>)</h3><div class="NLM_p last">Compound <b>46</b> was prepared according to the reaction sequence outlined in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a> and the general procedures described above for the preparation of generic compound <b>12</b>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>), 12.78 (s, 1 H), 12.70 (s, 1 H), 7.83 (d, <i>J</i> = 7.0 Hz, 1 H), 7.70 (s, 1 H), 7.55 (d, <i>J</i> = 8.6 Hz, 1 H), 7.32–7.27 (m, 1 H), 7.22–7.12 (m, 3 H), 6.64 (t, <i>J</i> = 6.60 Hz, 1 H), 6.53–6.49 (m, 1 H), 5.73 (s, 2 H), 3.64–3.56 (m 1 H), 2.36 (s, 3 H), 1.14 (d, <i>J</i> = 6.9 Hz, 6H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>), 163.6, 162.0, 160.0, 157.6, 155.7, 145.2, 137.1, 136.6, 131.3, 129.4, 128.3, 127.2, 123.8, 120.7, 118.0, 117.9, 117.8, 117.7, 116.6, 116.5, 116.4, 115.9, 115.7, 115.5, 111.6, 108.4, 53.6, 42.4, 21.9, 16.1. LRMS calcd for C<sub>25</sub>H<sub>24</sub>F<sub>2</sub>N<sub>3</sub>O<sub>4</sub>S (M + H)<sup>+</sup>, 500.1; found, 500.3</div></div><div id="sec4_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> <i>N</i>-(Cyclopropylsulfonyl)-1-[(2,5-difluorophenyl)methyl]-3-(1,2-dihydro-2-oxo-3-pyridinyl)-5-methyl-1<i>H</i>-indole-2-carboxamide (<b>47</b>)</h3><div class="NLM_p last">Compound <b>47</b> was prepared according to the reaction sequence outlined in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a> and the general procedures described above for the preparation of generic compound <b>12</b>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>), 12.79 (s, 1 H), 12.71 (s, 1 H), 7.81 (q, <i>J</i> = 1.9 Hz, 1 H), 7.69 (s, 1 H), 7.54–7.52 (m, 1 H), 7.32–7.27 (m, 1 H), 7.21–7.20 (m, 2 H), 7.18–7.13 (m, 1 H), 6.64–6.16 (m, 1 H), 6.60–6.56 (m, 1 H), 5.73 (s, 2 H), 2.97–2.91 (m, 1 H), 2.36 (s, 3 H), 0.97 (d, <i>J</i> = 6.3 Hz, 4 H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>), 163.5, 161.9, 160.0, 158.0, 157.6, 155.7, 145.0, 136.9, 136.5, 131.2, 128.1, 127.9, 127.2, 123.9, 120.7, 118.0, 117.9, 117.8, 117.7, 116.6, 115.9, 115.8, 111.6, 108.3, 42.4, 31.5, 21.9, 6.3. LRMS calcd for C<sub>25</sub>H<sub>22</sub>F<sub>2</sub>N<sub>3</sub>O<sub>4</sub>S (M + H)<sup>+</sup>, 498.1; found, 498.3.</div></div><div id="sec4_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> 1-[(2,5-Difluorophenyl)methyl]-3-(1,2-dihydro-2-oxo-3-pyridinyl)-5-ethyl-<i>N</i>-(methylsulfonyl)-1<i>H</i>-indole-2-carboxamide (<b>48</b>)</h3><div class="NLM_p last">Compound <b>48</b> was prepared according to the reaction sequence outlined in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a> and the general procedures described above for the preparation of generic compound <b>12</b>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>), 12.77 (s, 1 H), 12.64 (s, 1 H), 7.82 (d, <i>J</i> = 6.4 Hz, 1 H), 7.66 (s, 1 H), 7.53 (d, 8.9 Hz, 1 H), 7.32–7.27 (m, 1 H), 7.25 (s, 1 H), 7.24 (s, 1 H), 7.18–7.13 (m, 1 H), 6.63–6.6 (m, 1 H), 5.7 (s, 2 H), 3.25 (s, 3 H), 2.66 (q, <i>J</i> = 7.5 Hz, 2 H), 1.18 (t, <i>J</i> = 7.4 Hz, 3 H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>), 163.4, 159.9, 158.0, 157.6, 155.7, 155.6, 144.7, 137.9, 137.0, 136.4, 127.1, 119.5, 118.0, 117.8, 117.7, 116.7, 116.6, 116.0, 116.4, 115.9, 115.8, 115.7, 111.7, 108.2, 42.5, 42.0, 29.1, 17.0. LRMS calcd for C<sub>24</sub>H<sub>22</sub>F<sub>2</sub>N<sub>3</sub>O<sub>4</sub>S (M + H)<sup>+</sup>, 486.1; found, 486.0.</div></div><div id="sec4_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> 1-[(2,5-Difluorophenyl)methyl]-3-(1,2-dihydro-2-oxo-3-pyridinyl)-5-ethyl-<i>N</i>-(ethylsulfonyl)-1<i>H</i>-indole-2-carboxamide (<b>49</b>)</h3><div class="NLM_p last">Compound <b>49</b> was prepared according to the reaction sequence outlined in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a> and the general procedures described above for the preparation of generic compound <b>12</b>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>), 12.72 (s, 2 H), 7.83 (dd, <i>J</i> = 1.7, 1.8 Hz, 1 H), 7.69 (s, 1 H), 7.56 (d, <i>J</i> = 8.5 Hz, 1 H), 7.32–7.27 (m, 1 H), 7.25 (d, <i>J</i> = 8.9 Hz, 1 H), 7.21 (s, 1 H), 7.19–7.14 (m, 1 H), 6.65–6.57 (m, 2 H), 5.72 (s, 1 H), 3.35 (q, <i>J</i> = 7.3 Hz, 2 H), 2.66 (q, <i>J</i> = 7.5 Hz, 2 H), 1.18 (t, <i>J</i> = 7.6 Hz, 3 H), 1.05 (t, <i>J</i> = 7.4 Hz, 3 H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>), 163.5, 162.1, 159.9, 158.0, 157.6, 155.7, 145.1, 140.0, 137.9, 137.1, 136.6, 127.2, 119.5, 118.0, 117.9, 117.8, 117.7, 116.7, 116.6, 116.5, 115.8, 115.6, 111.7, 108.4, 47.7, 42.5, 31.3, 29.1, 17.0, 8.3. LRMS calcd for C<sub>25</sub>H<sub>24</sub>F<sub>2</sub>N<sub>3</sub>O<sub>4</sub>S (M + H)<sup>+</sup>, 500.1; found, 500.0.</div></div><div id="sec4_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> 1-[(2,5-Difluorophenyl)methyl]-3-(1,2-dihydro-2-oxo-3-pyridinyl)-5-ethyl-<i>N</i>-[(1-methylethyl)sulfonyl)-1<i>H</i>-indole-2-carboxamide (<b>50</b>)</h3><div class="NLM_p last">Compound <b>50</b> was prepared according to the reaction sequence outlined in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a> and the general procedures described above for the preparation of generic compound <b>12</b>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>), 12.79 (s, 1 H), 12.70 (s, 1 H), 7.83 (d, <i>J</i> = 5.4 Hz, 1 H), 7.70 (s, 1 H), 7.57 (d, <i>J</i> = 8.4 Hz, 1 H), 7.32–7.25 (m, 2 H), 7.20 (s, 1 H), 7.18–7.14 (m, 1 H), 6.64 (t, <i>J</i> = 6.6 Hz, 1 H), 6.56–6.53 (m, 1 H), 5.73 (s, 2 H), 3.62–3.57 (m, 1 H), 2.66 (q, <i>J</i> = 7.5 Hz, 2 H), 1.18 (d, <i>J</i> = 7.5 Hz, 3 H), 1.15 (d, <i>J</i> = 6.6 Hz, 6H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>), 163.6, 162.0, 160.0, 158.0, 157.6, 155.7, 145.3, 137.9, 137.2, 136.7, 128.0, 127.2, 123.8, 119.5, 118.0, 117.9, 117.8, 117.7, 116.7, 116.5, 116.4, 116.0, 115.8, 111.7, 108.5, 53.6, 42.5, 29.1, 17.0, 16.1. LRMS calcd for C<sub>26</sub>H<sub>26</sub>F<sub>2</sub>N<sub>3</sub>O<sub>4</sub>S (M + H)<sup>+</sup>, 514.2; found, 514.1.</div></div><div id="sec4_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> <i>N</i>-(Cyclopropylsulfonyl)-1-[(2,5-difluorophenyl)-methyl]-3-(1,2-dihydro-2-oxo-3-pyridinyl)-5-ethyl-1<i>H</i>-indole-2-carboxamide (<b>51</b>)</h3><div class="NLM_p last">Compound <b>51</b> was prepared according to the reaction sequence outlined in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a> and the general procedures described above for the preparation of generic compound <b>12</b>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>), 12.79 (s, 1 H), 12.71 (s, 1 H), 7.82 (q, <i>J</i> = 1.8 Hz, 1 H), 7.69 (s, 1 H), 7.56 (d, <i>J</i> = 8.6 Hz, 1 H), 7.32–7.15 (m, 4 H), 6.65–6.60 (m, 2 H), 5.73 (s, 2 H), 2.96–2.91 (m, 1 H), 2.68–2.64 (m, 2 H), 1.17 (t, <i>J</i> = 7.5 Hz, 3 H), 0.98 (d, <i>J</i> = 6.3 Hz, 4 H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>), 163.5, 161.9, 159.9, 158.0, 157.7, 155.7, 145.0, 137.9, 137.1, 136.6, 129.5, 127.2, 127.1, 123.9, 119.5, 118.0, 117.8, 116.7, 116.5, 115.9, 115.8, 115.7, 111.7, 108.3, 42.3, 31.6, 29.1, 17.0, 6.3. LRMS calcd for C<sub>26</sub>H<sub>24</sub>F<sub>2</sub>N<sub>3</sub>O<sub>4</sub>S (M + H)<sup>+</sup>, 512.1; found, 512.1.</div></div><div id="sec4_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> <i>N</i>-(Cyclopropylsulfonyl)-1-[(2,5-difluorophenyl)methyl]-3-(1,2-dihydro-2-oxo-3-pyridinyl)-5-(trifluoromethyl)-1<i>H</i>-indole-2-carboxamide (<b>52</b>)</h3><div class="NLM_p last">Compound <b>52</b> was prepared according to the reaction sequence outlined in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a> and the general procedures described above for the preparation of generic compound <b>12</b>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>), 12.78 (s, 2 H), 7.90 (d, <i>J</i> = 8.8 Hz, 1 H), 7.81 (q, <i>J</i> = 2.2 Hz, 1 H), 7.70 (s, 1 H), 7.66 (q, <i>J</i> = 1.6 Hz, 2 H), 7.32–7.27 (m, 1 H), 7.20–7.16 (m, 1 H), 6.71–6.68 (m, 1 H), 6.58 (t, <i>J</i> = 6.7 Hz, 1 H), 5.80 (s, 2 H), 2.95–2.90 (m, 1 H), 0.99 (s, 2 H), 0.90–0.85 (m, 2 H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>), 163.6, 163.0, 161.6, 160.0, 155.8, 144.6, 139.5, 136.8, 132.4, 129.5, 126.2, 123.0, 122.1, 119.6, 118.0, 117.9, 116.9, 116.2, 116.0, 113.1, 107.9, 68.3, 42.7, 32.9, 31.5, 30.7, 24.1, 23.2, 11.7, 6.3, 5.8. LRMS calcd for C<sub>25</sub>H<sub>19</sub>F<sub>5</sub>N<sub>3</sub>O<sub>4</sub>S (M + H)<sup>+</sup>, 552.1; found, 552.0.</div></div><div id="sec4_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> <i>N</i>-(Cyclopropylsulfonyl)-1-[(2,5-difluorophenyl)methyl]-3-(1,2-dihydro-2-oxo-3-pyridinyl)-5-(1,1-dimethylethyl)-1<i>H</i>-indole-2-carboxamide (<b>53</b>)</h3><div class="NLM_p last">Compound <b>53</b> was prepared according to the reaction sequence outlined in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a> and the general procedures described above for the preparation of generic compound <b>12</b>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>), 7.83 (q, <i>J</i> = 2.5 Hz, 1 H), 7.70 (d, <i>J</i> = 5.9 Hz, 1 H), 7.57 (d, <i>J</i> = 8.8 Hz, 1 H), 7.49 (q, <i>J</i> = 2.3 Hz, 1 H), 7.32 (d, <i>J</i> = 1.4 Hz, 1 H), 7.29 (q, <i>J</i> = 4.3 Hz, 1 H), 7.20–7.14 (m, 1 H), 6.65 (t, <i>J</i> = 7.4 Hz, 2 H), 5.73 (s, 2 H), 2.98–2.91 (m, 1 H), 1.28 (s, 9H), 0.99 (d, <i>J</i> = 5.7 Hz, 4 H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>), 174.0, 172.4, 170.4, 168.5, 168.1, 166.2, 155.6, 155.2, 147.2, 139.9, 138.5, 138.3, 137.1, 135.5, 134.3, 128.5, 128.3, 126.9, 126.8, 126.5, 126.3, 122.0, 118.8, 52.8, 45.7, 42.7, 42.0, 16.8. LRMS calcd for C<sub>28</sub>H<sub>28</sub>F<sub>2</sub>N<sub>3</sub>O<sub>4</sub>S (M + H)<sup>+</sup>, 540.2; found, 540.1.</div></div><div id="sec4_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> <i>N</i>-(Cyclopropylsulfonyl)-1-[(2,5-difluorophenyl)methyl]-3-(1,2-dihydro-2-oxo-3-pyridinyl)-5-(1-methylcyclopropyl)-1<i>H</i>-indole-2-carboxamide (<b>54</b>)</h3><div class="NLM_p last">Compound <b>54</b> was prepared according to the reaction sequence outlined in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a> and the general procedures described above for the preparation of generic compound <b>12</b>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>), 12.81 (s, 1 H), 12.72 (s, 1 H), 7.84 (q, <i>J</i> = 1.6 Hz, 1 H), 7.69 (d, <i>J</i> = 4.7 Hz, 1 H), 7.58 (d, <i>J</i> = 8.9 Hz, 1 H), 7.47–7.45 (m, 1 H), 7.33 (s, 1 H), 7.32–7.29 (m, 1 H), 7.19–7.15 (m, 1 H), 6.64–6.62 (m, 2 H), 5.74 (s, 2 H), 3.86 (s, 3 H), 2.97–2.92 (m, 1 H), 1.98 (s, 2 H), 1.74 (d, <i>J</i> = 6.5 Hz, 2 H), 0.98 (d, <i>J</i> = 6.3 Hz, 4 H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>), 173.9, 172.3, 168.5, 168.1, 166.2, 155.5, 151.1, 148.4, 148.0, 147.1, 146.6, 140.2, 138.3, 137.4, 136.6, 135.1, 134.2, 132.6, 129.3, 128.5, 128.3, 128.0, 126.9, 126.4, 126.2, 122.0, 118.8, 52.9, 42.0, 37.5, 31.3, 27.0, 26.3, 25.6, 16.8. LRMS calcd for C<sub>28</sub>H<sub>26</sub>F<sub>2</sub>N<sub>3</sub>O<sub>4</sub>S (M + H)<sup>+</sup>, 538.2; found, 538.1.</div></div><div id="sec4_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> (<i>N</i>-(Cyclopropylsulfonyl)-1-[(2,5-difluorophenyl)methyl]-3-(1,2-dihydro-2-oxo-3-pyridinyl)-6-fluoro-5-(methyl)-1<i>H</i>-indole-2-carboxamide (<b>56</b>)</h3><div class="NLM_p last">Compound <b>56</b> was prepared according to the reaction sequence outlined in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a> and the general procedures described above for the preparation of generic compound <b>12</b>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>), 7.78 (dd, <i>J</i> = 7.2, 2.0 Hz, 1 H), 7.67–7.65 (m, 1 H), 7.53 (d, <i>J</i> = 10.8 Hz, 1 H), 7.29–7.24 (m, 2 H), 7.18–7.12 (m, 1 H), 6.61–6.57 (m, 2 H), 5.69 (s, 2 H), 2.93–2.85 (s, 1 H), 2.26 (s, 3 H), 0.95 (d, <i>J</i> = 6.4 Hz, 4 H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>), 162.3, 160.7, 158.9, 157.0, 154.8, 144.0, 135.7, 122.5, 122.3, 119.2, 117.0, 116.8, 115.8, 115.6, 115.1, 114.9, 114.7, 107.3, 96.9, 96.7, 42.7, 31.5, 15.6, 15.5. HRMS calcd for C<sub>25</sub>H<sub>21</sub>F<sub>3</sub>N<sub>3</sub>O<sub>4</sub>S (M + H)<sup>+</sup>, 516.1205; found, 516.1200.</div></div><div id="sec4_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> <i>N</i>-(Cyclopropylsulfonyl)-1-[(2,5-difluorophenyl)methyl]-3-(1,2-dihydro-2-oxo-3-pyridinyl)-6-fluoro-5-(trifluoromethyl)-1<i>H</i>-indole-2-carboxamide (<b>59</b>)</h3><div class="NLM_p last">Compound <b>59</b> was prepared according to the reaction sequence outlined in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a> and the general procedures described above for the preparation of generic compound <b>12</b>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>), 12.70 (s, 1 H), 12.56 (s, 1 H), 7.99 (d, <i>J</i> = 12.2 Hz, 1 H), 7.81–7.79 (m, 2 H), 7.66 (d, <i>J</i> = 5.7 Hz, 1 H), 7.33–7.28 (s, 1 H), 7.23–7.17 (m, 1 H), 6.74–6.69 (m, 1 H), 6.56 (t, <i>J</i> = 6.8 Hz, 1 H), 5.77 (s, 2 H), 2.93–2.87 (m, 1 H), 0.98 (d, <i>J</i> = 6.1 Hz, 4 H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>), 173.4, 171.7, 170.6, 170.4, 169.3, 168.5, 168.3, 167.4, 166.4, 155.1, 150.5, 147.5, 142.0, 137.4, 133.1, 133.0, 132.1, 128.6, 128.5, 128.4, 128.0, 127.3, 126.8, 126.6, 118.3, 110.8, 110.6, 53.6, 42.0, 16.8. LRMS calcd for C<sub>25</sub>H<sub>18</sub>F<sub>6</sub>N<sub>3</sub>O<sub>4</sub>S (M + H)<sup>+</sup>, 570.1; found, 570.1.</div></div><div id="sec4_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> <i>N</i>-(Cyclopropylsulfonyl)-1-[(2,5-difluorophenyl)methyl]-3-(1,2-dihydro-2-oxo-3-pyridinyl)-5-ethyl-6-fluoro-1<i>H</i>-indole-2-carboxamide (<b>60</b>)</h3><div class="NLM_p">Compound <b>60</b> was prepared according to the reaction sequence outlined in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a> and the general procedures described above for the preparation of generic compound <b>12</b>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>), 12.71 (s, 2 H), 7.80 (q, <i>J</i> = 1.9 Hz, 1 H), 7.69 (s, 1 H), 7.55 (d, <i>J</i> = 11.7 Hz, 1 H), 7.32–7.27 (m, 2 H), 7.21–7.14 (m, 1 H), 6.66 (s, 2 H), 5.71 (s, 2 H), 2.95–2.88 (m, 1 H), 2.67 (q, <i>J</i> = 7.4 Hz, 2 H), 1.16 (t, <i>J</i> = 7.2 Hz, 3 H), 0.97 (d, <i>J</i> = 6.9 Hz, 4 H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>), 173.8, 172.1, 170.4, 170.2, 168.5, 168.2, 166.3, 155.5, 147.8, 147.2, 140.1, 138.2, 137.0, 134.0, 132.3, 128.5, 128.3, 127.1, 126.8, 126.5, 126.3, 118.8, 108.6, 108.4, 53.2, 42.0, 33.6, 26.1, 16.8. LRMS calcd for C<sub>26</sub>H<sub>23</sub>F<sub>3</sub>N<sub>3</sub>O<sub>4</sub>S (M + H)<sup>+</sup>, 530.1; found, 530.0.</div><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> Abbreviations Used</h3><tr><td class="NLM_term">HCV</td><td class="NLM_def"><p class="first last">hepatitis C virus</p></td></tr><tr><td class="NLM_term">PK</td><td class="NLM_def"><p class="first last">pharmacokinetics</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">AUC</td><td class="NLM_def"><p class="first last">area-under-the-curve</p></td></tr><tr><td class="NLM_term">SOC</td><td class="NLM_def"><p class="first last">standard of care</p></td></tr><tr><td class="NLM_term">SVR</td><td class="NLM_def"><p class="first last">sustained virologic response</p></td></tr><tr><td class="NLM_term">RdRp</td><td class="NLM_def"><p class="first last">RNA-dependent RNA polymerase</p></td></tr><tr><td class="NLM_term">RC</td><td class="NLM_def"><p class="first last">replicase complex</p></td></tr><tr><td class="NLM_term">NIs</td><td class="NLM_def"><p class="first last">nucleoside inhibitors</p></td></tr><tr><td class="NLM_term">NNIs</td><td class="NLM_def"><p class="first last">non-nucleoside inhibitors</p></td></tr><tr><td class="NLM_term">NIS</td><td class="NLM_def"><p class="first last"><i>N</i>-iodosuccinimide</p></td></tr><tr><td class="NLM_term">CDI</td><td class="NLM_def"><p class="first last">carbonyl diimidazole</p></td></tr><tr><td class="NLM_term">DBU</td><td class="NLM_def"><p class="first last">diazabicyclicunderdecane</p></td></tr><tr><td class="NLM_term">CYP</td><td class="NLM_def"><p class="first last">cytochrome P450</p></td></tr><tr><td class="NLM_term">hERG</td><td class="NLM_def"><p class="first last">the human ether-à-go-go-related gene</p></td></tr><tr><td class="NLM_term">PXR</td><td class="NLM_def"><p class="first last">pregnane X receptor</p></td></tr><tr><td class="NLM_term">TLC</td><td class="NLM_def"><p class="first last">thin layer chromatography</p></td></tr><tr><td class="NLM_term">rt or RT</td><td class="NLM_def"><p class="first last">room temperature</p></td></tr><tr><td class="NLM_term">min</td><td class="NLM_def"><p class="first last">minutes</p></td></tr><tr><td class="NLM_term">DME</td><td class="NLM_def"><p class="first last">dimethoxyethane</p></td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last">dimethylformamide</p></td></tr><tr><td class="NLM_term">DMSO</td><td class="NLM_def"><p class="first last">methyl sulfoxide</p></td></tr><tr><td class="NLM_term">THF</td><td class="NLM_def"><p class="first last">tetrahydrofuran</p></td></tr></table></div></div><div class="NLM_back"><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_75388" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_75388" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kevin X. Chen</span> - <span class="hlFld-Affiliation affiliation">Merck Research Laboratories,
2015 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#650e1d060b251c040d0a0a4b060a08"><span class="__cf_email__" data-cfemail="056e7d666b457c646d6a6a2b666a68">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bancha Vibulbhan</span> - <span class="hlFld-Affiliation affiliation">Merck Research Laboratories,
2015 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Weiying Yang</span> - <span class="hlFld-Affiliation affiliation">Merck Research Laboratories,
2015 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mousumi Sannigrahi</span> - <span class="hlFld-Affiliation affiliation">Merck Research Laboratories,
2015 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Francisco Velazquez</span> - <span class="hlFld-Affiliation affiliation">Merck Research Laboratories,
2015 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tin-Yau Chan</span> - <span class="hlFld-Affiliation affiliation">Merck Research Laboratories,
2015 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Srikanth Venkatraman</span> - <span class="hlFld-Affiliation affiliation">Merck Research Laboratories,
2015 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gopinadhan N. Anilkumar</span> - <span class="hlFld-Affiliation affiliation">Merck Research Laboratories,
2015 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Qingbei Zeng</span> - <span class="hlFld-Affiliation affiliation">Merck Research Laboratories,
2015 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Frank Bennet</span> - <span class="hlFld-Affiliation affiliation">Merck Research Laboratories,
2015 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yueheng Jiang</span> - <span class="hlFld-Affiliation affiliation">Merck Research Laboratories,
2015 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Charles A. Lesburg</span> - <span class="hlFld-Affiliation affiliation">Drug Design, Merck Research
Laboratories, 2015 Galloping Hill Road, Kenilworth, NJ 07033, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jose Duca</span> - <span class="hlFld-Affiliation affiliation">Merck Research Laboratories,
2015 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Patrick Pinto</span> - <span class="hlFld-Affiliation affiliation">Merck Research Laboratories,
2015 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stephen Gavalas</span> - <span class="hlFld-Affiliation affiliation">Merck Research Laboratories,
2015 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yuhua Huang</span> - <span class="hlFld-Affiliation affiliation">Merck Research Laboratories,
2015 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wanli Wu</span> - <span class="hlFld-Affiliation affiliation">Merck Research Laboratories,
2015 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Oleg Selyutin</span> - <span class="hlFld-Affiliation affiliation">Merck Research Laboratories,
2015 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sony Agrawal</span> - <span class="hlFld-Affiliation affiliation">Merck Research Laboratories,
2015 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Boris Feld</span> - <span class="hlFld-Affiliation affiliation">Merck Research Laboratories,
2015 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hsueh-Cheng Huang</span> - <span class="hlFld-Affiliation affiliation">Merck Research Laboratories,
2015 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Cheng Li</span> - <span class="hlFld-Affiliation affiliation">Merck Research Laboratories,
2015 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kuo-Chi Cheng</span> - <span class="hlFld-Affiliation affiliation">Merck Research Laboratories,
2015 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Neng-Yang Shih</span> - <span class="hlFld-Affiliation affiliation">Merck Research Laboratories,
2015 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joseph A. Kozlowski</span> - <span class="hlFld-Affiliation affiliation">Merck Research Laboratories,
2015 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stuart B. Rosenblum</span> - <span class="hlFld-Affiliation affiliation">Merck Research Laboratories,
2015 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Drug Design, Merck Research
Laboratories, 2015 Galloping Hill Road, Kenilworth, NJ 07033, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">F. George Njoroge</span> - <span class="hlFld-Affiliation affiliation">Merck Research Laboratories,
2015 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="testing" data-doi="10.1021/jm201258k" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i49">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_52565" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_52565" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 29 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Cohen, J.</span><span> </span><span class="NLM_article-title">The Scientific Challenge of Hepatitis C</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">285</span><span class="NLM_x">, </span> <span class="NLM_fpage">26</span><span class="NLM_x">–</span> <span class="NLM_lpage">30</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=1999&pages=26-30&author=J.+Cohen&title=The+Scientific+Challenge+of+Hepatitis+C"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCohen%26aufirst%3DJ.%26atitle%3DThe%2520Scientific%2520Challenge%2520of%2520Hepatitis%2520C%26jtitle%3DScience%26date%3D1999%26volume%3D285%26spage%3D26%26epage%3D30" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Alter, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kruszon-Moran, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nainan, O. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McQuillan, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moyer, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaslow, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Margolis, H. S.</span><span> </span><span class="NLM_article-title">The Prevalence of Hepatitis C Virus Infection in the United States, 1988 Through 1994</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">341</span><span class="NLM_x">, </span> <span class="NLM_fpage">556</span><span class="NLM_x">–</span> <span class="NLM_lpage">562</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=16&amp;doi=10.1021%2Fjm201258k&amp;key=10.1056%2FNEJM199908193410802" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=8&amp;doi=10.1021%2Fjm201258k&amp;key=10451460" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=32&amp;doi=10.1021%2Fjm201258k&amp;key=1%3ACAS%3A280%3ADyaK1Mzmt1Whsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=341&publication_year=1999&pages=556-562&author=M.+J.+Alterauthor=D.+Kruszon-Moranauthor=O.+V.+Nainanauthor=G.+M.+McQuillanauthor=F.+Gaoauthor=L.+A.+Moyerauthor=R.+A.+Kaslowauthor=H.+S.+Margolis&title=The+Prevalence+of+Hepatitis+C+Virus+Infection+in+the+United+States%2C+1988+Through+1994"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1bR"><div class="casContent"><span class="casTitleNuber">1b</span><div class="casTitle"><span class="NLM_cas:atitle">The prevalence of hepatitis C virus infection in the United States, 1988 through 1994</span></div><div class="casAuthors">Alter M J; Kruszon-Moran D; Nainan O V; McQuillan G M; Gao F; Moyer L A; Kaslow R A; Margolis H S</div><div class="citationInfo"><span class="NLM_cas:title">The New England journal of medicine</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">341</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">556-62</span>
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    </div><div class="casAbstract">BACKGROUND:  Because many persons with chronic hepatitis C virus (HCV) infection are asymptomatic, population-based serologic studies are needed to estimate the prevalence of the infection and to develop and evaluate prevention efforts.  METHODS:  We performed tests for antibody to HCV (anti-HCV) on serum samples from 21,241 persons six years old or older who participated in the third National Health and Nutrition Examination Survey, conducted during 1988 through 1994.  We determined the prevalence of HCV RNA by means of nucleic acid amplification and the genotype by means of sequencing.  RESULTS:  The overall prevalence of anti-HCV was 1.8 percent, corresponding to an estimated 3.9 million persons nationwide (95 percent confidence interval, 3.1 million to 4.8 million) with HCV infection.  Sixty-five percent of the persons with HCV infection were 30 to 49 years old.  Seventy-four percent were positive for HCV RNA, indicating that an estimated 2.7 million persons in the United States (95 percent confidence interval, 2.4 million to 3.0 million) were chronically infected, of whom 73.7 percent were infected with genotype 1 (56.7 percent with genotype 1a, and 17.0 percent with genotype 1b).  Among subjects 17 to 59 years of age, the strongest factors independently associated with HCV infection were illegal drug use and high-risk sexual behavior.  Other factors independently associated with infection included poverty, having had 12 or fewer years of education, and having been divorced or separated.  Neither sex nor racial-ethnic group was independently associated with HCV infection.  CONCLUSIONS:  In the United States, about 2.7 million persons are chronically infected with HCV.  People who use illegal drugs or engage in high-risk sexual behavior account for most persons with HCV infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRTwajewlRkP_tos8R3JUhXfW6udTcc2eZ2RuNLLB_247ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1Mzmt1Whsw%253D%253D&md5=d36f80ca56095fcd3cb19271f9e80dca</span></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=10.1056%2FNEJM199908193410802&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM199908193410802%26sid%3Dliteratum%253Aachs%26aulast%3DAlter%26aufirst%3DM.%2BJ.%26aulast%3DKruszon-Moran%26aufirst%3DD.%26aulast%3DNainan%26aufirst%3DO.%2BV.%26aulast%3DMcQuillan%26aufirst%3DG.%2BM.%26aulast%3DGao%26aufirst%3DF.%26aulast%3DMoyer%26aufirst%3DL.%2BA.%26aulast%3DKaslow%26aufirst%3DR.%2BA.%26aulast%3DMargolis%26aufirst%3DH.%2BS.%26atitle%3DThe%2520Prevalence%2520of%2520Hepatitis%2520C%2520Virus%2520Infection%2520in%2520the%2520United%2520States%252C%25201988%2520Through%25201994%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D1999%26volume%3D341%26spage%3D556%26epage%3D562" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Cuthbert, J. A.</span><span> </span><span class="NLM_article-title">Hepatitis C: Progress and Problems</span> <span class="citation_source-journal">Clin. Microbiol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">505</span><span class="NLM_x">–</span> <span class="NLM_lpage">532</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=8&amp;doi=10.1021%2Fjm201258k&amp;key=7834603" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=32&amp;doi=10.1021%2Fjm201258k&amp;key=1%3ACAS%3A280%3ADyaK2M7js1ajtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1994&pages=505-532&author=J.+A.+Cuthbert&title=Hepatitis+C%3A+Progress+and+Problems"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1cR"><div class="casContent"><span class="casTitleNuber">1c</span><div class="casTitle"><span class="NLM_cas:atitle">Hepatitis C: progress and problems</span></div><div class="casAuthors">Cuthbert J A</div><div class="citationInfo"><span class="NLM_cas:title">Clinical microbiology reviews</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">505-32</span>
        ISSN:<span class="NLM_cas:issn">0893-8512</span>.
    </div><div class="casAbstract">The hepatitis C virus (HCV), a single-stranded RNA virus, is the major cause of posttransfusion hepatitis.  HCV isolates differ in nucleotide and amino acid sequences.  Nucleotide changes are concentrated in hypervariable regions and may be related to immune selection.  In most immunocompetent persons, HCV infection is diagnosed serologically, using antigens from conserved regions.  Amplification of RNA may be necessary to detect infection in immunosuppressed patients.  Transmission by known parenteral routes is frequent; other means of spread are less common and may represent inapparent, percutaneous dissemination.  Infection can lead to classical acute hepatitis, but most infected persons have no history of acute disease.  Once infected, most individuals apparently remain carriers of the virus, with varying degrees of hepatocyte damage and fibrosis ensuing.  Chronic hepatitis may lead to cirrhosis and hepatocellular carcinoma.  However, disease progression varies widely, from less than 2 years to cirrhosis in some patients to more than 30 years with only chronic hepatitis in others.  Determinants important in deciding outcome are unknown.  Alpha interferon, which results in sustained remission in selected patients, is the only available therapy.  Long-term benefits from such therapy have not been demonstrated.  Prevention of HCV infection by vaccination is likely to be challenging if ongoing viral mutation results in escape from neutralization and clearance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQXDQuuyW-2sDEC-75aqa5AfW6udTcc2eZ2RuNLLB_247ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2M7js1ajtA%253D%253D&md5=b4434f7061f607052197da39e1916b0a</span></div><a href="/servlet/linkout?suffix=cit1c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCuthbert%26aufirst%3DJ.%2BA.%26atitle%3DHepatitis%2520C%253A%2520Progress%2520and%2520Problems%26jtitle%3DClin.%2520Microbiol.%2520Rev.%26date%3D1994%26volume%3D7%26spage%3D505%26epage%3D532" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Shepard, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finelli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alter, M. J.</span><span> </span><span class="NLM_article-title">Global epidemiology of hepatitis C virus infection</span> <span class="citation_source-journal">Lancet Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">558</span><span class="NLM_x">–</span> <span class="NLM_lpage">567</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=16&amp;doi=10.1021%2Fjm201258k&amp;key=10.1016%2FS1473-3099%2805%2970216-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=8&amp;doi=10.1021%2Fjm201258k&amp;key=16122679" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=32&amp;doi=10.1021%2Fjm201258k&amp;key=1%3ACAS%3A280%3ADC%252BD2Mvls1Wlsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=558-567&author=C.+W.+Shepardauthor=L.+Finelliauthor=M.+J.+Alter&title=Global+epidemiology+of+hepatitis+C+virus+infection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2aR"><div class="casContent"><span class="casTitleNuber">2a</span><div class="casTitle"><span class="NLM_cas:atitle">Global epidemiology of hepatitis C virus infection</span></div><div class="casAuthors">Shepard Colin W; Finelli Lyn; Alter Miriam J</div><div class="citationInfo"><span class="NLM_cas:title">The Lancet. Infectious diseases</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">558-67</span>
        ISSN:<span class="NLM_cas:issn">1473-3099</span>.
    </div><div class="casAbstract">Hepatitis C virus (HCV) is a major cause of liver disease worldwide and a potential cause of substantial morbidity and mortality in the future.  The complexity and uncertainty related to the geographic distribution of HCV infection and chronic hepatitis C, determination of its associated risk factors, and evaluation of cofactors that accelerate its progression, underscore the difficulties in global prevention and control of HCV.  Because there is no vaccine and no post-exposure prophylaxis for HCV, the focus of primary prevention efforts should be safer blood supply in the developing world, safe injection practices in health care and other settings, and decreasing the number of people who initiate injection drug use.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQyQ65qEM2alVm8bhe6roZYfW6udTcc2ebozQ5n-s3NLrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2Mvls1Wlsg%253D%253D&md5=4d5f81fa0c2191b8c32b328e39933fad</span></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=10.1016%2FS1473-3099%2805%2970216-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1473-3099%252805%252970216-4%26sid%3Dliteratum%253Aachs%26aulast%3DShepard%26aufirst%3DC.%2BW.%26aulast%3DFinelli%26aufirst%3DL.%26aulast%3DAlter%26aufirst%3DM.%2BJ.%26atitle%3DGlobal%2520epidemiology%2520of%2520hepatitis%2520C%2520virus%2520infection%26jtitle%3DLancet%2520Infect.%2520Dis.%26date%3D2005%26volume%3D5%26spage%3D558%26epage%3D567" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Monto, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, T. L.</span><span> </span><span class="NLM_article-title">The Epidemiology and Prevention of Hepatocellular Carcinoma</span> <span class="citation_source-journal">Semin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">441</span><span class="NLM_x">–</span> <span class="NLM_lpage">449</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=16&amp;doi=10.1021%2Fjm201258k&amp;key=10.1016%2FS0093-7754%2801%2990137-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=8&amp;doi=10.1021%2Fjm201258k&amp;key=11685737" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=32&amp;doi=10.1021%2Fjm201258k&amp;key=1%3ACAS%3A280%3ADC%252BD3MngvVOhtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2001&pages=441-449&author=A.+Montoauthor=T.+L.+Wright&title=The+Epidemiology+and+Prevention+of+Hepatocellular+Carcinoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2bR"><div class="casContent"><span class="casTitleNuber">2b</span><div class="casTitle"><span class="NLM_cas:atitle">The epidemiology and prevention of hepatocellular carcinoma</span></div><div class="casAuthors">Monto A; Wright T L</div><div class="citationInfo"><span class="NLM_cas:title">Seminars in oncology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">441-9</span>
        ISSN:<span class="NLM_cas:issn">0093-7754</span>.
    </div><div class="casAbstract">Hepatocellular carcinoma (HCC) is a common cancer.  Its incidence is higher in countries where hepatitis B is endemic.  HCC is substantially a complication of liver cirrhosis.  Hepatitis B virus (HBV) and hepatitis C virus (HCV) are the predominant causes of cirrhosis, and as such, HCC.  The link between HCC and alcoholic cirrhosis is less strong.  Other less common forms of chronic liver disease can also lead to HCC.  HBV is the HCC-determining disease worldwide.  In endemic regions, it tends to be acquired early in life.  The largest strides in prevention of HCC have been made with the HBV vaccine.  HCV has a lower global prevalence than HBV, but HCV causes the most HCC in economically developed regions.  In these areas, where the incidence of HCC is low, HCV now accounts for more than 50% of HCCs.  There is no vaccine for HCV, so prevention of HCV-associated HCC will focus on prevention of initial infection and elimination of infection through antiviral therapies.  HBV-HCV coinfection, and the combination of either with alcohol abuse or aflatoxin exposure seems to raise the risk of HCC development further.  Liver transplantation and other adjuvant therapies may offer better options for secondary prevention of HCC than resection alone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTuq0Don9pfEtTiMd2aNQVUfW6udTcc2ebozQ5n-s3NLrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3MngvVOhtw%253D%253D&md5=1b421c8469c206780be4d03eafb412e2</span></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=10.1016%2FS0093-7754%2801%2990137-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0093-7754%252801%252990137-X%26sid%3Dliteratum%253Aachs%26aulast%3DMonto%26aufirst%3DA.%26aulast%3DWright%26aufirst%3DT.%2BL.%26atitle%3DThe%2520Epidemiology%2520and%2520Prevention%2520of%2520Hepatocellular%2520Carcinoma%26jtitle%3DSemin.%2520Oncol.%26date%3D2001%26volume%3D28%26spage%3D441%26epage%3D449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Sheridan, C.</span><span> </span><span class="NLM_article-title">New Merck and Vertex drugs raise standard of care in hepatitis C</span> <span class="citation_source-journal">Nature Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">553</span><span class="NLM_x">–</span> <span class="NLM_lpage">554</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=16&amp;doi=10.1021%2Fjm201258k&amp;key=10.1038%2Fnbt0711-553" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=8&amp;doi=10.1021%2Fjm201258k&amp;key=21747363" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=32&amp;doi=10.1021%2Fjm201258k&amp;key=1%3ACAS%3A528%3ADC%252BC3MXoslymtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2011&pages=553-554&author=C.+Sheridan&title=New+Merck+and+Vertex+drugs+raise+standard+of+care+in+hepatitis+C"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3aR"><div class="casContent"><span class="casTitleNuber">3a</span><div class="casTitle"><span class="NLM_cas:atitle">New Merck and Vertex drugs raise standard of care in hepatitis C</span></div><div class="casAuthors">Sheridan, Cormac</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">553-554</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDRNfcMR5e4rVg90H21EOLACvtfcHk0lh8ZiLkIgc8Ng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXoslymtrw%253D&md5=35734099c95a7a35dfd35d90f5820641</span></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=10.1038%2Fnbt0711-553&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt0711-553%26sid%3Dliteratum%253Aachs%26aulast%3DSheridan%26aufirst%3DC.%26atitle%3DNew%2520Merck%2520and%2520Vertex%2520drugs%2520raise%2520standard%2520of%2520care%2520in%2520hepatitis%2520C%26jtitle%3DNature%2520Biotechnol.%26date%3D2011%26volume%3D29%26spage%3D553%26epage%3D554" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Fried, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiffman, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, D. K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marinos, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonçales, F. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Häussinger, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diago, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carosi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhumeaux, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Craxi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, J.</span><span> </span><span class="NLM_article-title">PEGinterferon-α-2a plus ribavirin for chronic hepatitis C virus infection</span> <span class="citation_source-journal">New Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">347</span><span class="NLM_x">, </span> <span class="NLM_fpage">975</span><span class="NLM_x">–</span> <span class="NLM_lpage">982</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=16&amp;doi=10.1021%2Fjm201258k&amp;key=10.1056%2FNEJMoa020047" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=8&amp;doi=10.1021%2Fjm201258k&amp;key=12324553" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=32&amp;doi=10.1021%2Fjm201258k&amp;key=1%3ACAS%3A528%3ADC%252BD38Xnt12rtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=347&publication_year=2002&pages=975-982&author=M.+W.+Friedauthor=M.+L.+Shiffmanauthor=D.+K.+R.+Reddyauthor=C.+Smithauthor=G.+Marinosauthor=F.+L.+Gon%C3%A7alesauthor=D.+H%C3%A4ussingerauthor=M.+Diagoauthor=G.+Carosiauthor=D.+Dhumeauxauthor=A.+Craxiauthor=A.+Linauthor=J.+Hoffmanauthor=J.+Yu&title=PEGinterferon-%CE%B1-2a+plus+ribavirin+for+chronic+hepatitis+C+virus+infection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3bR"><div class="casContent"><span class="casTitleNuber">3b</span><div class="casTitle"><span class="NLM_cas:atitle">Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection</span></div><div class="casAuthors">Fried, Michael W.; Shiffman, Mitchell L.; Reddy, K. Rajender; Smith, Coleman; Marinos, George; Goncales, Fernando L., Jr.; Haussinger, Dieter; Diago, Moises; Carosi, Giampiero; Dhumeaux, Daniel; Craxi, Antonio; Lin, Amy; Hoffman, Joseph; Yu, Jian</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">347</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">975-982</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Background: Treatment with peginterferon alfa-2a alone produces significantly higher sustained virol. responses than treatment with interferon alfa-2a alone in patients with chronic hepatitis C virus (HCV) infection.  We compared the efficacy and safety of peginterferon alfa-2a plus ribavirin, interferon alfa-2b plus ribavirin, and peginterferon alfa-2a alone in the initial treatment of chronic hepatitis C.  Methods: A total of 1121 patients were randomly assigned to treatment and received at least one dose of study medication, consisting of 180 μg of peginterferon alfa-2a once weekly plus daily ribavirin (1000 or 1200 mg, depending on body wt.), weekly peginterferon alfa-2a plus daily placebo, or 3 million units of interferon alfa-2b thrice weekly plus daily ribavirin for 48 wk.  Results: A significantly higher proportion of patients who received peginterferon alfa-2a plus ribavirin had a sustained virol. response (defined as the absence of detectable HCV RNA 24 wk after cessation of therapy) than of patients who received interferon alfa-2b plus ribavirin (56 % vs. 44 %, P<0.001) or peginterferon alfa-2a alone (56 % vs. 29 %, P<0.001).  The proportions of patients with HCV genotype 1 who had sustained virol. responses were 46 %, 36 %, and 21 %, resp., for the three regimens.  Among patients with HCV genotype 1 and high base-line levels of HCV RNA, the proportions of those with sustained virol. responses were 41 %, 33 %, and 13 %, resp.  The overall safety profiles of the three treatment regimens were similar; the incidence of influenza-like symptoms and depression was lower in the groups receiving peginterferon alfa-2a than in the group receiving interferon alfa-2b plus ribavirin.  Conclusions: In patients with chronic hepatitis C, once-weekly peginterferon alfa-2a plus ribavirin was tolerated as well as interferon alfa-2b plus ribavirin and produced significant improvements in the rate of sustained virol. response, as compared with interferon alfa-2b plus ribavirin or peginterferon alfa-2a alone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqblwkeNXWJzbVg90H21EOLACvtfcHk0ljlNongPZfQOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xnt12rtb0%253D&md5=2fd959d790b9505384fbd26ef44b2963</span></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa020047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa020047%26sid%3Dliteratum%253Aachs%26aulast%3DFried%26aufirst%3DM.%2BW.%26aulast%3DShiffman%26aufirst%3DM.%2BL.%26aulast%3DReddy%26aufirst%3DD.%2BK.%2BR.%26aulast%3DSmith%26aufirst%3DC.%26aulast%3DMarinos%26aufirst%3DG.%26aulast%3DGon%25C3%25A7ales%26aufirst%3DF.%2BL.%26aulast%3DH%25C3%25A4ussinger%26aufirst%3DD.%26aulast%3DDiago%26aufirst%3DM.%26aulast%3DCarosi%26aufirst%3DG.%26aulast%3DDhumeaux%26aufirst%3DD.%26aulast%3DCraxi%26aufirst%3DA.%26aulast%3DLin%26aufirst%3DA.%26aulast%3DHoffman%26aufirst%3DJ.%26aulast%3DYu%26aufirst%3DJ.%26atitle%3DPEGinterferon-%25CE%25B1-2a%2520plus%2520ribavirin%2520for%2520chronic%2520hepatitis%2520C%2520virus%2520infection%26jtitle%3DNew%2520Engl.%2520J.%2520Med.%26date%3D2002%26volume%3D347%26spage%3D975%26epage%3D982" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Di Bisceglie, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McHutchison, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, C. M.</span><span> </span><span class="NLM_article-title">New therapeutic strategies for hepatitis C</span> <span class="citation_source-journal">Hepatology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">224</span><span class="NLM_x">–</span> <span class="NLM_lpage">231</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2002&pages=224-231&author=A.+M.+Di+Bisceglieauthor=J.+McHutchisonauthor=C.+M.+Rice&title=New+therapeutic+strategies+for+hepatitis+C"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BBisceglie%26aufirst%3DA.%2BM.%26aulast%3DMcHutchison%26aufirst%3DJ.%26aulast%3DRice%26aufirst%3DC.%2BM.%26atitle%3DNew%2520therapeutic%2520strategies%2520for%2520hepatitis%2520C%26jtitle%3DHepatology%26date%3D2002%26volume%3D35%26spage%3D224%26epage%3D231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Choo, Q. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiner, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiner, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Overby, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradley, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houghton, M.</span><span> </span><span class="NLM_article-title">Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">244</span><span class="NLM_x">, </span> <span class="NLM_fpage">359</span><span class="NLM_x">–</span> <span class="NLM_lpage">362</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm201258k&amp;key=10.1126%2Fscience.2523562" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm201258k&amp;key=2523562" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm201258k&amp;key=1%3ACAS%3A528%3ADyaL1MXit1Khtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=244&publication_year=1989&pages=359-362&author=Q.+L.+Chooauthor=G.+Kuoauthor=A.+J.+Weinerauthor=A.+J.+Weinerauthor=L.+R.+Overbyauthor=D.+W.+Bradleyauthor=M.+Houghton&title=Isolation+of+a+cDNA+clone+derived+from+a+blood-borne+non-A%2C+non-B+viral+hepatitis+genome"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome</span></div><div class="casAuthors">Choo, Qui Lim; Kuo, George; Weiner, Amy J.; Overby, Lacy R.; Bradley, Daniel W.; Houghton, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">244</span>
        (<span class="NLM_cas:issue">4902</span>),
    <span class="NLM_cas:pages">359-62</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">A random-primed cDNA library was constructed from plasma contg. the uncharacterized non-A, non-B hepatitis (NANBH) agent and screened with serum from a patient diagnosed with NANBH.  A cDNA clone was isolated that was shown to encode an antigen assocd. specifically with NANBH infections.  This clone is not derived from host DNA but from an RNA mol. present in NANBH infections that consists of ≥10,000 nucleotides, and that is pos.-stranded with respect to the encoded NANBH antigen.  These data indicate that this clone is derived from the genome of the NANBH agent and are consistent with the agent being similar to the togaviridae or flaviviridae.  This mol. approach should be of great value in the isolation and characterization of other unidentified infectious agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqorpVFx7nEkrVg90H21EOLACvtfcHk0ljlNongPZfQOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXit1Khtrk%253D&md5=25161cf212790856dd29d3aaf78f20b8</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1126%2Fscience.2523562&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.2523562%26sid%3Dliteratum%253Aachs%26aulast%3DChoo%26aufirst%3DQ.%2BL.%26aulast%3DKuo%26aufirst%3DG.%26aulast%3DWeiner%26aufirst%3DA.%2BJ.%26aulast%3DWeiner%26aufirst%3DA.%2BJ.%26aulast%3DOverby%26aufirst%3DL.%2BR.%26aulast%3DBradley%26aufirst%3DD.%2BW.%26aulast%3DHoughton%26aufirst%3DM.%26atitle%3DIsolation%2520of%2520a%2520cDNA%2520clone%2520derived%2520from%2520a%2520blood-borne%2520non-A%252C%2520non-B%2520viral%2520hepatitis%2520genome%26jtitle%3DScience%26date%3D1989%26volume%3D244%26spage%3D359%26epage%3D362" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Chen, K. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Njoroge, F. G.</span><span> </span><span class="NLM_article-title">A review of HCV protease inhibitors</span> <span class="citation_source-journal">Curr. Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">821</span><span class="NLM_x">–</span> <span class="NLM_lpage">837</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2009&pages=821-837&author=K.+X.+Chenauthor=F.+G.+Njoroge&title=A+review+of+HCV+protease+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DK.%2BX.%26aulast%3DNjoroge%26aufirst%3DF.%2BG.%26atitle%3DA%2520review%2520of%2520HCV%2520protease%2520inhibitors%26jtitle%3DCurr.%2520Opin.%2520Invest.%2520Drugs%26date%3D2009%26volume%3D10%26spage%3D821%26epage%3D837" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Watkins, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ray, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chong, L. S.</span><span> </span><span class="NLM_article-title">HCV NS5B polymerase inhibitors</span> <span class="citation_source-journal">Curr. Opin. Drug Discovery Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">441</span><span class="NLM_x">–</span> <span class="NLM_lpage">465</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2010&pages=441-465&author=W.+J.+Watkinsauthor=A.+S.+Rayauthor=L.+S.+Chong&title=HCV+NS5B+polymerase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWatkins%26aufirst%3DW.%2BJ.%26aulast%3DRay%26aufirst%3DA.%2BS.%26aulast%3DChong%26aufirst%3DL.%2BS.%26atitle%3DHCV%2520NS5B%2520polymerase%2520inhibitors%26jtitle%3DCurr.%2520Opin.%2520Drug%2520Discovery%2520Dev.%26date%3D2010%26volume%3D13%26spage%3D441%26epage%3D465" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Legrand-Abravanel, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicot, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Izopet, J.</span><span> </span><span class="NLM_article-title">New NS5B polymerase inhibitors for hepatitis C</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">963</span><span class="NLM_x">–</span> <span class="NLM_lpage">975</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2010&pages=963-975&author=F.+Legrand-Abravanelauthor=F.+Nicotauthor=J.+Izopet&title=New+NS5B+polymerase+inhibitors+for+hepatitis+C"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLegrand-Abravanel%26aufirst%3DF.%26aulast%3DNicot%26aufirst%3DF.%26aulast%3DIzopet%26aufirst%3DJ.%26atitle%3DNew%2520NS5B%2520polymerase%2520inhibitors%2520for%2520hepatitis%2520C%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2010%26volume%3D19%26spage%3D963%26epage%3D975" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Gao, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nettles, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belema, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, V..N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fridell, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serrano-Wu, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langley, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, J.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Boyle, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemm, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knipe, J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chien, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colonno, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grasela, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meanwell, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamann, L. G.</span><span> </span><span class="NLM_article-title">Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">465</span><span class="NLM_x">, </span> <span class="NLM_fpage">96</span><span class="NLM_x">–</span> <span class="NLM_lpage">100</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5d&amp;dbid=16&amp;doi=10.1021%2Fjm201258k&amp;key=10.1038%2Fnature08960" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5d&amp;dbid=8&amp;doi=10.1021%2Fjm201258k&amp;key=20410884" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5d&amp;dbid=32&amp;doi=10.1021%2Fjm201258k&amp;key=1%3ACAS%3A528%3ADC%252BC3cXltVGhtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=465&publication_year=2010&pages=96-100&author=M.+Gaoauthor=R.+E.+Nettlesauthor=M.+Belemaauthor=L.+B.+Snyderauthor=V..N.+Nguyenauthor=R.+A.+Fridellauthor=M.+H.+Serrano-Wuauthor=D.+R.+Langleyauthor=J.-H.+Sunauthor=D.+R.+O%E2%80%99Boyleauthor=J.+A.+Lemmauthor=C.+Wangauthor=J.+O.+Knipeauthor=C.+Chienauthor=R.+J.+Colonnoauthor=D.+M.+Graselaauthor=N.+A.+Meanwellauthor=L.+G.+Hamann&title=Chemical+genetics+strategy+identifies+an+HCV+NS5A+inhibitor+with+a+potent+clinical+effect"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5dR"><div class="casContent"><span class="casTitleNuber">5d</span><div class="casTitle"><span class="NLM_cas:atitle">Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect</span></div><div class="casAuthors">Gao, Min; Nettles, Richard E.; Belema, Makonen; Snyder, Lawrence B.; Nguyen, Van N.; Fridell, Robert A.; Serrano-Wu, Michael H.; Langley, David R.; Sun, Jin-Hua; O'Boyle, Donald R., II; Lemm, Julie A.; Wang, Chunfu; Knipe, Jay O.; Chien, Caly; Colonno, Richard J.; Grasela, Dennis M.; Meanwell, Nicholas A.; Hamann, Lawrence G.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">465</span>
        (<span class="NLM_cas:issue">7294</span>),
    <span class="NLM_cas:pages">96-100</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The worldwide prevalence of chronic hepatitis C virus (HCV) infection is estd. to be approaching 200 million people.  Current therapy relies upon a combination of pegylated interferon-α and ribavirin, a poorly tolerated regimen typically assocd. with less than 50% sustained virol. response rate in those infected with genotype 1 virus.  The development of direct-acting antiviral agents to treat HCV has focused predominantly on inhibitors of the viral enzymes NS3 protease and the RNA-dependent RNA polymerase NS5B.  Here we describe the profile of BMS-790052, a small mol. inhibitor of the HCV NS5A protein that exhibits picomolar half-max. effective concns. (EC50) towards replicons expressing a broad range of HCV genotypes and the JFH-1 genotype 2a infectious virus in cell culture.  In a phase I clin. trial in patients chronically infected with HCV, administration of a single 100-mg dose of BMS-790052 was assocd. with a 3.3 log10 redn. in mean viral load measured 24 h post-dose that was sustained for an addnl. 120 h in two patients infected with genotype 1b virus.  Genotypic anal. of samples taken at baseline, 24 and 144 h post-dose revealed that the major HCV variants obsd. had substitutions at amino-acid positions identified using the in vitro replicon system.  These results provide the first clin. validation of an inhibitor of HCV NS5A, a protein with no known enzymic function, as an approach to the suppression of virus replication that offers potential as part of a therapeutic regimen based on combinations of HCV inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAY7Lig0xT9LVg90H21EOLACvtfcHk0licDlsVrUBhMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXltVGhtbo%253D&md5=620427e987f2bccd153270cde2ef5027</span></div><a href="/servlet/linkout?suffix=cit5d&amp;dbid=16384&amp;doi=10.1038%2Fnature08960&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature08960%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DM.%26aulast%3DNettles%26aufirst%3DR.%2BE.%26aulast%3DBelema%26aufirst%3DM.%26aulast%3DSnyder%26aufirst%3DL.%2BB.%26aulast%3DNguyen%26aufirst%3DV..N.%26aulast%3DFridell%26aufirst%3DR.%2BA.%26aulast%3DSerrano-Wu%26aufirst%3DM.%2BH.%26aulast%3DLangley%26aufirst%3DD.%2BR.%26aulast%3DSun%26aufirst%3DJ.-H.%26aulast%3DO%25E2%2580%2599Boyle%26aufirst%3DD.%2BR.%26aulast%3DLemm%26aufirst%3DJ.%2BA.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DKnipe%26aufirst%3DJ.%2BO.%26aulast%3DChien%26aufirst%3DC.%26aulast%3DColonno%26aufirst%3DR.%2BJ.%26aulast%3DGrasela%26aufirst%3DD.%2BM.%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26aulast%3DHamann%26aufirst%3DL.%2BG.%26atitle%3DChemical%2520genetics%2520strategy%2520identifies%2520an%2520HCV%2520NS5A%2520inhibitor%2520with%2520a%2520potent%2520clinical%2520effect%26jtitle%3DNature%26date%3D2010%26volume%3D465%26spage%3D96%26epage%3D100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">McHutchison, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Everson, G. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordon, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sulkowski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kauffman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNair, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alam, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muir, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Afdhal, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arora, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balan, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vargas, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernstein, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Black, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bzowej, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Bisceglie, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dienstag, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Everson, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faruqui, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franco, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fried, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghalib, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordon, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kugelmas, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawitz, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Northup, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poordad, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez-Torres, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rustgi, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schiff, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiffman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sulkowski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szabol, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Younossi, Z.</span><span> </span><span class="NLM_article-title">Telaprevir with peginterferon and ribavirin for chronic HCV genotype 1 infection</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">360</span><span class="NLM_x">, </span> <span class="NLM_fpage">1827</span><span class="NLM_x">–</span> <span class="NLM_lpage">1838</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=16&amp;doi=10.1021%2Fjm201258k&amp;key=10.1056%2FNEJMoa0806104" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=8&amp;doi=10.1021%2Fjm201258k&amp;key=19403902" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=32&amp;doi=10.1021%2Fjm201258k&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlsVGmtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=360&publication_year=2009&pages=1827-1838&author=J.+G.+McHutchisonauthor=G.+T.+Eversonauthor=S.+C.+Gordonauthor=I.+M.+Jacobsonauthor=M.+Sulkowskiauthor=R.+Kauffmanauthor=L.+McNairauthor=J.+Alamauthor=A.+J.+Muirauthor=N.+Afdhalauthor=S.+Aroraauthor=V.+Balanauthor=H.+Vargasauthor=D.+Bernsteinauthor=M.+Blackauthor=R.+Brownauthor=N.+Bzowejauthor=G.+Davisauthor=A.+Di+Bisceglieauthor=J.+Dienstagauthor=G.+Eversonauthor=S.+Faruquiauthor=J.+Francoauthor=M.+Friedauthor=R.+Ghalibauthor=S.+C.+Gordonauthor=J.+Grossauthor=I.+M.+Jacobsonauthor=D.+Jensenauthor=M.+Kugelmasauthor=P.+Kwoauthor=E.+Lawitzauthor=W.+Leeauthor=P.+Martinauthor=D.+Nelsonauthor=P.+Northupauthor=K.+Patelauthor=F.+Poordadauthor=R.+K.+Reddyauthor=M.+Rodriguez-Torresauthor=V.+Rustgiauthor=E.+Schiffauthor=K.+Shermanauthor=M.+Shiffmanauthor=M.+Sulkowskiauthor=G.+Szabolauthor=Z.+Younossi&title=Telaprevir+with+peginterferon+and+ribavirin+for+chronic+HCV+genotype+1+infection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6aR"><div class="casContent"><span class="casTitleNuber">6a</span><div class="casTitle"><span class="NLM_cas:atitle">Telaprevir with peginterferon and ribavirin for chronic HCV genotype 1 infection</span></div><div class="casAuthors">McHutchison, John G.; Everson, Gregory T.; Gordon, Stuart C.; Jacobson, Ira M.; Sulkowski, Mark; Kauffman, Robert; McNair, Lindsay; Alam, John; Muir, Andrew J.; Afdhal, N.; Arora, S.; Balan, V.; Vargas, H.; Bernstein, D.; Black, M.; Brown, R.; Bzowej, N.; Davis, G.; Di Bisceglie, A.; Dienstag, J.; Everson, G.; Faruqui, S.; Franco, J.; Fried, M.; Ghalib, R.; Gordon, S. C.; Gross, J.; Jacobson, I. M.; Jensen, D.; Kugelmas, M.; Kwo, P.; Lawitz, E.; Lee, W.; Martin, P.; Nelson, D.; Northup, P.; Patel, K.; Poordad, F.; Reddy, R. K.; Rodriguez-Torres, M.; Rustgi, V.; Schiff, E.; Sherman, K.; Shiffman, M.; Sulkowski, M.; Szabol, G.; Younossi, Z.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">360</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">1827-1838</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND Current therapy for chronic hepatitis C virus (HCV) infection is effective in less than 50% of patients infected with HCV genotype 1.  Telaprevir, a protease inhibitor specific to the HCV nonstructural 3/4A serine protease, rapidly reduced HCV RNA levels in early studies.  METHODS We randomly assigned patients infected with HCV genotype 1 to one of three telaprevir groups or to the control group.  The control group (called the PR48 group) received peginterferon alfa-2a (180 μg per wk) and ribavirin (1000 or 1200 mg per day, according to body wt.) for 48 wk, plus telaprevir-matched placebo for the first 12 wk (75 patients).  The telaprevir groups received telaprevir (1250 mg on day 1 and 750 mg every 8 h thereafter) for 12 wk, as well as peginterferon alfa-2a and ribavirin (at the same doses as in the PR48 group) for the same 12 wk (the T12PR12 group, 17 patients) or for a total of 24 wk (the T12PR24 group, 79 patients) or 48 wk (the T12PR48 group, 79 patients).  The primary outcome was a sustained virol. response (an undetectable HCV RNA level 24 wk after the end of therapy).  RESULTS The rate of sustained virol. response was 41% (31 of 75 patients) in the PR48 group, as compared with 61% (48 of 79 patients) in the T12PR24 group (P = 0.02), 67% (53 of 79 patients) in the T12PR48 group (P = 0.002), and 35% (6 of 17 patients) in the T12PR12 group (this group was exploratory and not compared with the control group).  Viral breakthrough occurred in 7% of patients receiving telaprevir.  The rate of discontinuation because of adverse events was higher in the three telaprevir-based groups (21%, vs. 11% in the PR48 group), with rash the most common reason for discontinuation.  CONCLUSIONS Treatment with a telaprevir-based regimen significantly improved sustained virol. response rates in patients with genotype 1 HCV, albeit with higher rates of discontinuation because of adverse events.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnK2pWAKIzM7Vg90H21EOLACvtfcHk0licDlsVrUBhMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlsVGmtrc%253D&md5=574eed8a6bd101631bb1e3d904a072b5</span></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa0806104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa0806104%26sid%3Dliteratum%253Aachs%26aulast%3DMcHutchison%26aufirst%3DJ.%2BG.%26aulast%3DEverson%26aufirst%3DG.%2BT.%26aulast%3DGordon%26aufirst%3DS.%2BC.%26aulast%3DJacobson%26aufirst%3DI.%2BM.%26aulast%3DSulkowski%26aufirst%3DM.%26aulast%3DKauffman%26aufirst%3DR.%26aulast%3DMcNair%26aufirst%3DL.%26aulast%3DAlam%26aufirst%3DJ.%26aulast%3DMuir%26aufirst%3DA.%2BJ.%26aulast%3DAfdhal%26aufirst%3DN.%26aulast%3DArora%26aufirst%3DS.%26aulast%3DBalan%26aufirst%3DV.%26aulast%3DVargas%26aufirst%3DH.%26aulast%3DBernstein%26aufirst%3DD.%26aulast%3DBlack%26aufirst%3DM.%26aulast%3DBrown%26aufirst%3DR.%26aulast%3DBzowej%26aufirst%3DN.%26aulast%3DDavis%26aufirst%3DG.%26aulast%3DDi%2BBisceglie%26aufirst%3DA.%26aulast%3DDienstag%26aufirst%3DJ.%26aulast%3DEverson%26aufirst%3DG.%26aulast%3DFaruqui%26aufirst%3DS.%26aulast%3DFranco%26aufirst%3DJ.%26aulast%3DFried%26aufirst%3DM.%26aulast%3DGhalib%26aufirst%3DR.%26aulast%3DGordon%26aufirst%3DS.%2BC.%26aulast%3DGross%26aufirst%3DJ.%26aulast%3DJacobson%26aufirst%3DI.%2BM.%26aulast%3DJensen%26aufirst%3DD.%26aulast%3DKugelmas%26aufirst%3DM.%26aulast%3DKwo%26aufirst%3DP.%26aulast%3DLawitz%26aufirst%3DE.%26aulast%3DLee%26aufirst%3DW.%26aulast%3DMartin%26aufirst%3DP.%26aulast%3DNelson%26aufirst%3DD.%26aulast%3DNorthup%26aufirst%3DP.%26aulast%3DPatel%26aufirst%3DK.%26aulast%3DPoordad%26aufirst%3DF.%26aulast%3DReddy%26aufirst%3DR.%2BK.%26aulast%3DRodriguez-Torres%26aufirst%3DM.%26aulast%3DRustgi%26aufirst%3DV.%26aulast%3DSchiff%26aufirst%3DE.%26aulast%3DSherman%26aufirst%3DK.%26aulast%3DShiffman%26aufirst%3DM.%26aulast%3DSulkowski%26aufirst%3DM.%26aulast%3DSzabol%26aufirst%3DG.%26aulast%3DYounossi%26aufirst%3DZ.%26atitle%3DTelaprevir%2520with%2520peginterferon%2520and%2520ribavirin%2520for%2520chronic%2520HCV%2520genotype%25201%2520infection%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2009%26volume%3D360%26spage%3D1827%26epage%3D1838" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Kwo, P. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawitz, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCone, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schiff, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vierling, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pound, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galati, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordon, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ravendhran, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossaro, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, F. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koury, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pedicone, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brass, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaudhri, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albrecht, J. K.</span><span> </span><span class="NLM_article-title">Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alpha-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">376</span><span class="NLM_x">, </span> <span class="NLM_fpage">705</span><span class="NLM_x">–</span> <span class="NLM_lpage">716</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=376&publication_year=2010&pages=705-716&author=P.+Y.+Kwoauthor=E.+J.+Lawitzauthor=J.+McConeauthor=E.+R.+Schiffauthor=J.+M.+Vierlingauthor=D.+Poundauthor=M.+N.+Davisauthor=J.+S.+Galatiauthor=S.+C.+Gordonauthor=N.+Ravendhranauthor=L.+Rossaroauthor=F.+H.+Andersonauthor=I.+M.+Jacobsonauthor=R.+Rubinauthor=K.+Kouryauthor=L.+D.+Pediconeauthor=C.+A.+Brassauthor=E.+Chaudhriauthor=J.+K.+Albrecht&title=Efficacy+of+boceprevir%2C+an+NS3+protease+inhibitor%2C+in+combination+with+peginterferon+alpha-2b+and+ribavirin+in+treatment-naive+patients+with+genotype+1+hepatitis+C+infection+%28SPRINT-1%29%3A+an+open-label%2C+randomised%2C+multicentre+phase+2+trial"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKwo%26aufirst%3DP.%2BY.%26aulast%3DLawitz%26aufirst%3DE.%2BJ.%26aulast%3DMcCone%26aufirst%3DJ.%26aulast%3DSchiff%26aufirst%3DE.%2BR.%26aulast%3DVierling%26aufirst%3DJ.%2BM.%26aulast%3DPound%26aufirst%3DD.%26aulast%3DDavis%26aufirst%3DM.%2BN.%26aulast%3DGalati%26aufirst%3DJ.%2BS.%26aulast%3DGordon%26aufirst%3DS.%2BC.%26aulast%3DRavendhran%26aufirst%3DN.%26aulast%3DRossaro%26aufirst%3DL.%26aulast%3DAnderson%26aufirst%3DF.%2BH.%26aulast%3DJacobson%26aufirst%3DI.%2BM.%26aulast%3DRubin%26aufirst%3DR.%26aulast%3DKoury%26aufirst%3DK.%26aulast%3DPedicone%26aufirst%3DL.%2BD.%26aulast%3DBrass%26aufirst%3DC.%2BA.%26aulast%3DChaudhri%26aufirst%3DE.%26aulast%3DAlbrecht%26aufirst%3DJ.%2BK.%26atitle%3DEfficacy%2520of%2520boceprevir%252C%2520an%2520NS3%2520protease%2520inhibitor%252C%2520in%2520combination%2520with%2520peginterferon%2520alpha-2b%2520and%2520ribavirin%2520in%2520treatment-naive%2520patients%2520with%2520genotype%25201%2520hepatitis%2520C%2520infection%2520%2528SPRINT-1%2529%253A%2520an%2520open-label%252C%2520randomised%252C%2520multicentre%2520phase%25202%2520trial%26jtitle%3DLancet%26date%3D2010%26volume%3D376%26spage%3D705%26epage%3D716" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Perni, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almquist, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Byrn, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chandorkar, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaturvedi, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Courtney, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decker, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dinehart, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gates, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harbeson, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heiser, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalkeri, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolaczkowski, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luong, Y.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, W. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomson, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tung, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwong, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, C.</span><span> </span><span class="NLM_article-title">Preclinical profile of VX-950, a potent, selective, and orally, bioavailable inhibitor of hepatitis C virus NS3–4A serine protease</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">899</span><span class="NLM_x">–</span> <span class="NLM_lpage">909</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2006&pages=899-909&author=R.+B.+Perniauthor=S.+J.+Almquistauthor=R.+A.+Byrnauthor=G.+Chandorkarauthor=P.+R.+Chaturvediauthor=L.+F.+Courtneyauthor=C.+J.+Deckerauthor=K.+Dinehartauthor=C.+A.+Gatesauthor=S.+L.+Harbesonauthor=A.+Heiserauthor=G.+Kalkeriauthor=E.+Kolaczkowskiauthor=K.+Linauthor=Y.-P.+Luongauthor=B.+G.+Raoauthor=W.+P.+Taylorauthor=J.+A.+Thomsonauthor=R.+D.+Tungauthor=Y.+Weiauthor=A.+D.+Kwongauthor=C.+Lin&title=Preclinical+profile+of+VX-950%2C+a+potent%2C+selective%2C+and+orally%2C+bioavailable+inhibitor+of+hepatitis+C+virus+NS3%E2%80%934A+serine+protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPerni%26aufirst%3DR.%2BB.%26aulast%3DAlmquist%26aufirst%3DS.%2BJ.%26aulast%3DByrn%26aufirst%3DR.%2BA.%26aulast%3DChandorkar%26aufirst%3DG.%26aulast%3DChaturvedi%26aufirst%3DP.%2BR.%26aulast%3DCourtney%26aufirst%3DL.%2BF.%26aulast%3DDecker%26aufirst%3DC.%2BJ.%26aulast%3DDinehart%26aufirst%3DK.%26aulast%3DGates%26aufirst%3DC.%2BA.%26aulast%3DHarbeson%26aufirst%3DS.%2BL.%26aulast%3DHeiser%26aufirst%3DA.%26aulast%3DKalkeri%26aufirst%3DG.%26aulast%3DKolaczkowski%26aufirst%3DE.%26aulast%3DLin%26aufirst%3DK.%26aulast%3DLuong%26aufirst%3DY.-P.%26aulast%3DRao%26aufirst%3DB.%2BG.%26aulast%3DTaylor%26aufirst%3DW.%2BP.%26aulast%3DThomson%26aufirst%3DJ.%2BA.%26aulast%3DTung%26aufirst%3DR.%2BD.%26aulast%3DWei%26aufirst%3DY.%26aulast%3DKwong%26aufirst%3DA.%2BD.%26aulast%3DLin%26aufirst%3DC.%26atitle%3DPreclinical%2520profile%2520of%2520VX-950%252C%2520a%2520potent%252C%2520selective%252C%2520and%2520orally%252C%2520bioavailable%2520inhibitor%2520of%2520hepatitis%2520C%2520virus%2520NS3%25E2%2580%25934A%2520serine%2520protease%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2006%26volume%3D50%26spage%3D899%26epage%3D909" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Njoroge, F. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shih, N.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piwinski, J. J.</span><span> </span><span class="NLM_article-title">Challenges in Modern Drug Discovery: A Case Study of Boceprevir, an HCV Protease Inhibitor for the Treatment of Hepatitis C Virus Infection</span> <span class="citation_source-journal">Acc. Chem. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">50</span><span class="NLM_x">–</span> <span class="NLM_lpage">59</span></span><div class="citationLinks">[<a href="/doi/10.1021/ar700109k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2008&pages=50-59&author=F.+G.+Njorogeauthor=K.+X.+Chenauthor=N.-Y.+Shihauthor=J.+J.+Piwinski&title=Challenges+in+Modern+Drug+Discovery%3A+A+Case+Study+of+Boceprevir%2C+an+HCV+Protease+Inhibitor+for+the+Treatment+of+Hepatitis+C+Virus+Infection"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=10.1021%2Far700109k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Far700109k%26sid%3Dliteratum%253Aachs%26aulast%3DNjoroge%26aufirst%3DF.%2BG.%26aulast%3DChen%26aufirst%3DK.%2BX.%26aulast%3DShih%26aufirst%3DN.-Y.%26aulast%3DPiwinski%26aufirst%3DJ.%2BJ.%26atitle%3DChallenges%2520in%2520Modern%2520Drug%2520Discovery%253A%2520A%2520Case%2520Study%2520of%2520Boceprevir%252C%2520an%2520HCV%2520Protease%2520Inhibitor%2520for%2520the%2520Treatment%2520of%2520Hepatitis%2520C%2520Virus%2520Infection%26jtitle%3DAcc.%2520Chem.%2520Res.%26date%3D2008%26volume%3D41%26spage%3D50%26epage%3D59" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Venkatraman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bogen, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arasappan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jao, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.-T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovey, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hendrata, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parekh, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinto, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Popov, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pike, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santhanam, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vibulbhan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butkiewicz, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chase, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hart, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agarwal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ingravallo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pichardo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baroudy, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malcolm, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prongay, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madison</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broske, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, K.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsieh, T. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brisson, J.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prelusky, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kormacher, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bogonowich-Knipp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pavlovsky, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prudence, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saksena, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganguly, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piwinski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Girijavallabhan, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Njoroge, F. G.</span><span> </span><span class="NLM_article-title">Discovery of (1<i>R</i>,5<i>S</i>)-<i>N</i>-[3-Amino-1-(cyclobutylmethyl)-2–3-dioxopropyl]-3-[2(<i>S</i>)-[[[(1,1-dimethylethyl)-amino]carbonyl]amino]-3,3-dimethyl-1-oxobutyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexan-2(<i>S</i>)-carboxamide (SCH 503034), a selective, potent, orally bioavailable, hepatitis C virus NS3 protease inhibitor: a potential therapeutic agent for the treatment of hepatitis C infection</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">6074</span><span class="NLM_x">–</span> <span class="NLM_lpage">6086</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060325b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6074-6086&author=S.+Venkatramanauthor=S.+L.+Bogenauthor=A.+Arasappanauthor=F.+Bennettauthor=K.+Chenauthor=E.+Jaoauthor=Y.-T.+Liuauthor=R.+Loveyauthor=S.+Hendrataauthor=Y.+Huangauthor=W.+Panauthor=T.+Parekhauthor=P.+Pintoauthor=V.+Popovauthor=R.+Pikeauthor=S.+Ruanauthor=B.+Santhanamauthor=B.+Vibulbhanauthor=W.+Wuauthor=W.+Yangauthor=W.+Yangauthor=J.+Kongauthor=X.+Liangauthor=J.+Wongauthor=R.+Liuauthor=N.+Butkiewiczauthor=R.+Chaseauthor=A.+Hartauthor=S.+Agarwalauthor=P.+Ingravalloauthor=J.+Pichardoauthor=R.+Kongauthor=B.+Baroudyauthor=B.+Malcolmauthor=Z.+Guoauthor=A.+Prongayauthor=+Madisonauthor=L.+Broskeauthor=X.+Cuiauthor=K.-C.+Chengauthor=T.+Y.+Hsiehauthor=J.-M.+Brissonauthor=D.+Preluskyauthor=W.+Kormacherauthor=R.+Whiteauthor=S.+Bogonowich-Knippauthor=A.+Pavlovskyauthor=B.+Prudenceauthor=A.+K.+Saksenaauthor=A.+Gangulyauthor=J.+Piwinskiauthor=V.+Girijavallabhanauthor=F.+G.+Njoroge&title=Discovery+of+%281R%2C5S%29-N-%5B3-Amino-1-%28cyclobutylmethyl%29-2%E2%80%933-dioxopropyl%5D-3-%5B2%28S%29-%5B%5B%5B%281%2C1-dimethylethyl%29-amino%5Dcarbonyl%5Damino%5D-3%2C3-dimethyl-1-oxobutyl%5D-6%2C6-dimethyl-3-azabicyclo%5B3.1.0%5Dhexan-2%28S%29-carboxamide+%28SCH+503034%29%2C+a+selective%2C+potent%2C+orally+bioavailable%2C+hepatitis+C+virus+NS3+protease+inhibitor%3A+a+potential+therapeutic+agent+for+the+treatment+of+hepatitis+C+infection"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=10.1021%2Fjm060325b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060325b%26sid%3Dliteratum%253Aachs%26aulast%3DVenkatraman%26aufirst%3DS.%26aulast%3DBogen%26aufirst%3DS.%2BL.%26aulast%3DArasappan%26aufirst%3DA.%26aulast%3DBennett%26aufirst%3DF.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DJao%26aufirst%3DE.%26aulast%3DLiu%26aufirst%3DY.-T.%26aulast%3DLovey%26aufirst%3DR.%26aulast%3DHendrata%26aufirst%3DS.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DPan%26aufirst%3DW.%26aulast%3DParekh%26aufirst%3DT.%26aulast%3DPinto%26aufirst%3DP.%26aulast%3DPopov%26aufirst%3DV.%26aulast%3DPike%26aufirst%3DR.%26aulast%3DRuan%26aufirst%3DS.%26aulast%3DSanthanam%26aufirst%3DB.%26aulast%3DVibulbhan%26aufirst%3DB.%26aulast%3DWu%26aufirst%3DW.%26aulast%3DYang%26aufirst%3DW.%26aulast%3DYang%26aufirst%3DW.%26aulast%3DKong%26aufirst%3DJ.%26aulast%3DLiang%26aufirst%3DX.%26aulast%3DWong%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DR.%26aulast%3DButkiewicz%26aufirst%3DN.%26aulast%3DChase%26aufirst%3DR.%26aulast%3DHart%26aufirst%3DA.%26aulast%3DAgarwal%26aufirst%3DS.%26aulast%3DIngravallo%26aufirst%3DP.%26aulast%3DPichardo%26aufirst%3DJ.%26aulast%3DKong%26aufirst%3DR.%26aulast%3DBaroudy%26aufirst%3DB.%26aulast%3DMalcolm%26aufirst%3DB.%26aulast%3DGuo%26aufirst%3DZ.%26aulast%3DProngay%26aufirst%3DA.%26aulast%3DMadison%26aulast%3DBroske%26aufirst%3DL.%26aulast%3DCui%26aufirst%3DX.%26aulast%3DCheng%26aufirst%3DK.-C.%26aulast%3DHsieh%26aufirst%3DT.%2BY.%26aulast%3DBrisson%26aufirst%3DJ.-M.%26aulast%3DPrelusky%26aufirst%3DD.%26aulast%3DKormacher%26aufirst%3DW.%26aulast%3DWhite%26aufirst%3DR.%26aulast%3DBogonowich-Knipp%26aufirst%3DS.%26aulast%3DPavlovsky%26aufirst%3DA.%26aulast%3DPrudence%26aufirst%3DB.%26aulast%3DSaksena%26aufirst%3DA.%2BK.%26aulast%3DGanguly%26aufirst%3DA.%26aulast%3DPiwinski%26aufirst%3DJ.%26aulast%3DGirijavallabhan%26aufirst%3DV.%26aulast%3DNjoroge%26aufirst%3DF.%2BG.%26atitle%3DDiscovery%2520of%2520%25281R%252C5S%2529-N-%255B3-Amino-1-%2528cyclobutylmethyl%2529-2%25E2%2580%25933-dioxopropyl%255D-3-%255B2%2528S%2529-%255B%255B%255B%25281%252C1-dimethylethyl%2529-amino%255Dcarbonyl%255Damino%255D-3%252C3-dimethyl-1-oxobutyl%255D-6%252C6-dimethyl-3-azabicyclo%255B3.1.0%255Dhexan-2%2528S%2529-carboxamide%2520%2528SCH%2520503034%2529%252C%2520a%2520selective%252C%2520potent%252C%2520orally%2520bioavailable%252C%2520hepatitis%2520C%2520virus%2520NS3%2520protease%2520inhibitor%253A%2520a%2520potential%2520therapeutic%2520agent%2520for%2520the%2520treatment%2520of%2520hepatitis%2520C%2520infection%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6074%26epage%3D6086" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Behrens, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomei, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Francesco, R.</span><span> </span><span class="NLM_article-title">Identification and properties of the RNA-dependent RNA polymerase of hepatitis C virus</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">12</span><span class="NLM_x">–</span> <span class="NLM_lpage">22</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1996&pages=12-22&author=S.+E.+Behrensauthor=L.+Tomeiauthor=R.+De+Francesco&title=Identification+and+properties+of+the+RNA-dependent+RNA+polymerase+of+hepatitis+C+virus"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBehrens%26aufirst%3DS.%2BE.%26aulast%3DTomei%26aufirst%3DL.%26aulast%3DDe%2BFrancesco%26aufirst%3DR.%26atitle%3DIdentification%2520and%2520properties%2520of%2520the%2520RNA-dependent%2520RNA%2520polymerase%2520of%2520hepatitis%2520C%2520virus%26jtitle%3DEMBO%2520J.%26date%3D1996%26volume%3D15%26spage%3D12%26epage%3D22" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit9b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Lohmann, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korner, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herian, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartenschlager, R.</span><span> </span><span class="NLM_article-title">Biochemical properties of hepatitis c virus ns5b RNAdependent RNA polymerase and identification of amino acid sequence motifs essential for enzymatic activity</span> <span class="citation_source-journal">J. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">8416</span><span class="NLM_x">–</span> <span class="NLM_lpage">8428</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=8&amp;doi=10.1021%2Fjm201258k&amp;key=9343198" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=32&amp;doi=10.1021%2Fjm201258k&amp;key=1%3ACAS%3A528%3ADyaK2sXmvV2hs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=1997&pages=8416-8428&author=V.+Lohmannauthor=F.+Kornerauthor=U.+Herianauthor=R.+Bartenschlager&title=Biochemical+properties+of+hepatitis+c+virus+ns5b+RNAdependent+RNA+polymerase+and+identification+of+amino+acid+sequence+motifs+essential+for+enzymatic+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9bR"><div class="casContent"><span class="casTitleNuber">9b</span><div class="casTitle"><span class="NLM_cas:atitle">Biochemical properties of hepatitis C virus NS5B RNA-dependent RNA polymerase and identification of amino acid sequence motifs essential for enzymic activity</span></div><div class="casAuthors">Lohmann, Volker; Korner, Frank; Herian, Ulrike; Bartenschlager, Ralf</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">8416-8428</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The NS5B protein of the hepatitis C virus (HCV) is an RNA-dependent RNA polymerase (RdRp) (S.-E. Behrens, L. Tomei, and R. De Francesco, EMBO J. 15:12-22, 1996) that is assumed to be required for replication of the viral genome.  To further study the biochem. and structural properties of this enzyme, an NS5B-hexahistidine fusion protein was expressed with recombinant baculoviruses in insect cells and purified to near homogeneity.  The enzyme was found to have a primer-dependent RdRp activity that was able to copy a complete in vitro-transcribed HCV genome in the absence of addnl. viral or cellular factors.  Filter binding assays and competition expts. showed that the purified enzyme binds RNA with no clear preference for HCV 3'-end sequences.  Binding to homopolymeric RNAs was also examd., and the following order of specificity was obsd.: poly(U) > poly(G) > poly(A) > poly(C).  An inverse order was found for the RdRp activity, which used poly(C) most efficiently as a template but was inactive on poly(U) and poly(G), suggesting that a high binding affinity between polymerase and template interferes with processivity.  By using a mutational anal., four amino acid sequence motifs crucial for RdRp activity were identified.  While most substitutions of conserved residues within these motifs severely reduced the enzymic activities, a single substitution in motif D which enhanced the RdRp activity by about 50% was found.  Deletion studies indicate that amino acid residues at the very termini, in particular the amino terminus, are important for RdRp activity but not for RNA binding.  Finally, we found a terminal transferase activity assocd. with the purified enzyme.  However, this activity was also detected with NS5B proteins with an inactive RdRp, with an NS4B protein purified in the same way, and with wild-type baculovirus, suggesting that it is not an inherent activity of NS5B.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdCeTDzvlRArVg90H21EOLACvtfcHk0lj_oRp27b7OGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXmvV2hs7s%253D&md5=98640d185270f0b331db0fa0624865cd</span></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLohmann%26aufirst%3DV.%26aulast%3DKorner%26aufirst%3DF.%26aulast%3DHerian%26aufirst%3DU.%26aulast%3DBartenschlager%26aufirst%3DR.%26atitle%3DBiochemical%2520properties%2520of%2520hepatitis%2520c%2520virus%2520ns5b%2520RNAdependent%2520RNA%2520polymerase%2520and%2520identification%2520of%2520amino%2520acid%2520sequence%2520motifs%2520essential%2520for%2520enzymatic%2520activity%26jtitle%3DJ.%2520Virol.%26date%3D1997%26volume%3D71%26spage%3D8416%26epage%3D8428" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Quinkert, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartenschlager, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lohmann, V.</span><span> </span><span class="NLM_article-title">Quantitative analysis of the hepatitis C virus replication complex</span> <span class="citation_source-journal">J. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">13594</span><span class="NLM_x">–</span> <span class="NLM_lpage">13605</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm201258k&amp;key=10.1128%2FJVI.79.21.13594-13605.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm201258k&amp;key=16227280" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm201258k&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFKjtr%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2005&pages=13594-13605&author=D.+Quinkertauthor=R.+Bartenschlagerauthor=V.+Lohmann&title=Quantitative+analysis+of+the+hepatitis+C+virus+replication+complex"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Quantitative analysis of the hepatitis C virus replication complex</span></div><div class="casAuthors">Quinkert, Doris; Bartenschlager, Ralf; Lohmann, Volker</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">13594-13605</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The hepatitis C virus (HCV) encodes a large polyprotein; therefore, all viral proteins are produced in equimolar amts. regardless of their function.  The aim of our study was to det. the ratio of nonstructural proteins to RNA that is required for HCV RNA replication.  We analyzed Huh-7 cells harboring full-length HCV genomes or subgenomic replicons and found in all cases a >1000-fold excess of HCV proteins over pos.- and neg.-strand RNA.  To examine whether all nonstructural protein copies are involved in RNA synthesis, we isolated active HCV replication complexes from replicon cells and examd. them for their content of viral RNA and proteins before and after treatment with protease and/or nuclease.  In vitro replicase activity, as well as almost the entire neg.- and pos.-strand RNA, was resistant to nuclease treatment, whereas <5% of the nonstructural proteins were protected from protease digest but accounted for the full in vitro replicase activity.  In consequence, only a minor fraction of the HCV nonstructural proteins was actively involved in RNA synthesis at a given time point but, due to the high amts. present in replicon cells, still representing a huge excess compared to the viral RNA.  Based on the comparison of nuclease-resistant viral RNA to protease-resistant viral proteins, we est. that an active HCV replicase complex consists of one neg.-strand RNA, two to ten pos.-strand RNAs, and several hundred nonstructural protein copies, which might be required as structural components of the vesicular compartments that are the site of HCV replication.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogSsRsSfAAvLVg90H21EOLACvtfcHk0lj_oRp27b7OGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFKjtr%252FJ&md5=c5060858a84ac062a62d2bfa0a5ca926</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1128%2FJVI.79.21.13594-13605.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.79.21.13594-13605.2005%26sid%3Dliteratum%253Aachs%26aulast%3DQuinkert%26aufirst%3DD.%26aulast%3DBartenschlager%26aufirst%3DR.%26aulast%3DLohmann%26aufirst%3DV.%26atitle%3DQuantitative%2520analysis%2520of%2520the%2520hepatitis%2520C%2520virus%2520replication%2520complex%26jtitle%3DJ.%2520Virol.%26date%3D2005%26volume%3D79%26spage%3D13594%26epage%3D13605" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Lesburg, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cable, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrari, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mannarino, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, P. C.</span><span> </span><span class="NLM_article-title">Crystal structure of the RNA-dependent RNA polymerase from hepatitis C virus reveals a fully encircled active site</span> <span class="citation_source-journal">Nature Struct. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">937</span><span class="NLM_x">–</span> <span class="NLM_lpage">943</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=16&amp;doi=10.1021%2Fjm201258k&amp;key=10.1038%2F13305" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=8&amp;doi=10.1021%2Fjm201258k&amp;key=10504728" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=32&amp;doi=10.1021%2Fjm201258k&amp;key=1%3ACAS%3A528%3ADyaK1MXmslCktLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1999&pages=937-943&author=C.+A.+Lesburgauthor=M.+B.+Cableauthor=E.+Ferrariauthor=Z.+Hongauthor=A.+F.+Mannarinoauthor=P.+C.+Weber&title=Crystal+structure+of+the+RNA-dependent+RNA+polymerase+from+hepatitis+C+virus+reveals+a+fully+encircled+active+site"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11aR"><div class="casContent"><span class="casTitleNuber">11a</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of the RNA-dependent RNA polymerase from hepatitis C virus reveals a fully encircled active site</span></div><div class="casAuthors">Lesburg, Charles A.; Cable, Michael B.; Ferrari, Eric; Hong, Zhi; Mannarino, Anthony F.; Weber, Patricia C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural Biology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">937-943</span>CODEN:
                <span class="NLM_cas:coden">NSBIEW</span>;
        ISSN:<span class="NLM_cas:issn">1072-8368</span>.
    
            (<span class="NLM_cas:orgname">Nature America</span>)
        </div><div class="casAbstract">Various classes of nucleotidyl polymerases with different transcriptional roles contain a conserved core structure.  Less is known, however, about the distinguishing features of these enzymes, particularly those of the RNA-dependent RNA polymerase class.  The 1.9 Å resoln. crystal structure of hepatitis C virus (HCV) nonstructural protein 5B (NS5B) presented here provides the first complete and detailed view of an RNA-dependent RNA polymerase.  While canonical polymerase features exist in the structure, NS5B adopts a unique shape due to extensive interactions between the fingers and thumb polymerase subdomains that serve to encircle the enzyme active site.  Several insertions in the fingers subdomain account for intersubdomain linkages that include two extended loops and a pair of antiparallel α-helixes.  The HCV NS5B apoenzyme structure reported here can accommodate a template:primer duplex without global conformational changes, supporting the hypothesis that this structure is essentially preserved during the reaction pathway.  This NS5B template:primer model also allows identification of a new structural motif involved in stabilizing the nascent base pair.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnLsPABmT0XbVg90H21EOLACvtfcHk0lgVbe0MgXvocg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmslCktLo%253D&md5=210fd9e96e7ca8d342ed1ae87f0b4acc</span></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=10.1038%2F13305&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F13305%26sid%3Dliteratum%253Aachs%26aulast%3DLesburg%26aufirst%3DC.%2BA.%26aulast%3DCable%26aufirst%3DM.%2BB.%26aulast%3DFerrari%26aufirst%3DE.%26aulast%3DHong%26aufirst%3DZ.%26aulast%3DMannarino%26aufirst%3DA.%2BF.%26aulast%3DWeber%26aufirst%3DP.%2BC.%26atitle%3DCrystal%2520structure%2520of%2520the%2520RNA-dependent%2520RNA%2520polymerase%2520from%2520hepatitis%2520C%2520virus%2520reveals%2520a%2520fully%2520encircled%2520active%2520site%26jtitle%3DNature%2520Struct.%2520Biol.%26date%3D1999%26volume%3D6%26spage%3D937%26epage%3D943" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit11b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Ago, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adachi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Habuka, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yatsunami, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyano, M.</span><span> </span><span class="NLM_article-title">Crystal structure of the RNA-dependent RNA polymerase of hepatitis C virus</span> <span class="citation_source-journal">Structure</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1417</span><span class="NLM_x">–</span> <span class="NLM_lpage">1426</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=16&amp;doi=10.1021%2Fjm201258k&amp;key=10.1016%2FS0969-2126%2800%2980031-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=8&amp;doi=10.1021%2Fjm201258k&amp;key=10574802" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=32&amp;doi=10.1021%2Fjm201258k&amp;key=1%3ACAS%3A528%3ADyaK1MXnslOit7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1999&pages=1417-1426&author=H.+Agoauthor=T.+Adachiauthor=A.+Yoshidaauthor=M.+Yamamotoauthor=N.+Habukaauthor=K.+Yatsunamiauthor=M.+Miyano&title=Crystal+structure+of+the+RNA-dependent+RNA+polymerase+of+hepatitis+C+virus"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11bR"><div class="casContent"><span class="casTitleNuber">11b</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of the RNA-dependent RNA polymerase of hepatitis C virus</span></div><div class="casAuthors">Ago, Hideo; Adachi, Tsuyoshi; Yoshida, Atsuhito; Yamamoto, Masaki; Habuka, Noriyuki; Yatsunami, Kimio; Miyano, Masashi</div><div class="citationInfo"><span class="NLM_cas:title">Structure (London)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1417-1426</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Current Biology Publications</span>)
        </div><div class="casAbstract">Hepatitis C virus (HCV) is the major etiol. agent of hepatocellular carcinoma, and HCV RNA-dependent RNA polymerase (RNA replicase) (I) is one of the main potential targets for anti-HCV agents.  HCV I performs run-off copying replication in an RNA-selective manner for the template-primer duplex and the substrate, but the structural basis of this reaction mechanism has still to be elucidated.  Here, the 3-dimensional structure of HCV I was detd. by x-ray crystallog. at 2.5 Å resoln.  The compact HCV I structure resembled a right hand, but had more complicated fingers and thumb domains than those of the other known polymerases, with a novel α-helix-rich subdomain (α fingers) as an addn. to the fingers domain.  The other fingers subdomain (β fingers) was folded in the same manner as the fingers domain of HIV virus reverse transcriptase, another RNA-dependent polymerase.  The ribose-recognition site of HCV I was constructed of hydrophilic residues, unlike those of DNA polymerases.  The C-terminal region of HCV I occupied the putative RNA-duplex-binding cleft.  The structural basis of the RNA selectivity of HCV I was elucidated from its crystal structure.  The putative substrate-binding site with a shallow hydrophilic cavity should have ribonucleoside triphosphate as the preferred substrate.  The authors propose that the unique α fingers might represent a common structural discriminator of the template-primer duplex that distinguishes between RNA and DNA during the replication of pos. single-stranded RNA by viral I enzymes.  The C-terminal region might exert a regulatory function on the initiation and activity of HCV I.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKp1aOmXjMKLVg90H21EOLACvtfcHk0lgVbe0MgXvocg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXnslOit7o%253D&md5=95fcc20ce2f28dab4d76d8dfac0aa4ee</span></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=10.1016%2FS0969-2126%2800%2980031-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0969-2126%252800%252980031-3%26sid%3Dliteratum%253Aachs%26aulast%3DAgo%26aufirst%3DH.%26aulast%3DAdachi%26aufirst%3DT.%26aulast%3DYoshida%26aufirst%3DA.%26aulast%3DYamamoto%26aufirst%3DM.%26aulast%3DHabuka%26aufirst%3DN.%26aulast%3DYatsunami%26aufirst%3DK.%26aulast%3DMiyano%26aufirst%3DM.%26atitle%3DCrystal%2520structure%2520of%2520the%2520RNA-dependent%2520RNA%2520polymerase%2520of%2520hepatitis%2520C%2520virus%26jtitle%3DStructure%26date%3D1999%26volume%3D7%26spage%3D1417%26epage%3D1426" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="note"><p class="first last">Reviews of non-nucleoside HCV NS5B polymerase inhibitors:</p></div><div class="NLM_citation" id="cit12a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Liu, Y.; He, Y.; Molla, A.</span><span> </span><span class="NLM_article-title">Hepatitis C Virus Polymerase as a Target for Antiviral Drug Intervention: Non-Nucleoside Inhibitors</span>. In:  <span class="citation_source-book">Antiviral Research: Strategies in Antiviral Drug Discovery</span>; <span class="NLM_contrib-group">LaFemina, R. L.</span>, Ed.; <span class="NLM_publisher-name">ASM Press</span>: <span class="NLM_publisher-loc">Washington, DC</span>,<span class="NLM_x"> </span><span class="NLM_year">2009</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">137</span><span class="NLM_x">–</span> <span class="NLM_lpage">151</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=16&amp;doi=10.1021%2Fjm201258k&amp;key=10.1128%2F9781555815493.ch8" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&pages=137-151&author=Y.+Liu&author=Y.+He&author=A.+Mollaauthor=R.+L.+LaFemina&title=Antiviral+Research%3A+Strategies+in+Antiviral+Drug+Discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12a&amp;dbid=16384&amp;doi=10.1128%2F9781555815493.ch8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1128%252F9781555815493.ch8%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DY.%26atitle%3DHepatitis%2520C%2520Virus%2520Polymerase%2520as%2520a%2520Target%2520for%2520Antiviral%2520Drug%2520Intervention%253A%2520Non-Nucleoside%2520Inhibitors%26btitle%3DAntiviral%2520Research%253A%2520Strategies%2520in%2520Antiviral%2520Drug%2520Discovery%26aulast%3DLaFemina%26aufirst%3DR.%2BL.%26pub%3DASM%2520Press%26date%3D2009%26spage%3D137%26epage%3D151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Beaulieu, P. L.</span><span> </span><span class="NLM_article-title">Non-nucleoside inhibitors of the hcv ns5b polymerase: progress in the discovery and development of novel agents for the treatment of hcv infections</span> <span class="citation_source-journal">Curr. Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">614</span><span class="NLM_x">–</span> <span class="NLM_lpage">634</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2007&pages=614-634&author=P.+L.+Beaulieu&title=Non-nucleoside+inhibitors+of+the+hcv+ns5b+polymerase%3A+progress+in+the+discovery+and+development+of+novel+agents+for+the+treatment+of+hcv+infections"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBeaulieu%26aufirst%3DP.%2BL.%26atitle%3DNon-nucleoside%2520inhibitors%2520of%2520the%2520hcv%2520ns5b%2520polymerase%253A%2520progress%2520in%2520the%2520discovery%2520and%2520development%2520of%2520novel%2520agents%2520for%2520the%2520treatment%2520of%2520hcv%2520infections%26jtitle%3DCurr.%2520Opin.%2520Invest.%2520Drugs%26date%3D2007%26volume%3D8%26spage%3D614%26epage%3D634" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="note"><p class="first last">Reviews of HCV NS5B polymerase inhibitors:</p></div><div class="NLM_citation" id="cit13a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Watkins, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ray, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chong, L. S.</span><span> </span><span class="NLM_article-title">HCV NS5B polymerase inhibitors</span> <span class="citation_source-journal">Curr. Opin. Drug Discovery Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">441</span><span class="NLM_x">–</span> <span class="NLM_lpage">465</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2010&pages=441-465&author=W.+J.+Watkinsauthor=A.+S.+Rayauthor=L.+S.+Chong&title=HCV+NS5B+polymerase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWatkins%26aufirst%3DW.%2BJ.%26aulast%3DRay%26aufirst%3DA.%2BS.%26aulast%3DChong%26aufirst%3DL.%2BS.%26atitle%3DHCV%2520NS5B%2520polymerase%2520inhibitors%26jtitle%3DCurr.%2520Opin.%2520Drug%2520Discovery%2520Dev.%26date%3D2010%26volume%3D13%26spage%3D441%26epage%3D465" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit13b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Legrand-Abravanel, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicot, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Izopet, J.</span><span> </span><span class="NLM_article-title">New NS5B polymerase inhibitors for hepatitis C</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">963</span><span class="NLM_x">–</span> <span class="NLM_lpage">975</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2010&pages=963-975&author=F.+Legrand-Abravanelauthor=F.+Nicotauthor=J.+Izopet&title=New+NS5B+polymerase+inhibitors+for+hepatitis+C"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLegrand-Abravanel%26aufirst%3DF.%26aulast%3DNicot%26aufirst%3DF.%26aulast%3DIzopet%26aufirst%3DJ.%26atitle%3DNew%2520NS5B%2520polymerase%2520inhibitors%2520for%2520hepatitis%2520C%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2010%26volume%3D19%26spage%3D963%26epage%3D975" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit13c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Beaulieu, P. L.</span><span> </span><span class="NLM_article-title">Recent advances in the development of NS5B polymerase inhibitors for the treatment of hepatitis C virus infection</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">145</span><span class="NLM_x">–</span> <span class="NLM_lpage">164</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13c&amp;dbid=16&amp;doi=10.1021%2Fjm201258k&amp;key=10.1517%2F13543770802672598" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13c&amp;dbid=32&amp;doi=10.1021%2Fjm201258k&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVCks74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=145-164&author=P.+L.+Beaulieu&title=Recent+advances+in+the+development+of+NS5B+polymerase+inhibitors+for+the+treatment+of+hepatitis+C+virus+infection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13cR"><div class="casContent"><span class="casTitleNuber">13c</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in the development of NS5B polymerase inhibitors for the treatment of hepatitis C virus infection</span></div><div class="casAuthors">Beaulieu, Pierre L.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">145-164</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  170 To 200 million people worldwide are believed to suffer from chronic hepatitis C virus (HCV) infection, a blood-born disease that targets the liver and progresses to organ cirrhosis and primary cancer in a significant proportion of patients.  The currently available treatment has limited efficacy and suffers from restricting side effects.  HCV infection is the principal cause of liver transplant in industrialized nations and between 8000 and 10,000 deaths result annually from the disease in the United States alone.  Virus-specific, more efficacious, and better-tolerated anti-HCV therapies are thus required to address the unmet medical need.  Objective: To review progress achieved since 2005 in the development of HCV NS5B polymerase inhibitors as potential therapy for the treatment of HCV infection with a primary focus on available patent and medical literature.  Results/conclusion: Several classes of small-mol. inhibitors of HCV NS5B have progressed into clin. development and demonstrated efficacy in reducing viral load in infected patients.  The results so far provide an encouraging foundation for the development of novel, more tolerable therapies and addressing emergence of resistance through combination of antiviral agents with complementary mechanisms of action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoo8VVFJs4oSbVg90H21EOLACvtfcHk0lh0Q5ZZy-O3_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVCks74%253D&md5=64b78562e2b4e3e8a166fdabf14f7efe</span></div><a href="/servlet/linkout?suffix=cit13c&amp;dbid=16384&amp;doi=10.1517%2F13543770802672598&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543770802672598%26sid%3Dliteratum%253Aachs%26aulast%3DBeaulieu%26aufirst%3DP.%2BL.%26atitle%3DRecent%2520advances%2520in%2520the%2520development%2520of%2520NS5B%2520polymerase%2520inhibitors%2520for%2520the%2520treatment%2520of%2520hepatitis%2520C%2520virus%2520infection%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2009%26volume%3D19%26spage%3D145%26epage%3D164" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Ma, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leveque, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Witte, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hendricks, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clausen, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cammack, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klumpp, K.</span><span> </span><span class="NLM_article-title">Inhibition of native hepatitis C virus replicase by nucleotide and non-nucleoside inhibitors</span> <span class="citation_source-journal">Virology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">332</span><span class="NLM_x">, </span> <span class="NLM_fpage">8</span><span class="NLM_x">–</span> <span class="NLM_lpage">15</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=332&publication_year=2005&pages=8-15&author=H.+Maauthor=V.+Levequeauthor=A.+De+Witteauthor=W.+Liauthor=T.+Hendricksauthor=S.+M.+Clausenauthor=N.+Cammackauthor=K.+Klumpp&title=Inhibition+of+native+hepatitis+C+virus+replicase+by+nucleotide+and+non-nucleoside+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DH.%26aulast%3DLeveque%26aufirst%3DV.%26aulast%3DDe%2BWitte%26aufirst%3DA.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DHendricks%26aufirst%3DT.%26aulast%3DClausen%26aufirst%3DS.%2BM.%26aulast%3DCammack%26aufirst%3DN.%26aulast%3DKlumpp%26aufirst%3DK.%26atitle%3DInhibition%2520of%2520native%2520hepatitis%2520C%2520virus%2520replicase%2520by%2520nucleotide%2520and%2520non-nucleoside%2520inhibitors%26jtitle%3DVirology%26date%3D2005%26volume%3D332%26spage%3D8%26epage%3D15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Manns, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rockstroh, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeuzem, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zoulim, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houghton, M.</span><span> </span><span class="NLM_article-title">The way forward in hcv treatment—finding the right path</span> <span class="citation_source-journal">Nature Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">991</span><span class="NLM_x">–</span> <span class="NLM_lpage">1000</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=991-1000&author=M.+P.+Mannsauthor=G.+R.+Fosterauthor=J.+K.+Rockstrohauthor=S.+Zeuzemauthor=F.+Zoulimauthor=M.+Houghton&title=The+way+forward+in+hcv+treatment%E2%80%94finding+the+right+path"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DManns%26aufirst%3DM.%2BP.%26aulast%3DFoster%26aufirst%3DG.%2BR.%26aulast%3DRockstroh%26aufirst%3DJ.%2BK.%26aulast%3DZeuzem%26aufirst%3DS.%26aulast%3DZoulim%26aufirst%3DF.%26aulast%3DHoughton%26aufirst%3DM.%26atitle%3DThe%2520way%2520forward%2520in%2520hcv%2520treatment%25E2%2580%2594finding%2520the%2520right%2520path%26jtitle%3DNature%2520Rev.%2520Drug%2520Discovery%26date%3D2007%26volume%3D6%26spage%3D991%26epage%3D1000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Pierra, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amador, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benzaria, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cretton-Scott, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Amours, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathieu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moussa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridges, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Standring, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sammadossi, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Storer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gosselin, G.</span><span> </span><span class="NLM_article-title">Synthesis and Pharmacokinetics of Valopicitabine (NM283), an Efficient Prodrug of the Potent Anti-HCV Agent 20-C-Methylcytidine</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">6614</span><span class="NLM_x">–</span> <span class="NLM_lpage">6620</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0603623" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6614-6620&author=C.+Pierraauthor=A.+Amadorauthor=S.+Benzariaauthor=E.+Cretton-Scottauthor=M.+D%E2%80%99Amoursauthor=J.+Maoauthor=S.+Mathieuauthor=A.+Moussaauthor=E.+G.+Bridgesauthor=D.+M.+Standringauthor=J.-P.+Sammadossiauthor=R.+Storerauthor=G.+Gosselin&title=Synthesis+and+Pharmacokinetics+of+Valopicitabine+%28NM283%29%2C+an+Efficient+Prodrug+of+the+Potent+Anti-HCV+Agent+20-C-Methylcytidine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16a&amp;dbid=16384&amp;doi=10.1021%2Fjm0603623&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0603623%26sid%3Dliteratum%253Aachs%26aulast%3DPierra%26aufirst%3DC.%26aulast%3DAmador%26aufirst%3DA.%26aulast%3DBenzaria%26aufirst%3DS.%26aulast%3DCretton-Scott%26aufirst%3DE.%26aulast%3DD%25E2%2580%2599Amours%26aufirst%3DM.%26aulast%3DMao%26aufirst%3DJ.%26aulast%3DMathieu%26aufirst%3DS.%26aulast%3DMoussa%26aufirst%3DA.%26aulast%3DBridges%26aufirst%3DE.%2BG.%26aulast%3DStandring%26aufirst%3DD.%2BM.%26aulast%3DSammadossi%26aufirst%3DJ.-P.%26aulast%3DStorer%26aufirst%3DR.%26aulast%3DGosselin%26aufirst%3DG.%26atitle%3DSynthesis%2520and%2520Pharmacokinetics%2520of%2520Valopicitabine%2520%2528NM283%2529%252C%2520an%2520Efficient%2520Prodrug%2520of%2520the%2520Potent%2520Anti-HCV%2520Agent%252020-C-Methylcytidine%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6614%26epage%3D6620" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit16b"><span><span class="NLM_label">(b) </span><div class="note"><p class="first last">(R1626)</p></div><span class="NLM_contrib-group">Smith, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalayanov, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sund, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winqvist, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maltseva, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leveque, V. J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajyagurr, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Pogam, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Najer, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benkestock, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, X.-X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaiser, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maag, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cammack, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swallow, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johannsson, N. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klumpp, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, M.</span><span> </span><span class="NLM_article-title">The Design, Synthesis, and Antiviral Activity of Monofluoro and Difluoro Analogues of 40-Axidocytidine against Hepatitis C Virus Replication: The Discovery of 40-Azido-20-deoxy-20-fluorocytidine and 40-Azido-20-dideoxy-20,20-difuorocytidine</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">2971</span><span class="NLM_x">–</span> <span class="NLM_lpage">2978</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm801595c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=2971-2978&author=D.+B.+Smithauthor=G.+Kalayanovauthor=G.+Sundauthor=A.+Winqvistauthor=T.+Maltsevaauthor=V.+J.-P.+Levequeauthor=S.+Rajyagurrauthor=S.+Le+Pogamauthor=I.+Najerauthor=K.+Benkestockauthor=X.-X.+Zhouauthor=A.+C.+Kaiserauthor=H.+Maagauthor=N.+Cammackauthor=J.+A.+Martinauthor=S.+Swallowauthor=N.+G.+Johannssonauthor=K.+Klumppauthor=M.+Smith&title=The+Design%2C+Synthesis%2C+and+Antiviral+Activity+of+Monofluoro+and+Difluoro+Analogues+of+40-Axidocytidine+against+Hepatitis+C+Virus+Replication%3A+The+Discovery+of+40-Azido-20-deoxy-20-fluorocytidine+and+40-Azido-20-dideoxy-20%2C20-difuorocytidine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16b&amp;dbid=16384&amp;doi=10.1021%2Fjm801595c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801595c%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DD.%2BB.%26aulast%3DKalayanov%26aufirst%3DG.%26aulast%3DSund%26aufirst%3DG.%26aulast%3DWinqvist%26aufirst%3DA.%26aulast%3DMaltseva%26aufirst%3DT.%26aulast%3DLeveque%26aufirst%3DV.%2BJ.-P.%26aulast%3DRajyagurr%26aufirst%3DS.%26aulast%3DLe%2BPogam%26aufirst%3DS.%26aulast%3DNajer%26aufirst%3DI.%26aulast%3DBenkestock%26aufirst%3DK.%26aulast%3DZhou%26aufirst%3DX.-X.%26aulast%3DKaiser%26aufirst%3DA.%2BC.%26aulast%3DMaag%26aufirst%3DH.%26aulast%3DCammack%26aufirst%3DN.%26aulast%3DMartin%26aufirst%3DJ.%2BA.%26aulast%3DSwallow%26aufirst%3DS.%26aulast%3DJohannsson%26aufirst%3DN.%2BG.%26aulast%3DKlumpp%26aufirst%3DK.%26aulast%3DSmith%26aufirst%3DM.%26atitle%3DThe%2520Design%252C%2520Synthesis%252C%2520and%2520Antiviral%2520Activity%2520of%2520Monofluoro%2520and%2520Difluoro%2520Analogues%2520of%252040-Axidocytidine%2520against%2520Hepatitis%2520C%2520Virus%2520Replication%253A%2520The%2520Discovery%2520of%252040-Azido-20-deoxy-20-fluorocytidine%2520and%252040-Azido-20-dideoxy-20%252C20-difuorocytidine%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D2971%26epage%3D2978" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit16c"><span><span class="NLM_label">(c) </span><div class="note"><p class="first last">(PSI-6130)</p></div><span class="NLM_contrib-group">Clark, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollecker, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mason, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stuyver, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tharnish, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lostia, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McBrayer, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schinazi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otto, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furman, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stec, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patterson, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pankiewicz, K. W.</span><span> </span><span class="NLM_article-title">Design, Synthesis, and Antiviral Activity of 20-Deoxy-20-fluoro-20-C-methylcytidine, a Potent Inhibitor of Hepatitis C Virus Replication</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">5504</span><span class="NLM_x">–</span> <span class="NLM_lpage">5508</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0502788" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=5504-5508&author=J.+L.+Clarkauthor=L.+Holleckerauthor=J.+C.+Masonauthor=L.+J.+Stuyverauthor=P.+M.+Tharnishauthor=S.+Lostiaauthor=T.+R.+McBrayerauthor=R.+Schinaziauthor=K.+A.+Watanabeauthor=M.+J.+Ottoauthor=P.+A.+Furmanauthor=W.+J.+Stecauthor=S.+E.+Pattersonauthor=K.+W.+Pankiewicz&title=Design%2C+Synthesis%2C+and+Antiviral+Activity+of+20-Deoxy-20-fluoro-20-C-methylcytidine%2C+a+Potent+Inhibitor+of+Hepatitis+C+Virus+Replication"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16c&amp;dbid=16384&amp;doi=10.1021%2Fjm0502788&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0502788%26sid%3Dliteratum%253Aachs%26aulast%3DClark%26aufirst%3DJ.%2BL.%26aulast%3DHollecker%26aufirst%3DL.%26aulast%3DMason%26aufirst%3DJ.%2BC.%26aulast%3DStuyver%26aufirst%3DL.%2BJ.%26aulast%3DTharnish%26aufirst%3DP.%2BM.%26aulast%3DLostia%26aufirst%3DS.%26aulast%3DMcBrayer%26aufirst%3DT.%2BR.%26aulast%3DSchinazi%26aufirst%3DR.%26aulast%3DWatanabe%26aufirst%3DK.%2BA.%26aulast%3DOtto%26aufirst%3DM.%2BJ.%26aulast%3DFurman%26aufirst%3DP.%2BA.%26aulast%3DStec%26aufirst%3DW.%2BJ.%26aulast%3DPatterson%26aufirst%3DS.%2BE.%26aulast%3DPankiewicz%26aufirst%3DK.%2BW.%26atitle%3DDesign%252C%2520Synthesis%252C%2520and%2520Antiviral%2520Activity%2520of%252020-Deoxy-20-fluoro-20-C-methylcytidine%252C%2520a%2520Potent%2520Inhibitor%2520of%2520Hepatitis%2520C%2520Virus%2520Replication%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D5504%26epage%3D5508" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit16d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Sofia, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bao, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagarathnam, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rachakonda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bansal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Espiritu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keilman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steuer, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otto, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furman, P. A.</span><span> </span><span class="NLM_article-title">Discovery of a β-<span class="smallcaps smallerCapital">d</span>-2′-deoxy-2′-α-fluoro-2′-β-C-methyluridine nucleotide prodrug (PSI-7977) for the treatment of hepatitis C virus</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">7202</span><span class="NLM_x">–</span> <span class="NLM_lpage">7218</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm100863x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16d&amp;dbid=32&amp;doi=10.1021%2Fjm201258k&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFKmtb%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=7202-7218&author=M.+J.+Sofiaauthor=D.+Baoauthor=W.+Changauthor=J.+Duauthor=D.+Nagarathnamauthor=S.+Rachakondaauthor=P.+G.+Reddyauthor=B.+S.+Rossauthor=P.+Wangauthor=H.+R.+Zhangauthor=S.+Bansalauthor=C.+Espirituauthor=M.+Keilmanauthor=A.+M.+Lamauthor=H.+M.+Steuerauthor=C.+Niuauthor=M.+J.+Ottoauthor=P.+A.+Furman&title=Discovery+of+a+%CE%B2-d-2%E2%80%B2-deoxy-2%E2%80%B2-%CE%B1-fluoro-2%E2%80%B2-%CE%B2-C-methyluridine+nucleotide+prodrug+%28PSI-7977%29+for+the+treatment+of+hepatitis+C+virus"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16dR"><div class="casContent"><span class="casTitleNuber">16d</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a β-D-2'-Deoxy-2'-α-fluoro-2'-β-C-methyluridine Nucleotide Prodrug (PSI-7977) for the Treatment of Hepatitis C Virus</span></div><div class="casAuthors">Sofia, Michael J.; Bao, Donghui; Chang, Wonsuk; Du, Jinfa; Nagarathnam, Dhanapalan; Rachakonda, Suguna; Reddy, P. Ganapati; Ross, Bruce S.; Wang, Peiyuan; Zhang, Hai-Ren; Bansal, Shalini; Espiritu, Christine; Keilman, Meg; Lam, Angela M.; Steuer, Holly M. Micolochick; Niu, Congrong; Otto, Michael J.; Furman, Phillip A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">7202-7218</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Hepatitis C virus (HCV) is a global health problem requiring novel approaches for effective treatment of this disease.  The HCV NS5B polymerase has been demonstrated to be a viable target for the development of HCV therapies.  β-D-2'-Deoxy-2'-α-fluoro-2'-β-C-Me nucleosides are selective inhibitors of the HCV NS5B polymerase and have demonstrated potent activity in the clinic.  Phosphoramidate prodrugs of the 5'-phosphate deriv. of the β-D-2'-deoxy-2'-α-fluoro-2'-β-C-methyluridine nucleoside were prepd. and showed significant potency in the HCV subgenomic replicon assay (<1 μM) and produced high levels of triphosphate 6 in primary hepatocytes and in the livers of rats, dogs, and monkeys when administered in vivo.  The single diastereomer 51 of diastereomeric mixt. 14 was crystd., and an X-ray structure was detd. establishing the phosphoramidate stereochem. as Sp, thus correlating for the first time the stereochem. of a phosphoramidate prodrug with biol. activity.  51 (PSI-7977) was selected as a clin. development candidate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWAkLi9-odWbVg90H21EOLACvtfcHk0liEG3PLpsSKYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFKmtb%252FO&md5=33d371e557e9d70562a326f97798f45c</span></div><a href="/servlet/linkout?suffix=cit16d&amp;dbid=16384&amp;doi=10.1021%2Fjm100863x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100863x%26sid%3Dliteratum%253Aachs%26aulast%3DSofia%26aufirst%3DM.%2BJ.%26aulast%3DBao%26aufirst%3DD.%26aulast%3DChang%26aufirst%3DW.%26aulast%3DDu%26aufirst%3DJ.%26aulast%3DNagarathnam%26aufirst%3DD.%26aulast%3DRachakonda%26aufirst%3DS.%26aulast%3DReddy%26aufirst%3DP.%2BG.%26aulast%3DRoss%26aufirst%3DB.%2BS.%26aulast%3DWang%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DH.%2BR.%26aulast%3DBansal%26aufirst%3DS.%26aulast%3DEspiritu%26aufirst%3DC.%26aulast%3DKeilman%26aufirst%3DM.%26aulast%3DLam%26aufirst%3DA.%2BM.%26aulast%3DSteuer%26aufirst%3DH.%2BM.%26aulast%3DNiu%26aufirst%3DC.%26aulast%3DOtto%26aufirst%3DM.%2BJ.%26aulast%3DFurman%26aufirst%3DP.%2BA.%26atitle%3DDiscovery%2520of%2520a%2520%25CE%25B2-d-2%25E2%2580%25B2-deoxy-2%25E2%2580%25B2-%25CE%25B1-fluoro-2%25E2%2580%25B2-%25CE%25B2-C-methyluridine%2520nucleotide%2520prodrug%2520%2528PSI-7977%2529%2520for%2520the%2520treatment%2520of%2520hepatitis%2520C%2520virus%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D7202%26epage%3D7218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit16e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Reddy, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bao, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chun, B.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagarathnam, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rachakonda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.-R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bansal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Espiritu, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keilman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steuer, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furman, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otto, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sofia, M. J.</span><span> </span><span class="NLM_article-title">20-Deoxy-20-a-fluoro-20-b-C-methyl 30,50-cyclic phosphate nucleotide prodrug analogs as inhibitors of HCV NS5B polymerase: discovery of PSI-352938</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">7376</span><span class="NLM_x">–</span> <span class="NLM_lpage">7380</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=7376-7380&author=P.+G.+Reddyauthor=D.+Baoauthor=W.+Changauthor=B.-K.+Chunauthor=J.+Duauthor=D.+Nagarathnamauthor=S.+Rachakondaauthor=B.+S.+Rossauthor=H.-R.+Zhangauthor=S.+Bansalauthor=C.+L.+Espirituauthor=M.+Keilmanauthor=A.+M.+Lamauthor=C.+Niuauthor=H.+M.+Steuerauthor=P.+A.+Furmanauthor=M.+J.+Ottoauthor=M.+J.+Sofia&title=20-Deoxy-20-a-fluoro-20-b-C-methyl+30%2C50-cyclic+phosphate+nucleotide+prodrug+analogs+as+inhibitors+of+HCV+NS5B+polymerase%3A+discovery+of+PSI-352938"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DReddy%26aufirst%3DP.%2BG.%26aulast%3DBao%26aufirst%3DD.%26aulast%3DChang%26aufirst%3DW.%26aulast%3DChun%26aufirst%3DB.-K.%26aulast%3DDu%26aufirst%3DJ.%26aulast%3DNagarathnam%26aufirst%3DD.%26aulast%3DRachakonda%26aufirst%3DS.%26aulast%3DRoss%26aufirst%3DB.%2BS.%26aulast%3DZhang%26aufirst%3DH.-R.%26aulast%3DBansal%26aufirst%3DS.%26aulast%3DEspiritu%26aufirst%3DC.%2BL.%26aulast%3DKeilman%26aufirst%3DM.%26aulast%3DLam%26aufirst%3DA.%2BM.%26aulast%3DNiu%26aufirst%3DC.%26aulast%3DSteuer%26aufirst%3DH.%2BM.%26aulast%3DFurman%26aufirst%3DP.%2BA.%26aulast%3DOtto%26aufirst%3DM.%2BJ.%26aulast%3DSofia%26aufirst%3DM.%2BJ.%26atitle%3D20-Deoxy-20-a-fluoro-20-b-C-methyl%252030%252C50-cyclic%2520phosphate%2520nucleotide%2520prodrug%2520analogs%2520as%2520inhibitors%2520of%2520HCV%2520NS5B%2520polymerase%253A%2520discovery%2520of%2520PSI-352938%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D7376%26epage%3D7380" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit16f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Cretton-Scott, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perigaud, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peyrottes, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Licklider, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camire, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larsson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La Colla, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hildebrand, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lallos, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bilello, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarville, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seifer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liuzzi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pierra, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Badaroux, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gosselin, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surleraux, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Standring, D. N.</span><span> </span><span class="NLM_article-title">In vitro antiviral activity and pharmacology of IDX184, a novel and potent inhibitor of HCV replication</span> <span class="citation_source-journal">J. Hepatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">S220</span><span class="NLM_x">–</span> <span class="NLM_lpage">S225</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2008&pages=S220-S225&author=E.+Cretton-Scottauthor=C.+Perigaudauthor=S.+Peyrottesauthor=L.+Lickliderauthor=M.+Camireauthor=M.+Larssonauthor=M.+La+Collaauthor=E.+Hildebrandauthor=L.+Lallosauthor=J.+Bilelloauthor=J.+McCarvilleauthor=M.+Seiferauthor=M.+Liuzziauthor=C.+Pierraauthor=E.+Badarouxauthor=G.+Gosselinauthor=D.+Surlerauxauthor=D.+N.+Standring&title=In+vitro+antiviral+activity+and+pharmacology+of+IDX184%2C+a+novel+and+potent+inhibitor+of+HCV+replication"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16f&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCretton-Scott%26aufirst%3DE.%26aulast%3DPerigaud%26aufirst%3DC.%26aulast%3DPeyrottes%26aufirst%3DS.%26aulast%3DLicklider%26aufirst%3DL.%26aulast%3DCamire%26aufirst%3DM.%26aulast%3DLarsson%26aufirst%3DM.%26aulast%3DLa%2BColla%26aufirst%3DM.%26aulast%3DHildebrand%26aufirst%3DE.%26aulast%3DLallos%26aufirst%3DL.%26aulast%3DBilello%26aufirst%3DJ.%26aulast%3DMcCarville%26aufirst%3DJ.%26aulast%3DSeifer%26aufirst%3DM.%26aulast%3DLiuzzi%26aufirst%3DM.%26aulast%3DPierra%26aufirst%3DC.%26aulast%3DBadaroux%26aufirst%3DE.%26aulast%3DGosselin%26aufirst%3DG.%26aulast%3DSurleraux%26aufirst%3DD.%26aulast%3DStandring%26aufirst%3DD.%2BN.%26atitle%3DIn%2520vitro%2520antiviral%2520activity%2520and%2520pharmacology%2520of%2520IDX184%252C%2520a%2520novel%2520and%2520potent%2520inhibitor%2520of%2520HCV%2520replication%26jtitle%3DJ.%2520Hepatol.%26date%3D2008%26volume%3D48%26spage%3DS220%26epage%3DS225" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit16g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">McGuigan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madela, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aljarah, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilles, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brancale, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zonta, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chamberlain, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vernachio, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutchins, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ames, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorovits, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganguly, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolykhalov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muhammadb, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patti, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henson, G.</span><span> </span><span class="NLM_article-title">Design, synthesis and evaluation of a novel double pro-drug: INX-08189. A new clinical candidate for hepatitis C virus</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">4850</span><span class="NLM_x">–</span> <span class="NLM_lpage">4854</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16g&amp;dbid=16&amp;doi=10.1021%2Fjm201258k&amp;key=10.1016%2Fj.bmcl.2010.06.094" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16g&amp;dbid=8&amp;doi=10.1021%2Fjm201258k&amp;key=20637609" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16g&amp;dbid=32&amp;doi=10.1021%2Fjm201258k&amp;key=1%3ACAS%3A528%3ADC%252BC3cXptlagurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=4850-4854&author=C.+McGuiganauthor=K.+Madelaauthor=M.+Aljarahauthor=A.+Gillesauthor=A.+Brancaleauthor=N.+Zontaauthor=S.+Chamberlainauthor=J.+Vernachioauthor=J.+Hutchinsauthor=A.+Hallauthor=B.+Amesauthor=E.+Gorovitsauthor=B.+Gangulyauthor=A.+Kolykhalovauthor=J.+Wangauthor=J.+Muhammadbauthor=J.+M.+Pattiauthor=G.+Henson&title=Design%2C+synthesis+and+evaluation+of+a+novel+double+pro-drug%3A+INX-08189.+A+new+clinical+candidate+for+hepatitis+C+virus"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16gR"><div class="casContent"><span class="casTitleNuber">16g</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis and evaluation of a novel double prodrug: INX-08189. A new clinical candidate for hepatitis C virus</span></div><div class="casAuthors">McGuigan, Christopher; Madela, Karolina; Aljarah, Mohamed; Gilles, Arnaud; Brancale, Andrea; Zonta, Nicola; Chamberlain, Stanley; Vernachio, John; Hutchins, Jeff; Hall, Andrea; Ames, Brenda; Gorovits, Elena; Ganguly, Babita; Kolykhalov, Alexander; Wang, Jin; Muhammad, Jerry; Patti, Joseph M.; Henson, Geoffrey</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">4850-4854</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We herein report a novel double prodrug approach applied to the anti-HCV agent 2'-β-C-Me guanosine.  A phosphoramidate ProTide motif and a 6-O-methoxy base prodrug moiety are combined to generate lipophilic prodrugs of the monophosphate of the guanine nucleoside.  Modification of the ester and amino acid moieties lead to a compd. INX-08189 that exhibits 10 nM potency in the HCV genotype 1b sub-genomic replicon, thus being 500 times more potent than the parent nucleoside.  The potency of the lead compd. INX-08189 was shown to be consistent with intracellular 2'-C-Me guanosine triphosphate levels in primary human hepatocytes.  The sepd. diastereomers of INX-08189 were shown to have similar activity in the replicon assay and were also shown to be similar substrates for enzyme processing.  INX-08189 has completed investigational new drug enabling studies and has been progressed into human clin. trials for the treatment of chronic HCV infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRKJa0VtEVwrVg90H21EOLACvtfcHk0lhwOmSoLut33A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXptlagurs%253D&md5=20d10847a850ddf681fe8accc4ed49db</span></div><a href="/servlet/linkout?suffix=cit16g&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.06.094&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.06.094%26sid%3Dliteratum%253Aachs%26aulast%3DMcGuigan%26aufirst%3DC.%26aulast%3DMadela%26aufirst%3DK.%26aulast%3DAljarah%26aufirst%3DM.%26aulast%3DGilles%26aufirst%3DA.%26aulast%3DBrancale%26aufirst%3DA.%26aulast%3DZonta%26aufirst%3DN.%26aulast%3DChamberlain%26aufirst%3DS.%26aulast%3DVernachio%26aufirst%3DJ.%26aulast%3DHutchins%26aufirst%3DJ.%26aulast%3DHall%26aufirst%3DA.%26aulast%3DAmes%26aufirst%3DB.%26aulast%3DGorovits%26aufirst%3DE.%26aulast%3DGanguly%26aufirst%3DB.%26aulast%3DKolykhalov%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DMuhammadb%26aufirst%3DJ.%26aulast%3DPatti%26aufirst%3DJ.%2BM.%26aulast%3DHenson%26aufirst%3DG.%26atitle%3DDesign%252C%2520synthesis%2520and%2520evaluation%2520of%2520a%2520novel%2520double%2520pro-drug%253A%2520INX-08189.%2520A%2520new%2520clinical%2520candidate%2520for%2520hepatitis%2520C%2520virus%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D4850%26epage%3D4854" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Kneteman, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howe, A. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pevear, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lund, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Douglas, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercer, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tyrrell, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Immermann, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaudhary, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Speth, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villano, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connell, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collett, M.</span><span> </span><span class="NLM_article-title">HCV796: A selective nonstructural protein 5B polymerase inhibitor with potent anti-hepatitis C virus activity in vitro, in mice with chimeric human livers, and in humans infected with hepatitis C virus</span> <span class="citation_source-journal">Hepatology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">745</span><span class="NLM_x">–</span> <span class="NLM_lpage">752</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm201258k&amp;key=10.1002%2Fhep.22717" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm201258k&amp;key=19072827" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm201258k&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjvFOnu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2009&pages=745-752&author=N.+M.+Knetemanauthor=A.+Y.+Howeauthor=T.+Gaoauthor=J.+Lewisauthor=D.+Pevearauthor=G.+Lundauthor=D.+Douglasauthor=D.+F.+Mercerauthor=D.+L.+Tyrrellauthor=F.+Immermannauthor=I.+Chaudharyauthor=J.+Spethauthor=S.+A.+Villanoauthor=J.+O%E2%80%99Connellauthor=M.+Collett&title=HCV796%3A+A+selective+nonstructural+protein+5B+polymerase+inhibitor+with+potent+anti-hepatitis+C+virus+activity+in+vitro%2C+in+mice+with+chimeric+human+livers%2C+and+in+humans+infected+with+hepatitis+C+virus"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">HCCV796: a selective nonstructural protein 5B polymerase inhibitor with potent anti-hepatitis C virus activity in vitro, in mice with chimeric human livers, and in humans infected with hepatitis C virus</span></div><div class="casAuthors">Kneteman, Norman M.; Howe, Anita Y. M.; Gao, Tiejun; Lewis, Jamie; Pevear, Dan; Lund, Gary; Douglas, Donna; Mercer, David F.; Tyrrell, D. Lorne J.; Immermann, Frederick; Chaudhary, Inder; Speth, John; Villano, Stephen A.; O'Connell, John; Collett, Marc</div><div class="citationInfo"><span class="NLM_cas:title">Hepatology (Hoboken, NJ, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">745-752</span>CODEN:
                <span class="NLM_cas:coden">HPTLD9</span>;
        ISSN:<span class="NLM_cas:issn">0270-9139</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Anti-hepatitis C virus (HCV) drug development has been challenged by a lack of experience with inhibitors inclusive of in vitro, animal model, and clin. study.  This manuscript outlines activity and correlation across such a spectrum of models and into clin. trials with a novel selective nonstructural protein 5B (NS5B) polymerase inhibitor, HCV796.  Enzyme assays yielded median inhibitory concn. (IC50) values of 0.01 to 0.14 μM for genotype 1, with half maximal effective concn. (EC50s) of 5 nM and 9 nM against genotype 1a and 1b replicons.  In the chimeric mouse model, a 2.02 ± 0.55 log redn. in HCV titer was seen with monotherapy, whereas a suboptimal dose of 30 mg/kg three times per day in combination with interferon demonstrated a 2.44 log redn. (P = 0.001 vs. interferon alone) Clin. outcomes in combination with pegylated interferon and ribavirin have revealed additive efficacy in treatment naive patients.  Abnormal liver function test results were obsd. in 8% of HCV-796 patients treated for over 8 wk, resulting in suspension of further trial activity.  Conclusion: The RNA-dependent RNA polymerase inhibitor HCV796 demonstrated potent anti-HCV activity consistently through enzyme inhibition assays, subgenomic replicon, and chimeric mouse studies.  Strong correlations of outcomes in the mouse model were seen with subsequent clin. trials, including a plateau in dose-related antiviral activity and additive impact from combination therapy with interferon.  These outcomes demonstrate the utility of the range of in vitro and in vivo models now available for anti-HCV drug development and support the potential utility of polymerase inhibitors in future combination therapies for HCV treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7ZCtNeI0RLLVg90H21EOLACvtfcHk0lhwOmSoLut33A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjvFOnu70%253D&md5=0dcebc9c1e93051ad46eae43b352e7cf</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1002%2Fhep.22717&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhep.22717%26sid%3Dliteratum%253Aachs%26aulast%3DKneteman%26aufirst%3DN.%2BM.%26aulast%3DHowe%26aufirst%3DA.%2BY.%26aulast%3DGao%26aufirst%3DT.%26aulast%3DLewis%26aufirst%3DJ.%26aulast%3DPevear%26aufirst%3DD.%26aulast%3DLund%26aufirst%3DG.%26aulast%3DDouglas%26aufirst%3DD.%26aulast%3DMercer%26aufirst%3DD.%2BF.%26aulast%3DTyrrell%26aufirst%3DD.%2BL.%26aulast%3DImmermann%26aufirst%3DF.%26aulast%3DChaudhary%26aufirst%3DI.%26aulast%3DSpeth%26aufirst%3DJ.%26aulast%3DVillano%26aufirst%3DS.%2BA.%26aulast%3DO%25E2%2580%2599Connell%26aufirst%3DJ.%26aulast%3DCollett%26aufirst%3DM.%26atitle%3DHCV796%253A%2520A%2520selective%2520nonstructural%2520protein%25205B%2520polymerase%2520inhibitor%2520with%2520potent%2520anti-hepatitis%2520C%2520virus%2520activity%2520in%2520vitro%252C%2520in%2520mice%2520with%2520chimeric%2520human%2520livers%252C%2520and%2520in%2520humans%2520infected%2520with%2520hepatitis%2520C%2520virus%26jtitle%3DHepatology%26date%3D2009%26volume%3D49%26spage%3D745%26epage%3D752" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Li, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tatlock, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linton, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jewell, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ludlum, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drowns, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahavendran, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skor, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunter, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herlihy, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parge, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickey, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chau, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nonomiya, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, C.</span><span> </span><span class="NLM_article-title">Discovery of (<i>R</i>)-6-Cyclopentyl-6-(2-(2,6-diethylpyridin-4-yl)ethyl)-3-((5,7-dimethyl-[1,2,4]triazolo[1,5-<i>a</i>]pyrimidin-2-yl)methyl)-4-hydroxy-5,6-dihydro-pyran-2-one (PF-00868554) as a Potent and Orally Available Hepatitis C Virus Polymerase Inhibitor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">1255</span><span class="NLM_x">–</span> <span class="NLM_lpage">1258</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm8014537" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=1255-1258&author=H.+Liauthor=J.+Tatlockauthor=A.+Lintonauthor=J.+Gonzalezauthor=T.+Jewellauthor=L.+Patelauthor=S.+Ludlumauthor=M.+Drownsauthor=S.+V.+Rahavendranauthor=H.+Skorauthor=R.+Hunterauthor=S.+T.+Shiauthor=K.+J.+Herlihyauthor=H.+Pargeauthor=M.+Hickeyauthor=X.+Yuauthor=F.+Chauauthor=J.+Nonomiyaauthor=C.+Lewis&title=Discovery+of+%28R%29-6-Cyclopentyl-6-%282-%282%2C6-diethylpyridin-4-yl%29ethyl%29-3-%28%285%2C7-dimethyl-%5B1%2C2%2C4%5Dtriazolo%5B1%2C5-a%5Dpyrimidin-2-yl%29methyl%29-4-hydroxy-5%2C6-dihydro-pyran-2-one+%28PF-00868554%29+as+a+Potent+and+Orally+Available+Hepatitis+C+Virus+Polymerase+Inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm8014537&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8014537%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DH.%26aulast%3DTatlock%26aufirst%3DJ.%26aulast%3DLinton%26aufirst%3DA.%26aulast%3DGonzalez%26aufirst%3DJ.%26aulast%3DJewell%26aufirst%3DT.%26aulast%3DPatel%26aufirst%3DL.%26aulast%3DLudlum%26aufirst%3DS.%26aulast%3DDrowns%26aufirst%3DM.%26aulast%3DRahavendran%26aufirst%3DS.%2BV.%26aulast%3DSkor%26aufirst%3DH.%26aulast%3DHunter%26aufirst%3DR.%26aulast%3DShi%26aufirst%3DS.%2BT.%26aulast%3DHerlihy%26aufirst%3DK.%2BJ.%26aulast%3DParge%26aufirst%3DH.%26aulast%3DHickey%26aufirst%3DM.%26aulast%3DYu%26aufirst%3DX.%26aulast%3DChau%26aufirst%3DF.%26aulast%3DNonomiya%26aufirst%3DJ.%26aulast%3DLewis%26aufirst%3DC.%26atitle%3DDiscovery%2520of%2520%2528R%2529-6-Cyclopentyl-6-%25282-%25282%252C6-diethylpyridin-4-yl%2529ethyl%2529-3-%2528%25285%252C7-dimethyl-%255B1%252C2%252C4%255Dtriazolo%255B1%252C5-a%255Dpyrimidin-2-yl%2529methyl%2529-4-hydroxy-5%252C6-dihydro-pyran-2-one%2520%2528PF-00868554%2529%2520as%2520a%2520Potent%2520and%2520Orally%2520Available%2520Hepatitis%2520C%2520Virus%2520Polymerase%2520Inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D1255%26epage%3D1258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Rodriguez-Torres, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawitz, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conway, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaita, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheikh, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghalib, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adrover, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silva, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosario, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourgault, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proulx, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McHutchison, J. G.</span><span> </span><span class="NLM_article-title">Safety and antiviral activity of the non-nucleoside polymerase inhibitor VX-222 in treatment naïve genotype 1 HCV infected patients</span> <span class="citation_source-journal">J. Hepatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">S14</span><span class="NLM_x">–</span> <span class="NLM_lpage">S18</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2010&pages=S14-S18&author=M.+Rodriguez-Torresauthor=E.+Lawitzauthor=B.+Conwayauthor=K.+Kaitaauthor=A.+M.+Sheikhauthor=R.+Ghalibauthor=R.+Adroverauthor=C.+Cooperauthor=M.+Silvaauthor=M.+Rosarioauthor=B.+Bourgaultauthor=L.+Proulxauthor=J.+G.+McHutchison&title=Safety+and+antiviral+activity+of+the+non-nucleoside+polymerase+inhibitor+VX-222+in+treatment+na%C3%AFve+genotype+1+HCV+infected+patients"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRodriguez-Torres%26aufirst%3DM.%26aulast%3DLawitz%26aufirst%3DE.%26aulast%3DConway%26aufirst%3DB.%26aulast%3DKaita%26aufirst%3DK.%26aulast%3DSheikh%26aufirst%3DA.%2BM.%26aulast%3DGhalib%26aufirst%3DR.%26aulast%3DAdrover%26aufirst%3DR.%26aulast%3DCooper%26aufirst%3DC.%26aulast%3DSilva%26aufirst%3DM.%26aulast%3DRosario%26aufirst%3DM.%26aulast%3DBourgault%26aufirst%3DB.%26aulast%3DProulx%26aufirst%3DL.%26aulast%3DMcHutchison%26aufirst%3DJ.%2BG.%26atitle%3DSafety%2520and%2520antiviral%2520activity%2520of%2520the%2520non-nucleoside%2520polymerase%2520inhibitor%2520VX-222%2520in%2520treatment%2520na%25C3%25AFve%2520genotype%25201%2520HCV%2520infected%2520patients%26jtitle%3DJ.%2520Hepatol.%26date%3D2010%26volume%3D52%26spage%3DS14%26epage%3DS18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Lawitz, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodrigues-Torres, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeMicco, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Godofsky, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Appleman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahimy, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crowley, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freddo, J.</span><span> </span><span class="NLM_article-title">Antiviral activity of ANA598, a potent non-nucleoside polymerase inhibitor, in chronic hepatitis C patients</span> <span class="citation_source-journal">J. Hepatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">S384</span><span class="NLM_x">–</span> <span class="NLM_lpage">S387</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2009&pages=S384-S387&author=E.+Lawitzauthor=M.+Rodrigues-Torresauthor=T.+DeMiccoauthor=T.+Nguyenauthor=E.+Godofskyauthor=J.+Applemanauthor=M.+Rahimyauthor=C.+Crowleyauthor=J.+Freddo&title=Antiviral+activity+of+ANA598%2C+a+potent+non-nucleoside+polymerase+inhibitor%2C+in+chronic+hepatitis+C+patients"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLawitz%26aufirst%3DE.%26aulast%3DRodrigues-Torres%26aufirst%3DM.%26aulast%3DDeMicco%26aufirst%3DT.%26aulast%3DNguyen%26aufirst%3DT.%26aulast%3DGodofsky%26aufirst%3DE.%26aulast%3DAppleman%26aufirst%3DJ.%26aulast%3DRahimy%26aufirst%3DM.%26aulast%3DCrowley%26aufirst%3DC.%26aulast%3DFreddo%26aufirst%3DJ.%26atitle%3DAntiviral%2520activity%2520of%2520ANA598%252C%2520a%2520potent%2520non-nucleoside%2520polymerase%2520inhibitor%252C%2520in%2520chronic%2520hepatitis%2520C%2520patients%26jtitle%3DJ.%2520Hepatol.%26date%3D2009%26volume%3D50%26spage%3DS384%26epage%3DS387" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Larrey, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benhamou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lohse, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trepo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moelleken, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bronowicki, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heim, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arastéh, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zarski, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourlière, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiest, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calleja, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Enríquez, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erhardt, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wedemeyer, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerlach, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berg, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stern, J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abdallah, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nehmiz, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boecher, W. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steffgen, J.</span><span> </span><span class="NLM_article-title">BI 207127 is a potent HCV RNA polymerase inhibitor during 5 days monotherapy in patients with chronic hepatitis C</span> <span class="citation_source-journal">Hepatology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">1044A</span><span class="NLM_x">–</span> <span class="NLM_lpage">1046A</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2009&pages=1044A-1046A&author=D.+Larreyauthor=Y.+Benhamouauthor=A.+W.+Lohseauthor=C.+Trepoauthor=C.+Moellekenauthor=J.-P.+Bronowickiauthor=M.+H.+Heimauthor=K.+Arast%C3%A9hauthor=J.-P.+Zarskiauthor=M.+Bourli%C3%A8reauthor=R.+Wiestauthor=J.+L.+Callejaauthor=J.+Enr%C3%ADquezauthor=A.+Erhardtauthor=H.+Wedemeyerauthor=T.+Gerlachauthor=T.+Bergauthor=J.+O.+Sternauthor=K.+Wuauthor=N.+Abdallahauthor=G.+Nehmizauthor=W.+O.+Boecherauthor=F.+M.+Bergerauthor=J.+Steffgen&title=BI+207127+is+a+potent+HCV+RNA+polymerase+inhibitor+during+5+days+monotherapy+in+patients+with+chronic+hepatitis+C"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLarrey%26aufirst%3DD.%26aulast%3DBenhamou%26aufirst%3DY.%26aulast%3DLohse%26aufirst%3DA.%2BW.%26aulast%3DTrepo%26aufirst%3DC.%26aulast%3DMoelleken%26aufirst%3DC.%26aulast%3DBronowicki%26aufirst%3DJ.-P.%26aulast%3DHeim%26aufirst%3DM.%2BH.%26aulast%3DArast%25C3%25A9h%26aufirst%3DK.%26aulast%3DZarski%26aufirst%3DJ.-P.%26aulast%3DBourli%25C3%25A8re%26aufirst%3DM.%26aulast%3DWiest%26aufirst%3DR.%26aulast%3DCalleja%26aufirst%3DJ.%2BL.%26aulast%3DEnr%25C3%25ADquez%26aufirst%3DJ.%26aulast%3DErhardt%26aufirst%3DA.%26aulast%3DWedemeyer%26aufirst%3DH.%26aulast%3DGerlach%26aufirst%3DT.%26aulast%3DBerg%26aufirst%3DT.%26aulast%3DStern%26aufirst%3DJ.%2BO.%26aulast%3DWu%26aufirst%3DK.%26aulast%3DAbdallah%26aufirst%3DN.%26aulast%3DNehmiz%26aufirst%3DG.%26aulast%3DBoecher%26aufirst%3DW.%2BO.%26aulast%3DBerger%26aufirst%3DF.%2BM.%26aulast%3DSteffgen%26aufirst%3DJ.%26atitle%3DBI%2520207127%2520is%2520a%2520potent%2520HCV%2520RNA%2520polymerase%2520inhibitor%2520during%25205%2520days%2520monotherapy%2520in%2520patients%2520with%2520chronic%2520hepatitis%2520C%26jtitle%3DHepatology%26date%3D2009%26volume%3D50%26spage%3D1044A%26epage%3D1046A" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span>BMS-791325 from Bristol-Myers Squibb Has Been Advanced to Phase II Clinical Trials; <a href="http://clinicaltrials.gov/ct2/show/NCT01193361?term=bms-791325&amp;rank=4" class="extLink">http://clinicaltrials.gov/ct2/show/NCT01193361?term=bms-791325&rank=4</a><span class="NLM_access-date"> (Accessed January 5, 2012)</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=BMS-791325+from+Bristol-Myers+Squibb+Has+Been+Advanced+to+Phase+II+Clinical+Trials%3B+http%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT01193361%3Fterm%3Dbms-791325%26rank%3D4+%28Accessed+January+5%2C+2012%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26jtitle%3DBMS-791325%2520from%2520Bristol-Myers%2520Squibb%2520Has%2520Been%2520Advanced%2520to%2520Phase%2520II%2520Clinical%2520Trials" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Ferrari, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palermo, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, H. C.</span><span> </span><span class="NLM_article-title">Hepatitis C Virus NS5B Polymerase Exhibits Distinct Nucleotide Requirements for Initiation and Elongation</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x">, </span> <span class="NLM_fpage">33893</span><span class="NLM_x">–</span> <span class="NLM_lpage">33901</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2008&pages=33893-33901&author=E.+Ferrariauthor=Z.+Heauthor=R.+E.+Palermoauthor=H.+C.+Huang&title=Hepatitis+C+Virus+NS5B+Polymerase+Exhibits+Distinct+Nucleotide+Requirements+for+Initiation+and+Elongation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFerrari%26aufirst%3DE.%26aulast%3DHe%26aufirst%3DZ.%26aulast%3DPalermo%26aufirst%3DR.%2BE.%26aulast%3DHuang%26aufirst%3DH.%2BC.%26atitle%3DHepatitis%2520C%2520Virus%2520NS5B%2520Polymerase%2520Exhibits%2520Distinct%2520Nucleotide%2520Requirements%2520for%2520Initiation%2520and%2520Elongation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2008%26volume%3D283%26spage%3D33893%26epage%3D33901" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Lohmann, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Körner, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, J.-O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herian, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Theilmann, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartenschlager, R.</span><span> </span><span class="NLM_article-title">Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">285</span><span class="NLM_x">, </span> <span class="NLM_fpage">110</span><span class="NLM_x">–</span> <span class="NLM_lpage">113</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm201258k&amp;key=10.1126%2Fscience.285.5424.110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm201258k&amp;key=10390360" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm201258k&amp;key=1%3ACAS%3A528%3ADyaK1MXksVCqurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=1999&pages=110-113&author=V.+Lohmannauthor=F.+K%C3%B6rnerauthor=J.-O.+Kochauthor=U.+Herianauthor=L.+Theilmannauthor=R.+Bartenschlager&title=Replication+of+subgenomic+hepatitis+C+virus+RNAs+in+a+hepatoma+cell+line"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line</span></div><div class="casAuthors">Lohmann, V.; Korner, F.; Koch, J.-O.; Herian, U.; Theilmann, L.; Bartenschlager, R.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">285</span>
        (<span class="NLM_cas:issue">5424</span>),
    <span class="NLM_cas:pages">110-113</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">An estd. 170 million persons worldwide are infected with hepatitis C virus (HCV), a major cause of chronic liver disease.  Despite increasing knowledge of genome structure and individual viral proteins, studies on virus replication and pathogenesis have been hampered by the lack of reliable and efficient cell culture systems.  A full-length consensus genome was cloned from viral RNA isolated from an infected human liver and used to construct subgenomic selectable replicons.  Upon transfection into a human hepatoma cell line, these RNAs replicated to high levels, permitting metabolic radiolabeling of viral RNA and proteins.  This work defines the structure of HCV replicons functional in cell culture and provides the basis for a long-sought cellular system that should allow detailed mol. studies of HCV and the development of antiviral drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7X754RT8y1LVg90H21EOLACvtfcHk0lgxj-VmErYnAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXksVCqurk%253D&md5=b075621b316209ecf4498c9b5b33e4b5</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1126%2Fscience.285.5424.110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.285.5424.110%26sid%3Dliteratum%253Aachs%26aulast%3DLohmann%26aufirst%3DV.%26aulast%3DK%25C3%25B6rner%26aufirst%3DF.%26aulast%3DKoch%26aufirst%3DJ.-O.%26aulast%3DHerian%26aufirst%3DU.%26aulast%3DTheilmann%26aufirst%3DL.%26aulast%3DBartenschlager%26aufirst%3DR.%26atitle%3DReplication%2520of%2520subgenomic%2520hepatitis%2520C%2520virus%2520RNAs%2520in%2520a%2520hepatoma%2520cell%2520line%26jtitle%3DScience%26date%3D1999%26volume%3D285%26spage%3D110%26epage%3D113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Anilkumar, G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lesburg, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selyutin, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenblum, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, T.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaccaro, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duca, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gavalas, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinto, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sannigrahi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velazquez, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venkatraman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vibulbhan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agrawal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butkiewicz, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feld, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrari, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, C.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palermo, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mcmonagle, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, H.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shih, N.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Njoroge, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozlowski, J. A.</span><span> </span><span class="NLM_article-title">I. Novel HCV NS5B Polymerase Inhibitors: Discovery of Indole 2-Carboxylic Acids with C-3-Heterocycles</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">5336</span><span class="NLM_x">–</span> <span class="NLM_lpage">5341</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=5336-5341&author=G.+N.+Anilkumarauthor=C.+A.+Lesburgauthor=O.+Selyutinauthor=S.+B.+Rosenblumauthor=Q.+Zengauthor=Y.+Jiangauthor=T.-Y.+Chanauthor=H.+Puauthor=H.+Vaccaroauthor=L.+Wangauthor=F.+Bennettauthor=K.+X.+Chenauthor=J.+Ducaauthor=S.+Gavalasauthor=Y.+Huangauthor=P.+Pintoauthor=M.+Sannigrahiauthor=F.+Velazquezauthor=S.+Venkatramanauthor=B.+Vibulbhanauthor=S.+Agrawalauthor=N.+Butkiewiczauthor=B.+Feldauthor=E.+Ferrariauthor=Z.+Heauthor=C.-K.+Jiangauthor=R.+E.+Palermoauthor=P.+Mcmonagleauthor=H.-C.+Huangauthor=N.-Y.+Shihauthor=G.+Njorogeauthor=J.+A.+Kozlowski&title=I.+Novel+HCV+NS5B+Polymerase+Inhibitors%3A+Discovery+of+Indole+2-Carboxylic+Acids+with+C-3-Heterocycles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAnilkumar%26aufirst%3DG.%2BN.%26aulast%3DLesburg%26aufirst%3DC.%2BA.%26aulast%3DSelyutin%26aufirst%3DO.%26aulast%3DRosenblum%26aufirst%3DS.%2BB.%26aulast%3DZeng%26aufirst%3DQ.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DChan%26aufirst%3DT.-Y.%26aulast%3DPu%26aufirst%3DH.%26aulast%3DVaccaro%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DBennett%26aufirst%3DF.%26aulast%3DChen%26aufirst%3DK.%2BX.%26aulast%3DDuca%26aufirst%3DJ.%26aulast%3DGavalas%26aufirst%3DS.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DPinto%26aufirst%3DP.%26aulast%3DSannigrahi%26aufirst%3DM.%26aulast%3DVelazquez%26aufirst%3DF.%26aulast%3DVenkatraman%26aufirst%3DS.%26aulast%3DVibulbhan%26aufirst%3DB.%26aulast%3DAgrawal%26aufirst%3DS.%26aulast%3DButkiewicz%26aufirst%3DN.%26aulast%3DFeld%26aufirst%3DB.%26aulast%3DFerrari%26aufirst%3DE.%26aulast%3DHe%26aufirst%3DZ.%26aulast%3DJiang%26aufirst%3DC.-K.%26aulast%3DPalermo%26aufirst%3DR.%2BE.%26aulast%3DMcmonagle%26aufirst%3DP.%26aulast%3DHuang%26aufirst%3DH.-C.%26aulast%3DShih%26aufirst%3DN.-Y.%26aulast%3DNjoroge%26aufirst%3DG.%26aulast%3DKozlowski%26aufirst%3DJ.%2BA.%26atitle%3DI.%2520Novel%2520HCV%2520NS5B%2520Polymerase%2520Inhibitors%253A%2520Discovery%2520of%2520Indole%25202-Carboxylic%2520Acids%2520with%2520C-3-Heterocycles%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D5336%26epage%3D5341" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Ishiyama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murata, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyaura, N.</span><span> </span><span class="NLM_article-title">Palladium(0)-Catalyzed Cross-Coupling Reaction of Alkoxydiboron with Haloarenes: A Direct Procedure for Arylboronic Esters</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">7508</span><span class="NLM_x">–</span> <span class="NLM_lpage">7510</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo00128a024" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm201258k&amp;key=1%3ACAS%3A528%3ADyaK2MXovFSku7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=1995&pages=7508-7510&author=T.+Ishiyamaauthor=M.+Murataauthor=N.+Miyaura&title=Palladium%280%29-Catalyzed+Cross-Coupling+Reaction+of+Alkoxydiboron+with+Haloarenes%3A+A+Direct+Procedure+for+Arylboronic+Esters"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Palladium(0)-Catalyzed Cross-Coupling Reaction of Alkoxydiboron with Haloarenes: A Direct Procedure for Arylboronic Esters</span></div><div class="casAuthors">Ishiyama, Tatsuo; Murata, Miki; Miyaura, Norio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">7508-10</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The palladium-catalyzed cross-coupling reaction of the pinacol ester of diboronic acid I with haloarenes gave a direct procedure for arylboronic esters II (Ar = aryl) from aryl halides in a range of 60-98%.  The reaction was catalyzed by PdCl2(dppf) (3 mol %) at 80° in the presence of KOAc (3 equiv) in DMSO and available with various functional groups such as nitrile, cyanide, ester, and carbonyl groups.  The trans-ArPd(II)(OAc)(PPh3)2 intermediate was isolated and characterized to propose the catalytic cycle involving the transmetalation between the phenylpalladium(II) acetate complex and I.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobehJBGFjDH7Vg90H21EOLACvtfcHk0lgxj-VmErYnAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXovFSku7g%253D&md5=2666902270ec1efc5742480b133f1255</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjo00128a024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00128a024%26sid%3Dliteratum%253Aachs%26aulast%3DIshiyama%26aufirst%3DT.%26aulast%3DMurata%26aufirst%3DM.%26aulast%3DMiyaura%26aufirst%3DN.%26atitle%3DPalladium%25280%2529-Catalyzed%2520Cross-Coupling%2520Reaction%2520of%2520Alkoxydiboron%2520with%2520Haloarenes%253A%2520A%2520Direct%2520Procedure%2520for%2520Arylboronic%2520Esters%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1995%26volume%3D60%26spage%3D7508%26epage%3D7510" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Jansen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dannhardt, G.</span><span> </span><span class="NLM_article-title">Variations of acidic functions at position 2 and substituents at positions 4, 5 and 6 of the indole moiety and their effect on NMDA–glycine site affinity</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">855</span><span class="NLM_x">–</span> <span class="NLM_lpage">865</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2003&pages=855-865&author=M.+Jansenauthor=G.+Dannhardt&title=Variations+of+acidic+functions+at+position+2+and+substituents+at+positions+4%2C+5+and+6+of+the+indole+moiety+and+their+effect+on+NMDA%E2%80%93glycine+site+affinity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJansen%26aufirst%3DM.%26aulast%3DDannhardt%26aufirst%3DG.%26atitle%3DVariations%2520of%2520acidic%2520functions%2520at%2520position%25202%2520and%2520substituents%2520at%2520positions%25204%252C%25205%2520and%25206%2520of%2520the%2520indole%2520moiety%2520and%2520their%2520effect%2520on%2520NMDA%25E2%2580%2593glycine%2520site%2520affinity%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2003%26volume%3D38%26spage%3D855%26epage%3D865" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="note"><p class="first last">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a> was generated using the program PyMOL (The PyMOL Molecular Graphics System, version 1.2r1, Schrödinger, LLC.).</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="note"><p class="first last">X-Ray crystal structure data of HCV NS5B in complex with <b>56</b> have been deposited in the Protein Data Bank with access code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3TYV">3TYV</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1a','cit1b','cit1c'],'ref2':['cit2a','cit2b'],'ref3':['cit3a','cit3b','cit3c'],'ref4':['cit4'],'ref5':['cit5a','cit5b','cit5c','cit5d'],'ref6':['cit6a','cit6b'],'ref7':['cit7'],'ref8':['cit8a','cit8b'],'ref9':['cit9a','cit9b'],'ref10':['cit10'],'ref11':['cit11a','cit11b'],'ref12':['cit12a','cit12b'],'ref13':['cit13a','cit13b','cit13c'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16a','cit16b','cit16c','cit16d','cit16e','cit16f','cit16g'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':[],'ref29':[]}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 26 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Long Ren, Guanglei Nan, Yongcheng Wang, <span class="NLM_string-name hlFld-ContribAuthor">Zhiyan Xiao</span>. </span><span class="cited-content_cbyCitation_article-title">Carboxylic Acid-Promoted Single-Step Indole Construction from Simple Anilines and Ketones via Aerobic Cross-Dehydrogenative Coupling. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2018,</strong> <em>83 </em>
                                    (23)
                                     , 14472-14488. <a href="https://doi.org/10.1021/acs.joc.8b02180" title="DOI URL">https://doi.org/10.1021/acs.joc.8b02180</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.8b02180&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.8b02180%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DCarboxylic%252BAcid-Promoted%252BSingle-Step%252BIndole%252BConstruction%252Bfrom%252BSimple%252BAnilines%252Band%252BKetones%252Bvia%252BAerobic%252BCross-Dehydrogenative%252BCoupling%26aulast%3DRen%26aufirst%3DLong%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D03092018%26date%3D13112018%26date%3D31102018%26volume%3D83%26issue%3D23%26spage%3D14472%26epage%3D14488" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jie  Qi</span>, <span class="hlFld-ContribAuthor ">Zaibin  Wang</span>, <span class="hlFld-ContribAuthor ">Bo  Lang</span>, <span class="hlFld-ContribAuthor ">Ping  Lu</span>, and <span class="hlFld-ContribAuthor ">Yanguang  Wang</span>  . </span><span class="cited-content_cbyCitation_article-title">TfOH-Catalyzed Reaction between 3-Diazoindolin-2-imines and Electron-Rich Arenes: Access to 3-Aryl-2-aminoindoles. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2017,</strong> <em>82 </em>
                                    (23)
                                     , 12640-12646. <a href="https://doi.org/10.1021/acs.joc.7b02423" title="DOI URL">https://doi.org/10.1021/acs.joc.7b02423</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.7b02423&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.7b02423%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DTfOH-Catalyzed%252BReaction%252Bbetween%252B3-Diazoindolin-2-imines%252Band%252BElectron-Rich%252BArenes%25253A%252BAccess%252Bto%252B3-Aryl-2-aminoindoles%26aulast%3DQi%26aufirst%3DJie%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D25092017%26date%3D20112017%26date%3D01122017%26date%3D10112017%26volume%3D82%26issue%3D23%26spage%3D12640%26epage%3D12646" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eslam  Pourbasheer</span>, <span class="hlFld-ContribAuthor ">Reza  Aalizadeh</span>, <span class="hlFld-ContribAuthor ">Samira  Shokouhi Tabar</span>, <span class="hlFld-ContribAuthor ">Mohammad Reza  Ganjali</span>, <span class="hlFld-ContribAuthor ">Parviz  Norouzi</span>, and <span class="hlFld-ContribAuthor ">Javad  Shadmanesh</span>  . </span><span class="cited-content_cbyCitation_article-title">2D and 3D Quantitative Structure–Activity Relationship Study of Hepatitis C Virus NS5B Polymerase Inhibitors by Comparative Molecular Field Analysis and Comparative Molecular Similarity Indices Analysis Methods. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2014,</strong> <em>54 </em>
                                    (10)
                                     , 2902-2914. <a href="https://doi.org/10.1021/ci500216c" title="DOI URL">https://doi.org/10.1021/ci500216c</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ci500216c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fci500216c%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3D2D%252Band%252B3D%252BQuantitative%252BStructure%2525E2%252580%252593Activity%252BRelationship%252BStudy%252Bof%252BHepatitis%252BC%252BVirus%252BNS5B%252BPolymerase%252BInhibitors%252Bby%252BComparative%252BMolecular%252BField%252BAnalysis%252Band%252BComparative%252BMolecular%252BSimilarity%252BIndices%252BAnalysis%252BMethods%26aulast%3DPourbasheer%26aufirst%3DEslam%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D08042014%26date%3D16092014%26date%3D27102014%26date%3D02092014%26volume%3D54%26issue%3D10%26spage%3D2902%26epage%3D2914" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kevin X.  Chen</span>, <span class="hlFld-ContribAuthor ">Srikanth  Venkatraman</span>, <span class="hlFld-ContribAuthor ">Gopinadhan N.  Anilkumar</span>, <span class="hlFld-ContribAuthor ">Qingbei  Zeng</span>, <span class="hlFld-ContribAuthor ">Charles A.  Lesburg</span>, <span class="hlFld-ContribAuthor ">Bancha  Vibulbhan</span>, <span class="hlFld-ContribAuthor ">Francisco  Velazquez</span>, <span class="hlFld-ContribAuthor ">Tin-Yau  Chan</span>, <span class="hlFld-ContribAuthor ">Frank  Bennet</span>, <span class="hlFld-ContribAuthor ">Yueheng  Jiang</span>, <span class="hlFld-ContribAuthor ">Patrick  Pinto</span>, <span class="hlFld-ContribAuthor ">Yuhua  Huang</span>, <span class="hlFld-ContribAuthor ">Oleg  Selyutin</span>, <span class="hlFld-ContribAuthor ">Sony  Agrawal</span>, <span class="hlFld-ContribAuthor ">Hsueh-Cheng  Huang</span>, <span class="hlFld-ContribAuthor ">Cheng  Li</span>, <span class="hlFld-ContribAuthor ">Kuo-Chi  Cheng</span>, <span class="hlFld-ContribAuthor ">Neng-Yang  Shih</span>, <span class="hlFld-ContribAuthor ">Joseph A.  Kozlowski</span>, <span class="hlFld-ContribAuthor ">Stuart B.  Rosenblum</span>, and <span class="hlFld-ContribAuthor ">F. George  Njoroge</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of SCH 900188: A Potent Hepatitis C Virus NS5B Polymerase Inhibitor Prodrug As a Development Candidate. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2014,</strong> <em>5 </em>
                                    (3)
                                     , 244-248. <a href="https://doi.org/10.1021/ml400192w" title="DOI URL">https://doi.org/10.1021/ml400192w</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ml400192w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fml400192w%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252BSCH%252B900188%25253A%252BA%252BPotent%252BHepatitis%252BC%252BVirus%252BNS5B%252BPolymerase%252BInhibitor%252BProdrug%252BAs%252Ba%252BDevelopment%252BCandidate%26aulast%3DChen%26aufirst%3DKevin%2BX.%26date%3D2014%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D17052013%26date%3D12082013%26date%3D16082013%26date%3D13032014%26date%3D12082013%26volume%3D5%26issue%3D3%26spage%3D244%26epage%3D248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maria Letizia  Barreca</span>, <span class="hlFld-ContribAuthor ">Nunzio  Iraci</span>, <span class="hlFld-ContribAuthor ">Giuseppe  Manfroni</span>, <span class="hlFld-ContribAuthor ">Rosy  Gaetani</span>, <span class="hlFld-ContribAuthor ">Chiara  Guercini</span>, <span class="hlFld-ContribAuthor ">Stefano  Sabatini</span>, <span class="hlFld-ContribAuthor ">Oriana  Tabarrini</span>, and <span class="hlFld-ContribAuthor ">Violetta  Cecchetti</span>  . </span><span class="cited-content_cbyCitation_article-title">Accounting for Target Flexibility and Water Molecules by Docking to Ensembles of Target Structures: The HCV NS5B Palm Site I Inhibitors Case Study. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2014,</strong> <em>54 </em>
                                    (2)
                                     , 481-497. <a href="https://doi.org/10.1021/ci400367m" title="DOI URL">https://doi.org/10.1021/ci400367m</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ci400367m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fci400367m%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DAccounting%252Bfor%252BTarget%252BFlexibility%252Band%252BWater%252BMolecules%252Bby%252BDocking%252Bto%252BEnsembles%252Bof%252BTarget%252BStructures%25253A%252BThe%252BHCV%252BNS5B%252BPalm%252BSite%252BI%252BInhibitors%252BCase%252BStudy%26aulast%3DBarreca%26aufirst%3DMaria%2BLetizia%26date%3D2014%26date%3D2013%26date%3D2013%26date%3D25062013%26date%3D05092013%26date%3D24022014%26date%3D18082013%26volume%3D54%26issue%3D2%26spage%3D481%26epage%3D497" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhiping  Che</span>, <span class="hlFld-ContribAuthor ">Shaoyong  Zhang</span>, <span class="hlFld-ContribAuthor ">Yonghua  Shao</span>, <span class="hlFld-ContribAuthor ">Lingling  Fan</span>, <span class="hlFld-ContribAuthor ">Hui  Xu</span>, <span class="hlFld-ContribAuthor ">Xiang  Yu</span>, <span class="hlFld-ContribAuthor ">Xiaoyan  Zhi</span>, <span class="hlFld-ContribAuthor ">Xiaojun  Yao</span>, and <span class="hlFld-ContribAuthor ">Rui  Zhang</span>  . </span><span class="cited-content_cbyCitation_article-title">Synthesis and Quantitative Structure–Activity Relationship (QSAR) Study of Novel N-Arylsulfonyl-3-acylindole Arylcarbonyl Hydrazone Derivatives as Nematicidal Agents. </span><span class="cited-content_cbyCitation_journal-name">Journal of Agricultural and Food Chemistry</span><span> <strong>2013,</strong> <em>61 </em>
                                    (24)
                                     , 5696-5705. <a href="https://doi.org/10.1021/jf400536q" title="DOI URL">https://doi.org/10.1021/jf400536q</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jf400536q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjf400536q%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Agricultural%2520and%2520Food%2520Chemistry%26atitle%3DSynthesis%252Band%252BQuantitative%252BStructure%2525E2%252580%252593Activity%252BRelationship%252B%252528QSAR%252529%252BStudy%252Bof%252BNovel%252BN-Arylsulfonyl-3-acylindole%252BArylcarbonyl%252BHydrazone%252BDerivatives%252Bas%252BNematicidal%252BAgents%26aulast%3DChe%26aufirst%3DZhiping%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D03022013%26date%3D19052013%26date%3D20052013%26date%3D05062013%26date%3D19062013%26date%3D20052013%26volume%3D61%26issue%3D24%26spage%3D5696%26epage%3D5705" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kevin X.  Chen</span>, <span class="hlFld-ContribAuthor ">Charles A.  Lesburg</span>, <span class="hlFld-ContribAuthor ">Bancha  Vibulbhan</span>, <span class="hlFld-ContribAuthor ">Weiying  Yang</span>, <span class="hlFld-ContribAuthor ">Tin-Yau  Chan</span>, <span class="hlFld-ContribAuthor ">Srikanth  Venkatraman</span>, <span class="hlFld-ContribAuthor ">Francisco  Velazquez</span>, <span class="hlFld-ContribAuthor ">Qingbei  Zeng</span>, <span class="hlFld-ContribAuthor ">Frank  Bennett</span>, <span class="hlFld-ContribAuthor ">Gopinadhan N.  Anilkumar</span>, <span class="hlFld-ContribAuthor ">Jose  Duca</span>, <span class="hlFld-ContribAuthor ">Yueheng  Jiang</span>, <span class="hlFld-ContribAuthor ">Patrick  Pinto</span>, <span class="hlFld-ContribAuthor ">Li  Wang</span>, <span class="hlFld-ContribAuthor ">Yuhua  Huang</span>, <span class="hlFld-ContribAuthor ">Oleg  Selyutin</span>, <span class="hlFld-ContribAuthor ">Stephen  Gavalas</span>, <span class="hlFld-ContribAuthor ">Haiyan  Pu</span>, <span class="hlFld-ContribAuthor ">Sony  Agrawal</span>, <span class="hlFld-ContribAuthor ">Boris  Feld</span>, <span class="hlFld-ContribAuthor ">Hsueh-Cheng  Huang</span>, <span class="hlFld-ContribAuthor ">Cheng  Li</span>, <span class="hlFld-ContribAuthor ">Kuo-Chi  Cheng</span>, <span class="hlFld-ContribAuthor ">Neng-Yang  Shih</span>, <span class="hlFld-ContribAuthor ">Joseph A.  Kozlowski</span>, <span class="hlFld-ContribAuthor ">Stuart B.  Rosenblum</span>, and <span class="hlFld-ContribAuthor ">F. George  Njoroge</span>  . </span><span class="cited-content_cbyCitation_article-title">A Novel Class of Highly Potent Irreversible Hepatitis C Virus NS5B Polymerase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (5)
                                     , 2089-2101. <a href="https://doi.org/10.1021/jm201322r" title="DOI URL">https://doi.org/10.1021/jm201322r</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm201322r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm201322r%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DA%252BNovel%252BClass%252Bof%252BHighly%252BPotent%252BIrreversible%252BHepatitis%252BC%252BVirus%252BNS5B%252BPolymerase%252BInhibitors%26aulast%3DChen%26aufirst%3DKevin%2BX.%26date%3D2012%26date%3D2012%26date%3D2011%26date%3D03102011%26date%3D22022012%26date%3D08032012%26date%3D16012012%26volume%3D55%26issue%3D5%26spage%3D2089%26epage%3D2101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Krishnan  Balasubramanian</span>. </span><span class="cited-content_cbyCitation_article-title">Computational and Artificial Intelligence Techniques for Drug Discovery and Administration. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,<a href="https://doi.org/10.1016/B978-0-12-820472-6.00015-3" title="DOI URL">https://doi.org/10.1016/B978-0-12-820472-6.00015-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-820472-6.00015-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-820472-6.00015-3%26sid%3Dliteratum%253Aachs%26atitle%3DComputational%252Band%252BArtificial%252BIntelligence%252BTechniques%252Bfor%252BDrug%252BDiscovery%252Band%252BAdministration%26aulast%3DBalasubramanian%26aufirst%3DKrishnan%26date%3D2021%26pub%3DElsevier%26atitle%3DReference%252BModule%252Bin%252BBiomedical%252BSciences%26date%3D2021%26volume%3D17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Satya Prakash  Gupta</span>. </span><span class="cited-content_cbyCitation_article-title">Roles of Fluorine in Drug Design and Drug Action. </span><span class="cited-content_cbyCitation_journal-name">Letters in Drug Design & Discovery</span><span> <strong>2019,</strong> <em>16 </em>
                                    (10)
                                     , 1089-1109. <a href="https://doi.org/10.2174/1570180816666190130154726" title="DOI URL">https://doi.org/10.2174/1570180816666190130154726</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1570180816666190130154726&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1570180816666190130154726%26sid%3Dliteratum%253Aachs%26jtitle%3DLetters%2520in%2520Drug%2520Design%2520%2526%2520Discovery%26atitle%3DRoles%252Bof%252BFluorine%252Bin%252BDrug%252BDesign%252Band%252BDrug%252BAction%26aulast%3DGupta%26aufirst%3DSatya%2BPrakash%26date%3D2019%26volume%3D16%26issue%3D10%26spage%3D1089%26epage%3D1109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ahmed A.  Ezat</span>, <span class="hlFld-ContribAuthor ">Abdo A.  Elfiky</span>, <span class="hlFld-ContribAuthor ">Wael M.  Elshemey</span>, <span class="hlFld-ContribAuthor ">Noha A.  Saleh</span>. </span><span class="cited-content_cbyCitation_article-title">Novel inhibitors against wild-type and mutated HCV NS3 serine protease: an in silico study. </span><span class="cited-content_cbyCitation_journal-name">VirusDisease</span><span> <strong>2019,</strong> <em>30 </em>
                                    (2)
                                     , 207-213. <a href="https://doi.org/10.1007/s13337-019-00516-7" title="DOI URL">https://doi.org/10.1007/s13337-019-00516-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s13337-019-00516-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs13337-019-00516-7%26sid%3Dliteratum%253Aachs%26jtitle%3DVirusDisease%26atitle%3DNovel%252Binhibitors%252Bagainst%252Bwild-type%252Band%252Bmutated%252BHCV%252BNS3%252Bserine%252Bprotease%25253A%252Ban%252Bin%252Bsilico%252Bstudy%26aulast%3DEzat%26aufirst%3DAhmed%2BA.%26date%3D2019%26date%3D2019%26volume%3D30%26issue%3D2%26spage%3D207%26epage%3D213" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Narayana Murthy  Ganta</span>, <span class="hlFld-ContribAuthor ">Gangaraju  Gedda</span>, <span class="hlFld-ContribAuthor ">Bethi  Rathnakar</span>, <span class="hlFld-ContribAuthor ">Mavurapu  Satyanarayana</span>, <span class="hlFld-ContribAuthor ">Bhaskar  Yamajala</span>, <span class="hlFld-ContribAuthor ">Mohamed Jawed  Ahsan</span>, <span class="hlFld-ContribAuthor ">Surender Singh  Jadav</span>, <span class="hlFld-ContribAuthor ">Tuniki  Balaraju</span>. </span><span class="cited-content_cbyCitation_article-title">A review on HCV inhibitors: Significance of non-structural polyproteins. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>164 </em>, 576-601. <a href="https://doi.org/10.1016/j.ejmech.2018.12.045" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.12.045</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.12.045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.12.045%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DA%252Breview%252Bon%252BHCV%252Binhibitors%25253A%252BSignificance%252Bof%252Bnon-structural%252Bpolyproteins%26aulast%3DGanta%26aufirst%3DNarayana%2BMurthy%26date%3D2019%26volume%3D164%26spage%3D576%26epage%3D601" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yogesh D.  Mane</span>, <span class="hlFld-ContribAuthor ">Smita S.  Patil</span>, <span class="hlFld-ContribAuthor ">Dhanraj O.  Biradar</span>, <span class="hlFld-ContribAuthor ">Bhimrao C.  Khade</span>. </span><span class="cited-content_cbyCitation_article-title">5-Bromo-1-(4-chlorobenzyl)-1H-indole-2-carboxamides as new potent antibacterial agents. </span><span class="cited-content_cbyCitation_journal-name">Heterocyclic Communications</span><span> <strong>2018,</strong> <em>24 </em>
                                    (6)
                                     , 327-332. <a href="https://doi.org/10.1515/hc-2018-0107" title="DOI URL">https://doi.org/10.1515/hc-2018-0107</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1515/hc-2018-0107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1515%2Fhc-2018-0107%26sid%3Dliteratum%253Aachs%26jtitle%3DHeterocyclic%2520Communications%26atitle%3D5-Bromo-1-%2525284-chlorobenzyl%252529-1H-indole-2-carboxamides%252Bas%252Bnew%252Bpotent%252Bantibacterial%252Bagents%26aulast%3DMane%26aufirst%3DYogesh%2BD.%26date%3D2018%26volume%3D24%26issue%3D6%26spage%3D327%26epage%3D332" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Letitia  Shunmugam</span>, <span class="hlFld-ContribAuthor ">Mahmoud E. S.  Soliman</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting HCV polymerase: a structural and dynamic perspective into the mechanism of selective covalent inhibition. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2018,</strong> <em>8 </em>
                                    (73)
                                     , 42210-42222. <a href="https://doi.org/10.1039/C8RA07346E" title="DOI URL">https://doi.org/10.1039/C8RA07346E</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8RA07346E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8RA07346E%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DTargeting%252BHCV%252Bpolymerase%25253A%252Ba%252Bstructural%252Band%252Bdynamic%252Bperspective%252Binto%252Bthe%252Bmechanism%252Bof%252Bselective%252Bcovalent%252Binhibition%26aulast%3DShunmugam%26aufirst%3DLetitia%26date%3D2018%26date%3D2018%26volume%3D8%26issue%3D73%26spage%3D42210%26epage%3D42222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Krishnan  Balasubramanian</span>, <span class="hlFld-ContribAuthor ">Vaishali M.  Patil</span>. </span><span class="cited-content_cbyCitation_article-title">Quantum molecular modeling of hepatitis C virus inhibition through non-structural protein 5B polymerase receptor binding of C5-arylidene rhodanines. </span><span class="cited-content_cbyCitation_journal-name">Computational Biology and Chemistry</span><span> <strong>2018,</strong> <em>73 </em>, 147-158. <a href="https://doi.org/10.1016/j.compbiolchem.2018.01.008" title="DOI URL">https://doi.org/10.1016/j.compbiolchem.2018.01.008</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.compbiolchem.2018.01.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.compbiolchem.2018.01.008%26sid%3Dliteratum%253Aachs%26jtitle%3DComputational%2520Biology%2520and%2520Chemistry%26atitle%3DQuantum%252Bmolecular%252Bmodeling%252Bof%252Bhepatitis%252BC%252Bvirus%252Binhibition%252Bthrough%252Bnon-structural%252Bprotein%252B5B%252Bpolymerase%252Breceptor%252Bbinding%252Bof%252BC5-arylidene%252Brhodanines%26aulast%3DBalasubramanian%26aufirst%3DKrishnan%26date%3D2018%26volume%3D73%26spage%3D147%26epage%3D158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Satya P.  Gupta</span>. </span><span class="cited-content_cbyCitation_article-title">The Medicinal Chemistry of Antihepatitis Agents III. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 133-210. <a href="https://doi.org/10.1016/B978-0-12-813330-9.00007-7" title="DOI URL">https://doi.org/10.1016/B978-0-12-813330-9.00007-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-813330-9.00007-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-813330-9.00007-7%26sid%3Dliteratum%253Aachs%26atitle%3DThe%252BMedicinal%252BChemistry%252Bof%252BAntihepatitis%252BAgents%252BIII%26aulast%3DGupta%26aufirst%3DSatya%2BP.%26date%3D2018%26spage%3D133%26epage%3D210%26pub%3DElsevier%26atitle%3DStudies%252Bon%252BHepatitis%252BViruses%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Erwann  Grenet</span>, <span class="hlFld-ContribAuthor ">Ashis  Das</span>, <span class="hlFld-ContribAuthor ">Paola  Caramenti</span>, <span class="hlFld-ContribAuthor ">Jérôme  Waser</span>. </span><span class="cited-content_cbyCitation_article-title">Rhodium-catalyzed C–H functionalization of heteroarenes using indoleBX hypervalent iodine reagents. </span><span class="cited-content_cbyCitation_journal-name">Beilstein Journal of Organic Chemistry</span><span> <strong>2018,</strong> <em>14 </em>, 1208-1214. <a href="https://doi.org/10.3762/bjoc.14.102" title="DOI URL">https://doi.org/10.3762/bjoc.14.102</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3762/bjoc.14.102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3762%2Fbjoc.14.102%26sid%3Dliteratum%253Aachs%26jtitle%3DBeilstein%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DRhodium-catalyzed%252BC%2525E2%252580%252593H%252Bfunctionalization%252Bof%252Bheteroarenes%252Busing%252BindoleBX%252Bhypervalent%252Biodine%252Breagents%26aulast%3DGrenet%26aufirst%3DErwann%26date%3D2018%26date%3D2018%26volume%3D14%26spage%3D1208%26epage%3D1214" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yogesh D.  Mane</span>, <span class="hlFld-ContribAuthor ">Yuvaraj P.  Sarnikar</span>, <span class="hlFld-ContribAuthor ">Santosh M.  Surwase</span>, <span class="hlFld-ContribAuthor ">Dhanraj O.  Biradar</span>, <span class="hlFld-ContribAuthor ">Pratapsinha B.  Gorepatil</span>, <span class="hlFld-ContribAuthor ">Vishnu S.  Shinde</span>, <span class="hlFld-ContribAuthor ">Bhimrao C.  Khade</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, and antimicrobial activity of novel 5-substituted indole-2-carboxamide derivatives. </span><span class="cited-content_cbyCitation_journal-name">Research on Chemical Intermediates</span><span> <strong>2017,</strong> <em>43 </em>
                                    (2)
                                     , 1253-1275. <a href="https://doi.org/10.1007/s11164-016-2696-3" title="DOI URL">https://doi.org/10.1007/s11164-016-2696-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11164-016-2696-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11164-016-2696-3%26sid%3Dliteratum%253Aachs%26jtitle%3DResearch%2520on%2520Chemical%2520Intermediates%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Band%252Bantimicrobial%252Bactivity%252Bof%252Bnovel%252B5-substituted%252Bindole-2-carboxamide%252Bderivatives%26aulast%3DMane%26aufirst%3DYogesh%2BD.%26date%3D2017%26date%3D2016%26volume%3D43%26issue%3D2%26spage%3D1253%26epage%3D1275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wenlian  Li</span>, <span class="hlFld-ContribAuthor ">Hongzong  Si</span>, <span class="hlFld-ContribAuthor ">Yang  Li</span>, <span class="hlFld-ContribAuthor ">Cuizhu  Ge</span>, <span class="hlFld-ContribAuthor ">Fucheng  Song</span>, <span class="hlFld-ContribAuthor ">Xiuting  Ma</span>, <span class="hlFld-ContribAuthor ">Yunbo  Duan</span>, <span class="hlFld-ContribAuthor ">Honglin  Zhai</span>. </span><span class="cited-content_cbyCitation_article-title">3D-QSAR and molecular docking studies on designing inhibitors of the hepatitis C virus NS5B polymerase. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Structure</span><span> <strong>2016,</strong> <em>1117 </em>, 227-239. <a href="https://doi.org/10.1016/j.molstruc.2016.03.073" title="DOI URL">https://doi.org/10.1016/j.molstruc.2016.03.073</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molstruc.2016.03.073&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molstruc.2016.03.073%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Structure%26atitle%3D3D-QSAR%252Band%252Bmolecular%252Bdocking%252Bstudies%252Bon%252Bdesigning%252Binhibitors%252Bof%252Bthe%252Bhepatitis%252BC%252Bvirus%252BNS5B%252Bpolymerase%26aulast%3DLi%26aufirst%3DWenlian%26date%3D2016%26volume%3D1117%26spage%3D227%26epage%3D239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jahan B.  Ghasemi</span>, <span class="hlFld-ContribAuthor ">Elmira  Nazarshodeh</span>, <span class="hlFld-ContribAuthor ">H.  Abedi</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular docking, 2D and 3D-QSAR studies of new indole-based derivatives as HCV-NS5B polymerase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of the Iranian Chemical Society</span><span> <strong>2015,</strong> <em>12 </em>
                                    (10)
                                     , 1789-1799. <a href="https://doi.org/10.1007/s13738-015-0654-4" title="DOI URL">https://doi.org/10.1007/s13738-015-0654-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s13738-015-0654-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs13738-015-0654-4%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520Iranian%2520Chemical%2520Society%26atitle%3DMolecular%252Bdocking%25252C%252B2D%252Band%252B3D-QSAR%252Bstudies%252Bof%252Bnew%252Bindole-based%252Bderivatives%252Bas%252BHCV-NS5B%252Bpolymerase%252Binhibitors%26aulast%3DGhasemi%26aufirst%3DJahan%2BB.%26date%3D2015%26date%3D2015%26volume%3D12%26issue%3D10%26spage%3D1789%26epage%3D1799" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fatima  Lebbad</span>, <span class="hlFld-ContribAuthor ">Meriem  Merad</span>, <span class="hlFld-ContribAuthor ">Wassila  Soufi</span>, <span class="hlFld-ContribAuthor ">Said  Ghalem</span>. </span><span class="cited-content_cbyCitation_article-title">Prediction of the ligands having the inhibitory activity against the HCV non-structural protein 5B polymerase. </span><span class="cited-content_cbyCitation_journal-name">Asian Pacific Journal of Tropical Disease</span><span> <strong>2015,</strong> <em>5 </em>
                                    (8)
                                     , 650-653. <a href="https://doi.org/10.1016/S2222-1808(15)60906-9" title="DOI URL">https://doi.org/10.1016/S2222-1808(15)60906-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/S2222-1808(15)60906-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FS2222-1808%2815%2960906-9%26sid%3Dliteratum%253Aachs%26jtitle%3DAsian%2520Pacific%2520Journal%2520of%2520Tropical%2520Disease%26atitle%3DPrediction%252Bof%252Bthe%252Bligands%252Bhaving%252Bthe%252Binhibitory%252Bactivity%252Bagainst%252Bthe%252BHCV%252Bnon-structural%252Bprotein%252B5B%252Bpolymerase%26aulast%3DLebbad%26aufirst%3DFatima%26date%3D2015%26volume%3D5%26issue%3D8%26spage%3D650%26epage%3D653" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ankita  Batra</span>, <span class="hlFld-ContribAuthor ">Sisir  Nandi</span>, <span class="hlFld-ContribAuthor ">Manish C.  Bagchi</span>. </span><span class="cited-content_cbyCitation_article-title">QSAR and pharmacophore modeling of indole-based C-3 pyridone compounds as HCV NS5B polymerase inhibitors utilizing computed molecular descriptors. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry Research</span><span> <strong>2015,</strong> <em>24 </em>
                                    (6)
                                     , 2432-2440. <a href="https://doi.org/10.1007/s00044-014-1304-6" title="DOI URL">https://doi.org/10.1007/s00044-014-1304-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00044-014-1304-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00044-014-1304-6%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%2520Research%26atitle%3DQSAR%252Band%252Bpharmacophore%252Bmodeling%252Bof%252Bindole-based%252BC-3%252Bpyridone%252Bcompounds%252Bas%252BHCV%252BNS5B%252Bpolymerase%252Binhibitors%252Butilizing%252Bcomputed%252Bmolecular%252Bdescriptors%26aulast%3DBatra%26aufirst%3DAnkita%26date%3D2015%26date%3D2014%26volume%3D24%26issue%3D6%26spage%3D2432%26epage%3D2440" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eleni  Vrontaki</span>, <span class="hlFld-ContribAuthor ">Georgia  Melagraki</span>, <span class="hlFld-ContribAuthor ">Thomas  Mavromoustakos</span>, <span class="hlFld-ContribAuthor ">Antreas  Afantitis</span>. </span><span class="cited-content_cbyCitation_article-title">Exploiting ChEMBL database to identify indole analogs as HCV replication inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Methods</span><span> <strong>2015,</strong> <em>71 </em>, 4-13. <a href="https://doi.org/10.1016/j.ymeth.2014.03.021" title="DOI URL">https://doi.org/10.1016/j.ymeth.2014.03.021</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ymeth.2014.03.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ymeth.2014.03.021%26sid%3Dliteratum%253Aachs%26jtitle%3DMethods%26atitle%3DExploiting%252BChEMBL%252Bdatabase%252Bto%252Bidentify%252Bindole%252Banalogs%252Bas%252BHCV%252Breplication%252Binhibitors%26aulast%3DVrontaki%26aufirst%3DEleni%26date%3D2015%26volume%3D71%26spage%3D4%26epage%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Romain  Haudecoeur</span>, <span class="hlFld-ContribAuthor ">Marine  Peuchmaur</span>, <span class="hlFld-ContribAuthor ">Abdelhakim  Ahmed-Belkacem</span>, <span class="hlFld-ContribAuthor ">Jean-Michel  Pawlotsky</span>, <span class="hlFld-ContribAuthor ">Ahcène  Boumendjel</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-Activity Relationships in the Development of Allosteric Hepatitis C Virus RNA-Dependent RNA Polymerase Inhibitors: Ten Years of Research. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2013,</strong> <em>33 </em>
                                    (5)
                                     , 934-984. <a href="https://doi.org/10.1002/med.21271" title="DOI URL">https://doi.org/10.1002/med.21271</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21271&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21271%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DStructure-Activity%252BRelationships%252Bin%252Bthe%252BDevelopment%252Bof%252BAllosteric%252BHepatitis%252BC%252BVirus%252BRNA-Dependent%252BRNA%252BPolymerase%252BInhibitors%25253A%252BTen%252BYears%252Bof%252BResearch%26aulast%3DHaudecoeur%26aufirst%3DRomain%26date%3D2013%26date%3D2012%26volume%3D33%26issue%3D5%26spage%3D934%26epage%3D984" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Beilei  Lei</span>, <span class="hlFld-ContribAuthor ">Jiazhong  Li</span>, <span class="hlFld-ContribAuthor ">Xiaojun  Yao</span>. </span><span class="cited-content_cbyCitation_article-title">A Novel Strategy of Structural Similarity Based Consensus Modeling. </span><span class="cited-content_cbyCitation_journal-name">Molecular Informatics</span><span> <strong>2013,</strong> <em>32 </em>
                                    (7)
                                     , 599-608. <a href="https://doi.org/10.1002/minf.201200170" title="DOI URL">https://doi.org/10.1002/minf.201200170</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/minf.201200170&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fminf.201200170%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Informatics%26atitle%3DA%252BNovel%252BStrategy%252Bof%252BStructural%252BSimilarity%252BBased%252BConsensus%252BModeling%26aulast%3DLei%26aufirst%3DBeilei%26date%3D2013%26date%3D2013%26volume%3D32%26issue%3D7%26spage%3D599%26epage%3D608" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bhargav A.  Patel</span>, <span class="hlFld-ContribAuthor ">Ramalingam  Krishnan</span>, <span class="hlFld-ContribAuthor ">Nikhil  Khadtare</span>, <span class="hlFld-ContribAuthor ">K.R.  Gurukumar</span>, <span class="hlFld-ContribAuthor ">Amartya  Basu</span>, <span class="hlFld-ContribAuthor ">Payal  Arora</span>, <span class="hlFld-ContribAuthor ">Aaditya  Bhatt</span>, <span class="hlFld-ContribAuthor ">Maulik R.  Patel</span>, <span class="hlFld-ContribAuthor ">Dibyendu  Dana</span>, <span class="hlFld-ContribAuthor ">Sanjai  Kumar</span>, <span class="hlFld-ContribAuthor ">Neerja  Kaushik-Basu</span>, <span class="hlFld-ContribAuthor ">Tanaji T.  Talele</span>. </span><span class="cited-content_cbyCitation_article-title">Design and synthesis of l- and d-phenylalanine derived rhodanines with novel C5-arylidenes as inhibitors of HCV NS5B polymerase. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2013,</strong> <em>21 </em>
                                    (11)
                                     , 3262-3271. <a href="https://doi.org/10.1016/j.bmc.2013.03.041" title="DOI URL">https://doi.org/10.1016/j.bmc.2013.03.041</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2013.03.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2013.03.041%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Band%252Bsynthesis%252Bof%252Bl-%252Band%252Bd-phenylalanine%252Bderived%252Brhodanines%252Bwith%252Bnovel%252BC5-arylidenes%252Bas%252Binhibitors%252Bof%252BHCV%252BNS5B%252Bpolymerase%26aulast%3DPatel%26aufirst%3DBhargav%2BA.%26date%3D2013%26volume%3D21%26issue%3D11%26spage%3D3262%26epage%3D3271" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ş.  Küçükgüzel</span>, <span class="hlFld-ContribAuthor ">İnci  Coşkun</span>, <span class="hlFld-ContribAuthor ">Sevil  Aydın</span>, <span class="hlFld-ContribAuthor ">Göknur  Aktay</span>, <span class="hlFld-ContribAuthor ">Şule  Gürsoy</span>, <span class="hlFld-ContribAuthor ">Özge  Çevik</span>, <span class="hlFld-ContribAuthor ">Özlem  Özakpınar</span>, <span class="hlFld-ContribAuthor ">Derya  Özsavcı</span>, <span class="hlFld-ContribAuthor ">Azize  Şener</span>, <span class="hlFld-ContribAuthor ">Neerja  Kaushik-Basu</span>, <span class="hlFld-ContribAuthor ">Amartya  Basu</span>, <span class="hlFld-ContribAuthor ">Tanaji  Talele</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Characterization of Celecoxib Derivatives as Possible Anti-Inflammatory, Analgesic, Antioxidant,  Anticancer and Anti-HCV Agents. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2013,</strong> <em>18 </em>
                                    (3)
                                     , 3595-3614. <a href="https://doi.org/10.3390/molecules18033595" title="DOI URL">https://doi.org/10.3390/molecules18033595</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules18033595&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules18033595%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DSynthesis%252Band%252BCharacterization%252Bof%252BCelecoxib%252BDerivatives%252Bas%252BPossible%252BAnti-Inflammatory%25252C%252BAnalgesic%25252C%252BAntioxidant%25252C%252BAnticancer%252Band%252BAnti-HCV%252BAgents%26aulast%3DK%25C3%25BC%25C3%25A7%25C3%25BCkg%25C3%25BCzel%26aufirst%3D%25C5%259E.%26date%3D2013%26date%3D2013%26volume%3D18%26issue%3D3%26spage%3D3595%26epage%3D3614" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-2/jm201258k/production/images/medium/jm-2011-01258k_0005.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-2/jm201258k/production/images/large/jm-2011-01258k_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201258k&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-2/jm201258k/production/images/medium/jm-2011-01258k_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-2/jm201258k/production/images/large/jm-2011-01258k_0007.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. HCV NS5B polymerase inhibitors early lead structures.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-2/jm201258k/production/images/large/jm-2011-01258k_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201258k&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-2/jm201258k/production/images/medium/jm-2011-01258k_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-2/jm201258k/production/images/large/jm-2011-01258k_0009.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-2/jm201258k/production/images/large/jm-2011-01258k_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201258k&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NIS, acetone, quant; (b) PdCl<sub>2</sub>(dppf)<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, 1,2-dimethoxyethane, 50–85%; (c) ArCH<sub>2</sub>Br or ArCH<sub>2</sub>Cl, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 40–90%; (d) 4 M HCl, <i>p</i>-dioxane; (e) LiOH, THF/H<sub>2</sub>O 30–60% (2 steps).</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-2/jm201258k/production/images/medium/jm-2011-01258k_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-2/jm201258k/production/images/large/jm-2011-01258k_0010.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-2/jm201258k/production/images/large/jm-2011-01258k_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201258k&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) LiOH, THF/H<sub>2</sub>O; (b) CDI, then RSO<sub>2</sub>NH<sub>2</sub>, DBU, THF, 50–80% (2 steps); (c) 4 M HCl, <i>p</i>-dioxane, 30–50%.</p></p></figure><figure data-id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-2/jm201258k/production/images/medium/jm-2011-01258k_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-2/jm201258k/production/images/large/jm-2011-01258k_0008.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. X-ray crystal structure of compound <b>56</b> bound to HCV NS5B polymerase.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-2/jm201258k/production/images/large/jm-2011-01258k_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201258k&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i49">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_84528" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_84528" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 29 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Cohen, J.</span><span> </span><span class="NLM_article-title">The Scientific Challenge of Hepatitis C</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">285</span><span class="NLM_x">, </span> <span class="NLM_fpage">26</span><span class="NLM_x">–</span> <span class="NLM_lpage">30</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=1999&pages=26-30&author=J.+Cohen&title=The+Scientific+Challenge+of+Hepatitis+C"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCohen%26aufirst%3DJ.%26atitle%3DThe%2520Scientific%2520Challenge%2520of%2520Hepatitis%2520C%26jtitle%3DScience%26date%3D1999%26volume%3D285%26spage%3D26%26epage%3D30" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Alter, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kruszon-Moran, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nainan, O. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McQuillan, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moyer, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaslow, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Margolis, H. S.</span><span> </span><span class="NLM_article-title">The Prevalence of Hepatitis C Virus Infection in the United States, 1988 Through 1994</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">341</span><span class="NLM_x">, </span> <span class="NLM_fpage">556</span><span class="NLM_x">–</span> <span class="NLM_lpage">562</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=16&amp;doi=10.1021%2Fjm201258k&amp;key=10.1056%2FNEJM199908193410802" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=8&amp;doi=10.1021%2Fjm201258k&amp;key=10451460" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=32&amp;doi=10.1021%2Fjm201258k&amp;key=1%3ACAS%3A280%3ADyaK1Mzmt1Whsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=341&publication_year=1999&pages=556-562&author=M.+J.+Alterauthor=D.+Kruszon-Moranauthor=O.+V.+Nainanauthor=G.+M.+McQuillanauthor=F.+Gaoauthor=L.+A.+Moyerauthor=R.+A.+Kaslowauthor=H.+S.+Margolis&title=The+Prevalence+of+Hepatitis+C+Virus+Infection+in+the+United+States%2C+1988+Through+1994"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1bR"><div class="casContent"><span class="casTitleNuber">1b</span><div class="casTitle"><span class="NLM_cas:atitle">The prevalence of hepatitis C virus infection in the United States, 1988 through 1994</span></div><div class="casAuthors">Alter M J; Kruszon-Moran D; Nainan O V; McQuillan G M; Gao F; Moyer L A; Kaslow R A; Margolis H S</div><div class="citationInfo"><span class="NLM_cas:title">The New England journal of medicine</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">341</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">556-62</span>
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    </div><div class="casAbstract">BACKGROUND:  Because many persons with chronic hepatitis C virus (HCV) infection are asymptomatic, population-based serologic studies are needed to estimate the prevalence of the infection and to develop and evaluate prevention efforts.  METHODS:  We performed tests for antibody to HCV (anti-HCV) on serum samples from 21,241 persons six years old or older who participated in the third National Health and Nutrition Examination Survey, conducted during 1988 through 1994.  We determined the prevalence of HCV RNA by means of nucleic acid amplification and the genotype by means of sequencing.  RESULTS:  The overall prevalence of anti-HCV was 1.8 percent, corresponding to an estimated 3.9 million persons nationwide (95 percent confidence interval, 3.1 million to 4.8 million) with HCV infection.  Sixty-five percent of the persons with HCV infection were 30 to 49 years old.  Seventy-four percent were positive for HCV RNA, indicating that an estimated 2.7 million persons in the United States (95 percent confidence interval, 2.4 million to 3.0 million) were chronically infected, of whom 73.7 percent were infected with genotype 1 (56.7 percent with genotype 1a, and 17.0 percent with genotype 1b).  Among subjects 17 to 59 years of age, the strongest factors independently associated with HCV infection were illegal drug use and high-risk sexual behavior.  Other factors independently associated with infection included poverty, having had 12 or fewer years of education, and having been divorced or separated.  Neither sex nor racial-ethnic group was independently associated with HCV infection.  CONCLUSIONS:  In the United States, about 2.7 million persons are chronically infected with HCV.  People who use illegal drugs or engage in high-risk sexual behavior account for most persons with HCV infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRTwajewlRkP_tos8R3JUhXfW6udTcc2easdOxmIASac7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1Mzmt1Whsw%253D%253D&md5=d36f80ca56095fcd3cb19271f9e80dca</span></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=10.1056%2FNEJM199908193410802&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM199908193410802%26sid%3Dliteratum%253Aachs%26aulast%3DAlter%26aufirst%3DM.%2BJ.%26aulast%3DKruszon-Moran%26aufirst%3DD.%26aulast%3DNainan%26aufirst%3DO.%2BV.%26aulast%3DMcQuillan%26aufirst%3DG.%2BM.%26aulast%3DGao%26aufirst%3DF.%26aulast%3DMoyer%26aufirst%3DL.%2BA.%26aulast%3DKaslow%26aufirst%3DR.%2BA.%26aulast%3DMargolis%26aufirst%3DH.%2BS.%26atitle%3DThe%2520Prevalence%2520of%2520Hepatitis%2520C%2520Virus%2520Infection%2520in%2520the%2520United%2520States%252C%25201988%2520Through%25201994%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D1999%26volume%3D341%26spage%3D556%26epage%3D562" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Cuthbert, J. A.</span><span> </span><span class="NLM_article-title">Hepatitis C: Progress and Problems</span> <span class="citation_source-journal">Clin. Microbiol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">505</span><span class="NLM_x">–</span> <span class="NLM_lpage">532</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=8&amp;doi=10.1021%2Fjm201258k&amp;key=7834603" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=32&amp;doi=10.1021%2Fjm201258k&amp;key=1%3ACAS%3A280%3ADyaK2M7js1ajtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1994&pages=505-532&author=J.+A.+Cuthbert&title=Hepatitis+C%3A+Progress+and+Problems"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1cR"><div class="casContent"><span class="casTitleNuber">1c</span><div class="casTitle"><span class="NLM_cas:atitle">Hepatitis C: progress and problems</span></div><div class="casAuthors">Cuthbert J A</div><div class="citationInfo"><span class="NLM_cas:title">Clinical microbiology reviews</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">505-32</span>
        ISSN:<span class="NLM_cas:issn">0893-8512</span>.
    </div><div class="casAbstract">The hepatitis C virus (HCV), a single-stranded RNA virus, is the major cause of posttransfusion hepatitis.  HCV isolates differ in nucleotide and amino acid sequences.  Nucleotide changes are concentrated in hypervariable regions and may be related to immune selection.  In most immunocompetent persons, HCV infection is diagnosed serologically, using antigens from conserved regions.  Amplification of RNA may be necessary to detect infection in immunosuppressed patients.  Transmission by known parenteral routes is frequent; other means of spread are less common and may represent inapparent, percutaneous dissemination.  Infection can lead to classical acute hepatitis, but most infected persons have no history of acute disease.  Once infected, most individuals apparently remain carriers of the virus, with varying degrees of hepatocyte damage and fibrosis ensuing.  Chronic hepatitis may lead to cirrhosis and hepatocellular carcinoma.  However, disease progression varies widely, from less than 2 years to cirrhosis in some patients to more than 30 years with only chronic hepatitis in others.  Determinants important in deciding outcome are unknown.  Alpha interferon, which results in sustained remission in selected patients, is the only available therapy.  Long-term benefits from such therapy have not been demonstrated.  Prevention of HCV infection by vaccination is likely to be challenging if ongoing viral mutation results in escape from neutralization and clearance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQXDQuuyW-2sDEC-75aqa5AfW6udTcc2easdOxmIASac7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2M7js1ajtA%253D%253D&md5=b4434f7061f607052197da39e1916b0a</span></div><a href="/servlet/linkout?suffix=cit1c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCuthbert%26aufirst%3DJ.%2BA.%26atitle%3DHepatitis%2520C%253A%2520Progress%2520and%2520Problems%26jtitle%3DClin.%2520Microbiol.%2520Rev.%26date%3D1994%26volume%3D7%26spage%3D505%26epage%3D532" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Shepard, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finelli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alter, M. J.</span><span> </span><span class="NLM_article-title">Global epidemiology of hepatitis C virus infection</span> <span class="citation_source-journal">Lancet Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">558</span><span class="NLM_x">–</span> <span class="NLM_lpage">567</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=16&amp;doi=10.1021%2Fjm201258k&amp;key=10.1016%2FS1473-3099%2805%2970216-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=8&amp;doi=10.1021%2Fjm201258k&amp;key=16122679" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=32&amp;doi=10.1021%2Fjm201258k&amp;key=1%3ACAS%3A280%3ADC%252BD2Mvls1Wlsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=558-567&author=C.+W.+Shepardauthor=L.+Finelliauthor=M.+J.+Alter&title=Global+epidemiology+of+hepatitis+C+virus+infection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2aR"><div class="casContent"><span class="casTitleNuber">2a</span><div class="casTitle"><span class="NLM_cas:atitle">Global epidemiology of hepatitis C virus infection</span></div><div class="casAuthors">Shepard Colin W; Finelli Lyn; Alter Miriam J</div><div class="citationInfo"><span class="NLM_cas:title">The Lancet. Infectious diseases</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">558-67</span>
        ISSN:<span class="NLM_cas:issn">1473-3099</span>.
    </div><div class="casAbstract">Hepatitis C virus (HCV) is a major cause of liver disease worldwide and a potential cause of substantial morbidity and mortality in the future.  The complexity and uncertainty related to the geographic distribution of HCV infection and chronic hepatitis C, determination of its associated risk factors, and evaluation of cofactors that accelerate its progression, underscore the difficulties in global prevention and control of HCV.  Because there is no vaccine and no post-exposure prophylaxis for HCV, the focus of primary prevention efforts should be safer blood supply in the developing world, safe injection practices in health care and other settings, and decreasing the number of people who initiate injection drug use.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQyQ65qEM2alVm8bhe6roZYfW6udTcc2easdOxmIASac7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2Mvls1Wlsg%253D%253D&md5=4d5f81fa0c2191b8c32b328e39933fad</span></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=10.1016%2FS1473-3099%2805%2970216-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1473-3099%252805%252970216-4%26sid%3Dliteratum%253Aachs%26aulast%3DShepard%26aufirst%3DC.%2BW.%26aulast%3DFinelli%26aufirst%3DL.%26aulast%3DAlter%26aufirst%3DM.%2BJ.%26atitle%3DGlobal%2520epidemiology%2520of%2520hepatitis%2520C%2520virus%2520infection%26jtitle%3DLancet%2520Infect.%2520Dis.%26date%3D2005%26volume%3D5%26spage%3D558%26epage%3D567" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Monto, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, T. L.</span><span> </span><span class="NLM_article-title">The Epidemiology and Prevention of Hepatocellular Carcinoma</span> <span class="citation_source-journal">Semin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">441</span><span class="NLM_x">–</span> <span class="NLM_lpage">449</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=16&amp;doi=10.1021%2Fjm201258k&amp;key=10.1016%2FS0093-7754%2801%2990137-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=8&amp;doi=10.1021%2Fjm201258k&amp;key=11685737" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=32&amp;doi=10.1021%2Fjm201258k&amp;key=1%3ACAS%3A280%3ADC%252BD3MngvVOhtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2001&pages=441-449&author=A.+Montoauthor=T.+L.+Wright&title=The+Epidemiology+and+Prevention+of+Hepatocellular+Carcinoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2bR"><div class="casContent"><span class="casTitleNuber">2b</span><div class="casTitle"><span class="NLM_cas:atitle">The epidemiology and prevention of hepatocellular carcinoma</span></div><div class="casAuthors">Monto A; Wright T L</div><div class="citationInfo"><span class="NLM_cas:title">Seminars in oncology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">441-9</span>
        ISSN:<span class="NLM_cas:issn">0093-7754</span>.
    </div><div class="casAbstract">Hepatocellular carcinoma (HCC) is a common cancer.  Its incidence is higher in countries where hepatitis B is endemic.  HCC is substantially a complication of liver cirrhosis.  Hepatitis B virus (HBV) and hepatitis C virus (HCV) are the predominant causes of cirrhosis, and as such, HCC.  The link between HCC and alcoholic cirrhosis is less strong.  Other less common forms of chronic liver disease can also lead to HCC.  HBV is the HCC-determining disease worldwide.  In endemic regions, it tends to be acquired early in life.  The largest strides in prevention of HCC have been made with the HBV vaccine.  HCV has a lower global prevalence than HBV, but HCV causes the most HCC in economically developed regions.  In these areas, where the incidence of HCC is low, HCV now accounts for more than 50% of HCCs.  There is no vaccine for HCV, so prevention of HCV-associated HCC will focus on prevention of initial infection and elimination of infection through antiviral therapies.  HBV-HCV coinfection, and the combination of either with alcohol abuse or aflatoxin exposure seems to raise the risk of HCC development further.  Liver transplantation and other adjuvant therapies may offer better options for secondary prevention of HCC than resection alone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTuq0Don9pfEtTiMd2aNQVUfW6udTcc2eYw6wzTyejrOLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3MngvVOhtw%253D%253D&md5=1b421c8469c206780be4d03eafb412e2</span></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=10.1016%2FS0093-7754%2801%2990137-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0093-7754%252801%252990137-X%26sid%3Dliteratum%253Aachs%26aulast%3DMonto%26aufirst%3DA.%26aulast%3DWright%26aufirst%3DT.%2BL.%26atitle%3DThe%2520Epidemiology%2520and%2520Prevention%2520of%2520Hepatocellular%2520Carcinoma%26jtitle%3DSemin.%2520Oncol.%26date%3D2001%26volume%3D28%26spage%3D441%26epage%3D449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Sheridan, C.</span><span> </span><span class="NLM_article-title">New Merck and Vertex drugs raise standard of care in hepatitis C</span> <span class="citation_source-journal">Nature Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">553</span><span class="NLM_x">–</span> <span class="NLM_lpage">554</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=16&amp;doi=10.1021%2Fjm201258k&amp;key=10.1038%2Fnbt0711-553" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=8&amp;doi=10.1021%2Fjm201258k&amp;key=21747363" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=32&amp;doi=10.1021%2Fjm201258k&amp;key=1%3ACAS%3A528%3ADC%252BC3MXoslymtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2011&pages=553-554&author=C.+Sheridan&title=New+Merck+and+Vertex+drugs+raise+standard+of+care+in+hepatitis+C"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3aR"><div class="casContent"><span class="casTitleNuber">3a</span><div class="casTitle"><span class="NLM_cas:atitle">New Merck and Vertex drugs raise standard of care in hepatitis C</span></div><div class="casAuthors">Sheridan, Cormac</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">553-554</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDRNfcMR5e4rVg90H21EOLACvtfcHk0lgLLKo1tEHfQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXoslymtrw%253D&md5=35734099c95a7a35dfd35d90f5820641</span></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=10.1038%2Fnbt0711-553&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt0711-553%26sid%3Dliteratum%253Aachs%26aulast%3DSheridan%26aufirst%3DC.%26atitle%3DNew%2520Merck%2520and%2520Vertex%2520drugs%2520raise%2520standard%2520of%2520care%2520in%2520hepatitis%2520C%26jtitle%3DNature%2520Biotechnol.%26date%3D2011%26volume%3D29%26spage%3D553%26epage%3D554" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Fried, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiffman, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, D. K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marinos, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonçales, F. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Häussinger, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diago, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carosi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhumeaux, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Craxi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, J.</span><span> </span><span class="NLM_article-title">PEGinterferon-α-2a plus ribavirin for chronic hepatitis C virus infection</span> <span class="citation_source-journal">New Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">347</span><span class="NLM_x">, </span> <span class="NLM_fpage">975</span><span class="NLM_x">–</span> <span class="NLM_lpage">982</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=16&amp;doi=10.1021%2Fjm201258k&amp;key=10.1056%2FNEJMoa020047" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=8&amp;doi=10.1021%2Fjm201258k&amp;key=12324553" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=32&amp;doi=10.1021%2Fjm201258k&amp;key=1%3ACAS%3A528%3ADC%252BD38Xnt12rtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=347&publication_year=2002&pages=975-982&author=M.+W.+Friedauthor=M.+L.+Shiffmanauthor=D.+K.+R.+Reddyauthor=C.+Smithauthor=G.+Marinosauthor=F.+L.+Gon%C3%A7alesauthor=D.+H%C3%A4ussingerauthor=M.+Diagoauthor=G.+Carosiauthor=D.+Dhumeauxauthor=A.+Craxiauthor=A.+Linauthor=J.+Hoffmanauthor=J.+Yu&title=PEGinterferon-%CE%B1-2a+plus+ribavirin+for+chronic+hepatitis+C+virus+infection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3bR"><div class="casContent"><span class="casTitleNuber">3b</span><div class="casTitle"><span class="NLM_cas:atitle">Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection</span></div><div class="casAuthors">Fried, Michael W.; Shiffman, Mitchell L.; Reddy, K. Rajender; Smith, Coleman; Marinos, George; Goncales, Fernando L., Jr.; Haussinger, Dieter; Diago, Moises; Carosi, Giampiero; Dhumeaux, Daniel; Craxi, Antonio; Lin, Amy; Hoffman, Joseph; Yu, Jian</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">347</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">975-982</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Background: Treatment with peginterferon alfa-2a alone produces significantly higher sustained virol. responses than treatment with interferon alfa-2a alone in patients with chronic hepatitis C virus (HCV) infection.  We compared the efficacy and safety of peginterferon alfa-2a plus ribavirin, interferon alfa-2b plus ribavirin, and peginterferon alfa-2a alone in the initial treatment of chronic hepatitis C.  Methods: A total of 1121 patients were randomly assigned to treatment and received at least one dose of study medication, consisting of 180 μg of peginterferon alfa-2a once weekly plus daily ribavirin (1000 or 1200 mg, depending on body wt.), weekly peginterferon alfa-2a plus daily placebo, or 3 million units of interferon alfa-2b thrice weekly plus daily ribavirin for 48 wk.  Results: A significantly higher proportion of patients who received peginterferon alfa-2a plus ribavirin had a sustained virol. response (defined as the absence of detectable HCV RNA 24 wk after cessation of therapy) than of patients who received interferon alfa-2b plus ribavirin (56 % vs. 44 %, P<0.001) or peginterferon alfa-2a alone (56 % vs. 29 %, P<0.001).  The proportions of patients with HCV genotype 1 who had sustained virol. responses were 46 %, 36 %, and 21 %, resp., for the three regimens.  Among patients with HCV genotype 1 and high base-line levels of HCV RNA, the proportions of those with sustained virol. responses were 41 %, 33 %, and 13 %, resp.  The overall safety profiles of the three treatment regimens were similar; the incidence of influenza-like symptoms and depression was lower in the groups receiving peginterferon alfa-2a than in the group receiving interferon alfa-2b plus ribavirin.  Conclusions: In patients with chronic hepatitis C, once-weekly peginterferon alfa-2a plus ribavirin was tolerated as well as interferon alfa-2b plus ribavirin and produced significant improvements in the rate of sustained virol. response, as compared with interferon alfa-2b plus ribavirin or peginterferon alfa-2a alone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqblwkeNXWJzbVg90H21EOLACvtfcHk0lgLLKo1tEHfQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xnt12rtb0%253D&md5=2fd959d790b9505384fbd26ef44b2963</span></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa020047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa020047%26sid%3Dliteratum%253Aachs%26aulast%3DFried%26aufirst%3DM.%2BW.%26aulast%3DShiffman%26aufirst%3DM.%2BL.%26aulast%3DReddy%26aufirst%3DD.%2BK.%2BR.%26aulast%3DSmith%26aufirst%3DC.%26aulast%3DMarinos%26aufirst%3DG.%26aulast%3DGon%25C3%25A7ales%26aufirst%3DF.%2BL.%26aulast%3DH%25C3%25A4ussinger%26aufirst%3DD.%26aulast%3DDiago%26aufirst%3DM.%26aulast%3DCarosi%26aufirst%3DG.%26aulast%3DDhumeaux%26aufirst%3DD.%26aulast%3DCraxi%26aufirst%3DA.%26aulast%3DLin%26aufirst%3DA.%26aulast%3DHoffman%26aufirst%3DJ.%26aulast%3DYu%26aufirst%3DJ.%26atitle%3DPEGinterferon-%25CE%25B1-2a%2520plus%2520ribavirin%2520for%2520chronic%2520hepatitis%2520C%2520virus%2520infection%26jtitle%3DNew%2520Engl.%2520J.%2520Med.%26date%3D2002%26volume%3D347%26spage%3D975%26epage%3D982" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Di Bisceglie, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McHutchison, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, C. M.</span><span> </span><span class="NLM_article-title">New therapeutic strategies for hepatitis C</span> <span class="citation_source-journal">Hepatology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">224</span><span class="NLM_x">–</span> <span class="NLM_lpage">231</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2002&pages=224-231&author=A.+M.+Di+Bisceglieauthor=J.+McHutchisonauthor=C.+M.+Rice&title=New+therapeutic+strategies+for+hepatitis+C"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BBisceglie%26aufirst%3DA.%2BM.%26aulast%3DMcHutchison%26aufirst%3DJ.%26aulast%3DRice%26aufirst%3DC.%2BM.%26atitle%3DNew%2520therapeutic%2520strategies%2520for%2520hepatitis%2520C%26jtitle%3DHepatology%26date%3D2002%26volume%3D35%26spage%3D224%26epage%3D231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Choo, Q. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiner, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiner, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Overby, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradley, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houghton, M.</span><span> </span><span class="NLM_article-title">Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">244</span><span class="NLM_x">, </span> <span class="NLM_fpage">359</span><span class="NLM_x">–</span> <span class="NLM_lpage">362</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm201258k&amp;key=10.1126%2Fscience.2523562" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm201258k&amp;key=2523562" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm201258k&amp;key=1%3ACAS%3A528%3ADyaL1MXit1Khtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=244&publication_year=1989&pages=359-362&author=Q.+L.+Chooauthor=G.+Kuoauthor=A.+J.+Weinerauthor=A.+J.+Weinerauthor=L.+R.+Overbyauthor=D.+W.+Bradleyauthor=M.+Houghton&title=Isolation+of+a+cDNA+clone+derived+from+a+blood-borne+non-A%2C+non-B+viral+hepatitis+genome"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome</span></div><div class="casAuthors">Choo, Qui Lim; Kuo, George; Weiner, Amy J.; Overby, Lacy R.; Bradley, Daniel W.; Houghton, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">244</span>
        (<span class="NLM_cas:issue">4902</span>),
    <span class="NLM_cas:pages">359-62</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">A random-primed cDNA library was constructed from plasma contg. the uncharacterized non-A, non-B hepatitis (NANBH) agent and screened with serum from a patient diagnosed with NANBH.  A cDNA clone was isolated that was shown to encode an antigen assocd. specifically with NANBH infections.  This clone is not derived from host DNA but from an RNA mol. present in NANBH infections that consists of ≥10,000 nucleotides, and that is pos.-stranded with respect to the encoded NANBH antigen.  These data indicate that this clone is derived from the genome of the NANBH agent and are consistent with the agent being similar to the togaviridae or flaviviridae.  This mol. approach should be of great value in the isolation and characterization of other unidentified infectious agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqorpVFx7nEkrVg90H21EOLACvtfcHk0lj6LKyhFEc0-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXit1Khtrk%253D&md5=25161cf212790856dd29d3aaf78f20b8</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1126%2Fscience.2523562&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.2523562%26sid%3Dliteratum%253Aachs%26aulast%3DChoo%26aufirst%3DQ.%2BL.%26aulast%3DKuo%26aufirst%3DG.%26aulast%3DWeiner%26aufirst%3DA.%2BJ.%26aulast%3DWeiner%26aufirst%3DA.%2BJ.%26aulast%3DOverby%26aufirst%3DL.%2BR.%26aulast%3DBradley%26aufirst%3DD.%2BW.%26aulast%3DHoughton%26aufirst%3DM.%26atitle%3DIsolation%2520of%2520a%2520cDNA%2520clone%2520derived%2520from%2520a%2520blood-borne%2520non-A%252C%2520non-B%2520viral%2520hepatitis%2520genome%26jtitle%3DScience%26date%3D1989%26volume%3D244%26spage%3D359%26epage%3D362" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Chen, K. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Njoroge, F. G.</span><span> </span><span class="NLM_article-title">A review of HCV protease inhibitors</span> <span class="citation_source-journal">Curr. Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">821</span><span class="NLM_x">–</span> <span class="NLM_lpage">837</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2009&pages=821-837&author=K.+X.+Chenauthor=F.+G.+Njoroge&title=A+review+of+HCV+protease+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DK.%2BX.%26aulast%3DNjoroge%26aufirst%3DF.%2BG.%26atitle%3DA%2520review%2520of%2520HCV%2520protease%2520inhibitors%26jtitle%3DCurr.%2520Opin.%2520Invest.%2520Drugs%26date%3D2009%26volume%3D10%26spage%3D821%26epage%3D837" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Watkins, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ray, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chong, L. S.</span><span> </span><span class="NLM_article-title">HCV NS5B polymerase inhibitors</span> <span class="citation_source-journal">Curr. Opin. Drug Discovery Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">441</span><span class="NLM_x">–</span> <span class="NLM_lpage">465</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2010&pages=441-465&author=W.+J.+Watkinsauthor=A.+S.+Rayauthor=L.+S.+Chong&title=HCV+NS5B+polymerase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWatkins%26aufirst%3DW.%2BJ.%26aulast%3DRay%26aufirst%3DA.%2BS.%26aulast%3DChong%26aufirst%3DL.%2BS.%26atitle%3DHCV%2520NS5B%2520polymerase%2520inhibitors%26jtitle%3DCurr.%2520Opin.%2520Drug%2520Discovery%2520Dev.%26date%3D2010%26volume%3D13%26spage%3D441%26epage%3D465" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Legrand-Abravanel, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicot, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Izopet, J.</span><span> </span><span class="NLM_article-title">New NS5B polymerase inhibitors for hepatitis C</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">963</span><span class="NLM_x">–</span> <span class="NLM_lpage">975</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2010&pages=963-975&author=F.+Legrand-Abravanelauthor=F.+Nicotauthor=J.+Izopet&title=New+NS5B+polymerase+inhibitors+for+hepatitis+C"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLegrand-Abravanel%26aufirst%3DF.%26aulast%3DNicot%26aufirst%3DF.%26aulast%3DIzopet%26aufirst%3DJ.%26atitle%3DNew%2520NS5B%2520polymerase%2520inhibitors%2520for%2520hepatitis%2520C%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2010%26volume%3D19%26spage%3D963%26epage%3D975" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Gao, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nettles, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belema, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, V..N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fridell, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serrano-Wu, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langley, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, J.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Boyle, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemm, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knipe, J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chien, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colonno, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grasela, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meanwell, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamann, L. G.</span><span> </span><span class="NLM_article-title">Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">465</span><span class="NLM_x">, </span> <span class="NLM_fpage">96</span><span class="NLM_x">–</span> <span class="NLM_lpage">100</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5d&amp;dbid=16&amp;doi=10.1021%2Fjm201258k&amp;key=10.1038%2Fnature08960" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5d&amp;dbid=8&amp;doi=10.1021%2Fjm201258k&amp;key=20410884" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5d&amp;dbid=32&amp;doi=10.1021%2Fjm201258k&amp;key=1%3ACAS%3A528%3ADC%252BC3cXltVGhtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=465&publication_year=2010&pages=96-100&author=M.+Gaoauthor=R.+E.+Nettlesauthor=M.+Belemaauthor=L.+B.+Snyderauthor=V..N.+Nguyenauthor=R.+A.+Fridellauthor=M.+H.+Serrano-Wuauthor=D.+R.+Langleyauthor=J.-H.+Sunauthor=D.+R.+O%E2%80%99Boyleauthor=J.+A.+Lemmauthor=C.+Wangauthor=J.+O.+Knipeauthor=C.+Chienauthor=R.+J.+Colonnoauthor=D.+M.+Graselaauthor=N.+A.+Meanwellauthor=L.+G.+Hamann&title=Chemical+genetics+strategy+identifies+an+HCV+NS5A+inhibitor+with+a+potent+clinical+effect"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5dR"><div class="casContent"><span class="casTitleNuber">5d</span><div class="casTitle"><span class="NLM_cas:atitle">Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect</span></div><div class="casAuthors">Gao, Min; Nettles, Richard E.; Belema, Makonen; Snyder, Lawrence B.; Nguyen, Van N.; Fridell, Robert A.; Serrano-Wu, Michael H.; Langley, David R.; Sun, Jin-Hua; O'Boyle, Donald R., II; Lemm, Julie A.; Wang, Chunfu; Knipe, Jay O.; Chien, Caly; Colonno, Richard J.; Grasela, Dennis M.; Meanwell, Nicholas A.; Hamann, Lawrence G.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">465</span>
        (<span class="NLM_cas:issue">7294</span>),
    <span class="NLM_cas:pages">96-100</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The worldwide prevalence of chronic hepatitis C virus (HCV) infection is estd. to be approaching 200 million people.  Current therapy relies upon a combination of pegylated interferon-α and ribavirin, a poorly tolerated regimen typically assocd. with less than 50% sustained virol. response rate in those infected with genotype 1 virus.  The development of direct-acting antiviral agents to treat HCV has focused predominantly on inhibitors of the viral enzymes NS3 protease and the RNA-dependent RNA polymerase NS5B.  Here we describe the profile of BMS-790052, a small mol. inhibitor of the HCV NS5A protein that exhibits picomolar half-max. effective concns. (EC50) towards replicons expressing a broad range of HCV genotypes and the JFH-1 genotype 2a infectious virus in cell culture.  In a phase I clin. trial in patients chronically infected with HCV, administration of a single 100-mg dose of BMS-790052 was assocd. with a 3.3 log10 redn. in mean viral load measured 24 h post-dose that was sustained for an addnl. 120 h in two patients infected with genotype 1b virus.  Genotypic anal. of samples taken at baseline, 24 and 144 h post-dose revealed that the major HCV variants obsd. had substitutions at amino-acid positions identified using the in vitro replicon system.  These results provide the first clin. validation of an inhibitor of HCV NS5A, a protein with no known enzymic function, as an approach to the suppression of virus replication that offers potential as part of a therapeutic regimen based on combinations of HCV inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAY7Lig0xT9LVg90H21EOLACvtfcHk0lj6LKyhFEc0-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXltVGhtbo%253D&md5=620427e987f2bccd153270cde2ef5027</span></div><a href="/servlet/linkout?suffix=cit5d&amp;dbid=16384&amp;doi=10.1038%2Fnature08960&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature08960%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DM.%26aulast%3DNettles%26aufirst%3DR.%2BE.%26aulast%3DBelema%26aufirst%3DM.%26aulast%3DSnyder%26aufirst%3DL.%2BB.%26aulast%3DNguyen%26aufirst%3DV..N.%26aulast%3DFridell%26aufirst%3DR.%2BA.%26aulast%3DSerrano-Wu%26aufirst%3DM.%2BH.%26aulast%3DLangley%26aufirst%3DD.%2BR.%26aulast%3DSun%26aufirst%3DJ.-H.%26aulast%3DO%25E2%2580%2599Boyle%26aufirst%3DD.%2BR.%26aulast%3DLemm%26aufirst%3DJ.%2BA.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DKnipe%26aufirst%3DJ.%2BO.%26aulast%3DChien%26aufirst%3DC.%26aulast%3DColonno%26aufirst%3DR.%2BJ.%26aulast%3DGrasela%26aufirst%3DD.%2BM.%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26aulast%3DHamann%26aufirst%3DL.%2BG.%26atitle%3DChemical%2520genetics%2520strategy%2520identifies%2520an%2520HCV%2520NS5A%2520inhibitor%2520with%2520a%2520potent%2520clinical%2520effect%26jtitle%3DNature%26date%3D2010%26volume%3D465%26spage%3D96%26epage%3D100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">McHutchison, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Everson, G. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordon, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sulkowski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kauffman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNair, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alam, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muir, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Afdhal, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arora, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balan, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vargas, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernstein, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Black, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bzowej, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Bisceglie, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dienstag, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Everson, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faruqui, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franco, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fried, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghalib, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordon, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kugelmas, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawitz, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Northup, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poordad, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez-Torres, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rustgi, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schiff, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiffman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sulkowski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szabol, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Younossi, Z.</span><span> </span><span class="NLM_article-title">Telaprevir with peginterferon and ribavirin for chronic HCV genotype 1 infection</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">360</span><span class="NLM_x">, </span> <span class="NLM_fpage">1827</span><span class="NLM_x">–</span> <span class="NLM_lpage">1838</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=16&amp;doi=10.1021%2Fjm201258k&amp;key=10.1056%2FNEJMoa0806104" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=8&amp;doi=10.1021%2Fjm201258k&amp;key=19403902" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=32&amp;doi=10.1021%2Fjm201258k&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlsVGmtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=360&publication_year=2009&pages=1827-1838&author=J.+G.+McHutchisonauthor=G.+T.+Eversonauthor=S.+C.+Gordonauthor=I.+M.+Jacobsonauthor=M.+Sulkowskiauthor=R.+Kauffmanauthor=L.+McNairauthor=J.+Alamauthor=A.+J.+Muirauthor=N.+Afdhalauthor=S.+Aroraauthor=V.+Balanauthor=H.+Vargasauthor=D.+Bernsteinauthor=M.+Blackauthor=R.+Brownauthor=N.+Bzowejauthor=G.+Davisauthor=A.+Di+Bisceglieauthor=J.+Dienstagauthor=G.+Eversonauthor=S.+Faruquiauthor=J.+Francoauthor=M.+Friedauthor=R.+Ghalibauthor=S.+C.+Gordonauthor=J.+Grossauthor=I.+M.+Jacobsonauthor=D.+Jensenauthor=M.+Kugelmasauthor=P.+Kwoauthor=E.+Lawitzauthor=W.+Leeauthor=P.+Martinauthor=D.+Nelsonauthor=P.+Northupauthor=K.+Patelauthor=F.+Poordadauthor=R.+K.+Reddyauthor=M.+Rodriguez-Torresauthor=V.+Rustgiauthor=E.+Schiffauthor=K.+Shermanauthor=M.+Shiffmanauthor=M.+Sulkowskiauthor=G.+Szabolauthor=Z.+Younossi&title=Telaprevir+with+peginterferon+and+ribavirin+for+chronic+HCV+genotype+1+infection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6aR"><div class="casContent"><span class="casTitleNuber">6a</span><div class="casTitle"><span class="NLM_cas:atitle">Telaprevir with peginterferon and ribavirin for chronic HCV genotype 1 infection</span></div><div class="casAuthors">McHutchison, John G.; Everson, Gregory T.; Gordon, Stuart C.; Jacobson, Ira M.; Sulkowski, Mark; Kauffman, Robert; McNair, Lindsay; Alam, John; Muir, Andrew J.; Afdhal, N.; Arora, S.; Balan, V.; Vargas, H.; Bernstein, D.; Black, M.; Brown, R.; Bzowej, N.; Davis, G.; Di Bisceglie, A.; Dienstag, J.; Everson, G.; Faruqui, S.; Franco, J.; Fried, M.; Ghalib, R.; Gordon, S. C.; Gross, J.; Jacobson, I. M.; Jensen, D.; Kugelmas, M.; Kwo, P.; Lawitz, E.; Lee, W.; Martin, P.; Nelson, D.; Northup, P.; Patel, K.; Poordad, F.; Reddy, R. K.; Rodriguez-Torres, M.; Rustgi, V.; Schiff, E.; Sherman, K.; Shiffman, M.; Sulkowski, M.; Szabol, G.; Younossi, Z.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">360</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">1827-1838</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND Current therapy for chronic hepatitis C virus (HCV) infection is effective in less than 50% of patients infected with HCV genotype 1.  Telaprevir, a protease inhibitor specific to the HCV nonstructural 3/4A serine protease, rapidly reduced HCV RNA levels in early studies.  METHODS We randomly assigned patients infected with HCV genotype 1 to one of three telaprevir groups or to the control group.  The control group (called the PR48 group) received peginterferon alfa-2a (180 μg per wk) and ribavirin (1000 or 1200 mg per day, according to body wt.) for 48 wk, plus telaprevir-matched placebo for the first 12 wk (75 patients).  The telaprevir groups received telaprevir (1250 mg on day 1 and 750 mg every 8 h thereafter) for 12 wk, as well as peginterferon alfa-2a and ribavirin (at the same doses as in the PR48 group) for the same 12 wk (the T12PR12 group, 17 patients) or for a total of 24 wk (the T12PR24 group, 79 patients) or 48 wk (the T12PR48 group, 79 patients).  The primary outcome was a sustained virol. response (an undetectable HCV RNA level 24 wk after the end of therapy).  RESULTS The rate of sustained virol. response was 41% (31 of 75 patients) in the PR48 group, as compared with 61% (48 of 79 patients) in the T12PR24 group (P = 0.02), 67% (53 of 79 patients) in the T12PR48 group (P = 0.002), and 35% (6 of 17 patients) in the T12PR12 group (this group was exploratory and not compared with the control group).  Viral breakthrough occurred in 7% of patients receiving telaprevir.  The rate of discontinuation because of adverse events was higher in the three telaprevir-based groups (21%, vs. 11% in the PR48 group), with rash the most common reason for discontinuation.  CONCLUSIONS Treatment with a telaprevir-based regimen significantly improved sustained virol. response rates in patients with genotype 1 HCV, albeit with higher rates of discontinuation because of adverse events.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnK2pWAKIzM7Vg90H21EOLACvtfcHk0lieFflNuRlS5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlsVGmtrc%253D&md5=574eed8a6bd101631bb1e3d904a072b5</span></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa0806104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa0806104%26sid%3Dliteratum%253Aachs%26aulast%3DMcHutchison%26aufirst%3DJ.%2BG.%26aulast%3DEverson%26aufirst%3DG.%2BT.%26aulast%3DGordon%26aufirst%3DS.%2BC.%26aulast%3DJacobson%26aufirst%3DI.%2BM.%26aulast%3DSulkowski%26aufirst%3DM.%26aulast%3DKauffman%26aufirst%3DR.%26aulast%3DMcNair%26aufirst%3DL.%26aulast%3DAlam%26aufirst%3DJ.%26aulast%3DMuir%26aufirst%3DA.%2BJ.%26aulast%3DAfdhal%26aufirst%3DN.%26aulast%3DArora%26aufirst%3DS.%26aulast%3DBalan%26aufirst%3DV.%26aulast%3DVargas%26aufirst%3DH.%26aulast%3DBernstein%26aufirst%3DD.%26aulast%3DBlack%26aufirst%3DM.%26aulast%3DBrown%26aufirst%3DR.%26aulast%3DBzowej%26aufirst%3DN.%26aulast%3DDavis%26aufirst%3DG.%26aulast%3DDi%2BBisceglie%26aufirst%3DA.%26aulast%3DDienstag%26aufirst%3DJ.%26aulast%3DEverson%26aufirst%3DG.%26aulast%3DFaruqui%26aufirst%3DS.%26aulast%3DFranco%26aufirst%3DJ.%26aulast%3DFried%26aufirst%3DM.%26aulast%3DGhalib%26aufirst%3DR.%26aulast%3DGordon%26aufirst%3DS.%2BC.%26aulast%3DGross%26aufirst%3DJ.%26aulast%3DJacobson%26aufirst%3DI.%2BM.%26aulast%3DJensen%26aufirst%3DD.%26aulast%3DKugelmas%26aufirst%3DM.%26aulast%3DKwo%26aufirst%3DP.%26aulast%3DLawitz%26aufirst%3DE.%26aulast%3DLee%26aufirst%3DW.%26aulast%3DMartin%26aufirst%3DP.%26aulast%3DNelson%26aufirst%3DD.%26aulast%3DNorthup%26aufirst%3DP.%26aulast%3DPatel%26aufirst%3DK.%26aulast%3DPoordad%26aufirst%3DF.%26aulast%3DReddy%26aufirst%3DR.%2BK.%26aulast%3DRodriguez-Torres%26aufirst%3DM.%26aulast%3DRustgi%26aufirst%3DV.%26aulast%3DSchiff%26aufirst%3DE.%26aulast%3DSherman%26aufirst%3DK.%26aulast%3DShiffman%26aufirst%3DM.%26aulast%3DSulkowski%26aufirst%3DM.%26aulast%3DSzabol%26aufirst%3DG.%26aulast%3DYounossi%26aufirst%3DZ.%26atitle%3DTelaprevir%2520with%2520peginterferon%2520and%2520ribavirin%2520for%2520chronic%2520HCV%2520genotype%25201%2520infection%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2009%26volume%3D360%26spage%3D1827%26epage%3D1838" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Kwo, P. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawitz, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCone, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schiff, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vierling, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pound, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galati, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordon, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ravendhran, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossaro, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, F. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koury, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pedicone, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brass, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaudhri, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albrecht, J. K.</span><span> </span><span class="NLM_article-title">Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alpha-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">376</span><span class="NLM_x">, </span> <span class="NLM_fpage">705</span><span class="NLM_x">–</span> <span class="NLM_lpage">716</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=376&publication_year=2010&pages=705-716&author=P.+Y.+Kwoauthor=E.+J.+Lawitzauthor=J.+McConeauthor=E.+R.+Schiffauthor=J.+M.+Vierlingauthor=D.+Poundauthor=M.+N.+Davisauthor=J.+S.+Galatiauthor=S.+C.+Gordonauthor=N.+Ravendhranauthor=L.+Rossaroauthor=F.+H.+Andersonauthor=I.+M.+Jacobsonauthor=R.+Rubinauthor=K.+Kouryauthor=L.+D.+Pediconeauthor=C.+A.+Brassauthor=E.+Chaudhriauthor=J.+K.+Albrecht&title=Efficacy+of+boceprevir%2C+an+NS3+protease+inhibitor%2C+in+combination+with+peginterferon+alpha-2b+and+ribavirin+in+treatment-naive+patients+with+genotype+1+hepatitis+C+infection+%28SPRINT-1%29%3A+an+open-label%2C+randomised%2C+multicentre+phase+2+trial"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKwo%26aufirst%3DP.%2BY.%26aulast%3DLawitz%26aufirst%3DE.%2BJ.%26aulast%3DMcCone%26aufirst%3DJ.%26aulast%3DSchiff%26aufirst%3DE.%2BR.%26aulast%3DVierling%26aufirst%3DJ.%2BM.%26aulast%3DPound%26aufirst%3DD.%26aulast%3DDavis%26aufirst%3DM.%2BN.%26aulast%3DGalati%26aufirst%3DJ.%2BS.%26aulast%3DGordon%26aufirst%3DS.%2BC.%26aulast%3DRavendhran%26aufirst%3DN.%26aulast%3DRossaro%26aufirst%3DL.%26aulast%3DAnderson%26aufirst%3DF.%2BH.%26aulast%3DJacobson%26aufirst%3DI.%2BM.%26aulast%3DRubin%26aufirst%3DR.%26aulast%3DKoury%26aufirst%3DK.%26aulast%3DPedicone%26aufirst%3DL.%2BD.%26aulast%3DBrass%26aufirst%3DC.%2BA.%26aulast%3DChaudhri%26aufirst%3DE.%26aulast%3DAlbrecht%26aufirst%3DJ.%2BK.%26atitle%3DEfficacy%2520of%2520boceprevir%252C%2520an%2520NS3%2520protease%2520inhibitor%252C%2520in%2520combination%2520with%2520peginterferon%2520alpha-2b%2520and%2520ribavirin%2520in%2520treatment-naive%2520patients%2520with%2520genotype%25201%2520hepatitis%2520C%2520infection%2520%2528SPRINT-1%2529%253A%2520an%2520open-label%252C%2520randomised%252C%2520multicentre%2520phase%25202%2520trial%26jtitle%3DLancet%26date%3D2010%26volume%3D376%26spage%3D705%26epage%3D716" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Perni, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almquist, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Byrn, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chandorkar, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaturvedi, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Courtney, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decker, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dinehart, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gates, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harbeson, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heiser, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalkeri, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolaczkowski, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luong, Y.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, W. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomson, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tung, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwong, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, C.</span><span> </span><span class="NLM_article-title">Preclinical profile of VX-950, a potent, selective, and orally, bioavailable inhibitor of hepatitis C virus NS3–4A serine protease</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">899</span><span class="NLM_x">–</span> <span class="NLM_lpage">909</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2006&pages=899-909&author=R.+B.+Perniauthor=S.+J.+Almquistauthor=R.+A.+Byrnauthor=G.+Chandorkarauthor=P.+R.+Chaturvediauthor=L.+F.+Courtneyauthor=C.+J.+Deckerauthor=K.+Dinehartauthor=C.+A.+Gatesauthor=S.+L.+Harbesonauthor=A.+Heiserauthor=G.+Kalkeriauthor=E.+Kolaczkowskiauthor=K.+Linauthor=Y.-P.+Luongauthor=B.+G.+Raoauthor=W.+P.+Taylorauthor=J.+A.+Thomsonauthor=R.+D.+Tungauthor=Y.+Weiauthor=A.+D.+Kwongauthor=C.+Lin&title=Preclinical+profile+of+VX-950%2C+a+potent%2C+selective%2C+and+orally%2C+bioavailable+inhibitor+of+hepatitis+C+virus+NS3%E2%80%934A+serine+protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPerni%26aufirst%3DR.%2BB.%26aulast%3DAlmquist%26aufirst%3DS.%2BJ.%26aulast%3DByrn%26aufirst%3DR.%2BA.%26aulast%3DChandorkar%26aufirst%3DG.%26aulast%3DChaturvedi%26aufirst%3DP.%2BR.%26aulast%3DCourtney%26aufirst%3DL.%2BF.%26aulast%3DDecker%26aufirst%3DC.%2BJ.%26aulast%3DDinehart%26aufirst%3DK.%26aulast%3DGates%26aufirst%3DC.%2BA.%26aulast%3DHarbeson%26aufirst%3DS.%2BL.%26aulast%3DHeiser%26aufirst%3DA.%26aulast%3DKalkeri%26aufirst%3DG.%26aulast%3DKolaczkowski%26aufirst%3DE.%26aulast%3DLin%26aufirst%3DK.%26aulast%3DLuong%26aufirst%3DY.-P.%26aulast%3DRao%26aufirst%3DB.%2BG.%26aulast%3DTaylor%26aufirst%3DW.%2BP.%26aulast%3DThomson%26aufirst%3DJ.%2BA.%26aulast%3DTung%26aufirst%3DR.%2BD.%26aulast%3DWei%26aufirst%3DY.%26aulast%3DKwong%26aufirst%3DA.%2BD.%26aulast%3DLin%26aufirst%3DC.%26atitle%3DPreclinical%2520profile%2520of%2520VX-950%252C%2520a%2520potent%252C%2520selective%252C%2520and%2520orally%252C%2520bioavailable%2520inhibitor%2520of%2520hepatitis%2520C%2520virus%2520NS3%25E2%2580%25934A%2520serine%2520protease%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2006%26volume%3D50%26spage%3D899%26epage%3D909" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Njoroge, F. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shih, N.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piwinski, J. J.</span><span> </span><span class="NLM_article-title">Challenges in Modern Drug Discovery: A Case Study of Boceprevir, an HCV Protease Inhibitor for the Treatment of Hepatitis C Virus Infection</span> <span class="citation_source-journal">Acc. Chem. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">50</span><span class="NLM_x">–</span> <span class="NLM_lpage">59</span></span><div class="citationLinks">[<a href="/doi/10.1021/ar700109k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2008&pages=50-59&author=F.+G.+Njorogeauthor=K.+X.+Chenauthor=N.-Y.+Shihauthor=J.+J.+Piwinski&title=Challenges+in+Modern+Drug+Discovery%3A+A+Case+Study+of+Boceprevir%2C+an+HCV+Protease+Inhibitor+for+the+Treatment+of+Hepatitis+C+Virus+Infection"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=10.1021%2Far700109k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Far700109k%26sid%3Dliteratum%253Aachs%26aulast%3DNjoroge%26aufirst%3DF.%2BG.%26aulast%3DChen%26aufirst%3DK.%2BX.%26aulast%3DShih%26aufirst%3DN.-Y.%26aulast%3DPiwinski%26aufirst%3DJ.%2BJ.%26atitle%3DChallenges%2520in%2520Modern%2520Drug%2520Discovery%253A%2520A%2520Case%2520Study%2520of%2520Boceprevir%252C%2520an%2520HCV%2520Protease%2520Inhibitor%2520for%2520the%2520Treatment%2520of%2520Hepatitis%2520C%2520Virus%2520Infection%26jtitle%3DAcc.%2520Chem.%2520Res.%26date%3D2008%26volume%3D41%26spage%3D50%26epage%3D59" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Venkatraman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bogen, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arasappan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jao, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.-T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovey, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hendrata, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parekh, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinto, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Popov, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pike, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santhanam, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vibulbhan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butkiewicz, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chase, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hart, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agarwal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ingravallo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pichardo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baroudy, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malcolm, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prongay, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madison</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broske, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, K.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsieh, T. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brisson, J.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prelusky, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kormacher, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bogonowich-Knipp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pavlovsky, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prudence, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saksena, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganguly, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piwinski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Girijavallabhan, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Njoroge, F. G.</span><span> </span><span class="NLM_article-title">Discovery of (1<i>R</i>,5<i>S</i>)-<i>N</i>-[3-Amino-1-(cyclobutylmethyl)-2–3-dioxopropyl]-3-[2(<i>S</i>)-[[[(1,1-dimethylethyl)-amino]carbonyl]amino]-3,3-dimethyl-1-oxobutyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexan-2(<i>S</i>)-carboxamide (SCH 503034), a selective, potent, orally bioavailable, hepatitis C virus NS3 protease inhibitor: a potential therapeutic agent for the treatment of hepatitis C infection</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">6074</span><span class="NLM_x">–</span> <span class="NLM_lpage">6086</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060325b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6074-6086&author=S.+Venkatramanauthor=S.+L.+Bogenauthor=A.+Arasappanauthor=F.+Bennettauthor=K.+Chenauthor=E.+Jaoauthor=Y.-T.+Liuauthor=R.+Loveyauthor=S.+Hendrataauthor=Y.+Huangauthor=W.+Panauthor=T.+Parekhauthor=P.+Pintoauthor=V.+Popovauthor=R.+Pikeauthor=S.+Ruanauthor=B.+Santhanamauthor=B.+Vibulbhanauthor=W.+Wuauthor=W.+Yangauthor=W.+Yangauthor=J.+Kongauthor=X.+Liangauthor=J.+Wongauthor=R.+Liuauthor=N.+Butkiewiczauthor=R.+Chaseauthor=A.+Hartauthor=S.+Agarwalauthor=P.+Ingravalloauthor=J.+Pichardoauthor=R.+Kongauthor=B.+Baroudyauthor=B.+Malcolmauthor=Z.+Guoauthor=A.+Prongayauthor=+Madisonauthor=L.+Broskeauthor=X.+Cuiauthor=K.-C.+Chengauthor=T.+Y.+Hsiehauthor=J.-M.+Brissonauthor=D.+Preluskyauthor=W.+Kormacherauthor=R.+Whiteauthor=S.+Bogonowich-Knippauthor=A.+Pavlovskyauthor=B.+Prudenceauthor=A.+K.+Saksenaauthor=A.+Gangulyauthor=J.+Piwinskiauthor=V.+Girijavallabhanauthor=F.+G.+Njoroge&title=Discovery+of+%281R%2C5S%29-N-%5B3-Amino-1-%28cyclobutylmethyl%29-2%E2%80%933-dioxopropyl%5D-3-%5B2%28S%29-%5B%5B%5B%281%2C1-dimethylethyl%29-amino%5Dcarbonyl%5Damino%5D-3%2C3-dimethyl-1-oxobutyl%5D-6%2C6-dimethyl-3-azabicyclo%5B3.1.0%5Dhexan-2%28S%29-carboxamide+%28SCH+503034%29%2C+a+selective%2C+potent%2C+orally+bioavailable%2C+hepatitis+C+virus+NS3+protease+inhibitor%3A+a+potential+therapeutic+agent+for+the+treatment+of+hepatitis+C+infection"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=10.1021%2Fjm060325b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060325b%26sid%3Dliteratum%253Aachs%26aulast%3DVenkatraman%26aufirst%3DS.%26aulast%3DBogen%26aufirst%3DS.%2BL.%26aulast%3DArasappan%26aufirst%3DA.%26aulast%3DBennett%26aufirst%3DF.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DJao%26aufirst%3DE.%26aulast%3DLiu%26aufirst%3DY.-T.%26aulast%3DLovey%26aufirst%3DR.%26aulast%3DHendrata%26aufirst%3DS.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DPan%26aufirst%3DW.%26aulast%3DParekh%26aufirst%3DT.%26aulast%3DPinto%26aufirst%3DP.%26aulast%3DPopov%26aufirst%3DV.%26aulast%3DPike%26aufirst%3DR.%26aulast%3DRuan%26aufirst%3DS.%26aulast%3DSanthanam%26aufirst%3DB.%26aulast%3DVibulbhan%26aufirst%3DB.%26aulast%3DWu%26aufirst%3DW.%26aulast%3DYang%26aufirst%3DW.%26aulast%3DYang%26aufirst%3DW.%26aulast%3DKong%26aufirst%3DJ.%26aulast%3DLiang%26aufirst%3DX.%26aulast%3DWong%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DR.%26aulast%3DButkiewicz%26aufirst%3DN.%26aulast%3DChase%26aufirst%3DR.%26aulast%3DHart%26aufirst%3DA.%26aulast%3DAgarwal%26aufirst%3DS.%26aulast%3DIngravallo%26aufirst%3DP.%26aulast%3DPichardo%26aufirst%3DJ.%26aulast%3DKong%26aufirst%3DR.%26aulast%3DBaroudy%26aufirst%3DB.%26aulast%3DMalcolm%26aufirst%3DB.%26aulast%3DGuo%26aufirst%3DZ.%26aulast%3DProngay%26aufirst%3DA.%26aulast%3DMadison%26aulast%3DBroske%26aufirst%3DL.%26aulast%3DCui%26aufirst%3DX.%26aulast%3DCheng%26aufirst%3DK.-C.%26aulast%3DHsieh%26aufirst%3DT.%2BY.%26aulast%3DBrisson%26aufirst%3DJ.-M.%26aulast%3DPrelusky%26aufirst%3DD.%26aulast%3DKormacher%26aufirst%3DW.%26aulast%3DWhite%26aufirst%3DR.%26aulast%3DBogonowich-Knipp%26aufirst%3DS.%26aulast%3DPavlovsky%26aufirst%3DA.%26aulast%3DPrudence%26aufirst%3DB.%26aulast%3DSaksena%26aufirst%3DA.%2BK.%26aulast%3DGanguly%26aufirst%3DA.%26aulast%3DPiwinski%26aufirst%3DJ.%26aulast%3DGirijavallabhan%26aufirst%3DV.%26aulast%3DNjoroge%26aufirst%3DF.%2BG.%26atitle%3DDiscovery%2520of%2520%25281R%252C5S%2529-N-%255B3-Amino-1-%2528cyclobutylmethyl%2529-2%25E2%2580%25933-dioxopropyl%255D-3-%255B2%2528S%2529-%255B%255B%255B%25281%252C1-dimethylethyl%2529-amino%255Dcarbonyl%255Damino%255D-3%252C3-dimethyl-1-oxobutyl%255D-6%252C6-dimethyl-3-azabicyclo%255B3.1.0%255Dhexan-2%2528S%2529-carboxamide%2520%2528SCH%2520503034%2529%252C%2520a%2520selective%252C%2520potent%252C%2520orally%2520bioavailable%252C%2520hepatitis%2520C%2520virus%2520NS3%2520protease%2520inhibitor%253A%2520a%2520potential%2520therapeutic%2520agent%2520for%2520the%2520treatment%2520of%2520hepatitis%2520C%2520infection%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6074%26epage%3D6086" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Behrens, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomei, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Francesco, R.</span><span> </span><span class="NLM_article-title">Identification and properties of the RNA-dependent RNA polymerase of hepatitis C virus</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">12</span><span class="NLM_x">–</span> <span class="NLM_lpage">22</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1996&pages=12-22&author=S.+E.+Behrensauthor=L.+Tomeiauthor=R.+De+Francesco&title=Identification+and+properties+of+the+RNA-dependent+RNA+polymerase+of+hepatitis+C+virus"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBehrens%26aufirst%3DS.%2BE.%26aulast%3DTomei%26aufirst%3DL.%26aulast%3DDe%2BFrancesco%26aufirst%3DR.%26atitle%3DIdentification%2520and%2520properties%2520of%2520the%2520RNA-dependent%2520RNA%2520polymerase%2520of%2520hepatitis%2520C%2520virus%26jtitle%3DEMBO%2520J.%26date%3D1996%26volume%3D15%26spage%3D12%26epage%3D22" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit9b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Lohmann, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korner, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herian, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartenschlager, R.</span><span> </span><span class="NLM_article-title">Biochemical properties of hepatitis c virus ns5b RNAdependent RNA polymerase and identification of amino acid sequence motifs essential for enzymatic activity</span> <span class="citation_source-journal">J. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">8416</span><span class="NLM_x">–</span> <span class="NLM_lpage">8428</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=8&amp;doi=10.1021%2Fjm201258k&amp;key=9343198" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=32&amp;doi=10.1021%2Fjm201258k&amp;key=1%3ACAS%3A528%3ADyaK2sXmvV2hs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=1997&pages=8416-8428&author=V.+Lohmannauthor=F.+Kornerauthor=U.+Herianauthor=R.+Bartenschlager&title=Biochemical+properties+of+hepatitis+c+virus+ns5b+RNAdependent+RNA+polymerase+and+identification+of+amino+acid+sequence+motifs+essential+for+enzymatic+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9bR"><div class="casContent"><span class="casTitleNuber">9b</span><div class="casTitle"><span class="NLM_cas:atitle">Biochemical properties of hepatitis C virus NS5B RNA-dependent RNA polymerase and identification of amino acid sequence motifs essential for enzymic activity</span></div><div class="casAuthors">Lohmann, Volker; Korner, Frank; Herian, Ulrike; Bartenschlager, Ralf</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">8416-8428</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The NS5B protein of the hepatitis C virus (HCV) is an RNA-dependent RNA polymerase (RdRp) (S.-E. Behrens, L. Tomei, and R. De Francesco, EMBO J. 15:12-22, 1996) that is assumed to be required for replication of the viral genome.  To further study the biochem. and structural properties of this enzyme, an NS5B-hexahistidine fusion protein was expressed with recombinant baculoviruses in insect cells and purified to near homogeneity.  The enzyme was found to have a primer-dependent RdRp activity that was able to copy a complete in vitro-transcribed HCV genome in the absence of addnl. viral or cellular factors.  Filter binding assays and competition expts. showed that the purified enzyme binds RNA with no clear preference for HCV 3'-end sequences.  Binding to homopolymeric RNAs was also examd., and the following order of specificity was obsd.: poly(U) > poly(G) > poly(A) > poly(C).  An inverse order was found for the RdRp activity, which used poly(C) most efficiently as a template but was inactive on poly(U) and poly(G), suggesting that a high binding affinity between polymerase and template interferes with processivity.  By using a mutational anal., four amino acid sequence motifs crucial for RdRp activity were identified.  While most substitutions of conserved residues within these motifs severely reduced the enzymic activities, a single substitution in motif D which enhanced the RdRp activity by about 50% was found.  Deletion studies indicate that amino acid residues at the very termini, in particular the amino terminus, are important for RdRp activity but not for RNA binding.  Finally, we found a terminal transferase activity assocd. with the purified enzyme.  However, this activity was also detected with NS5B proteins with an inactive RdRp, with an NS4B protein purified in the same way, and with wild-type baculovirus, suggesting that it is not an inherent activity of NS5B.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdCeTDzvlRArVg90H21EOLACvtfcHk0lgYMDJtHdEB6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXmvV2hs7s%253D&md5=98640d185270f0b331db0fa0624865cd</span></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLohmann%26aufirst%3DV.%26aulast%3DKorner%26aufirst%3DF.%26aulast%3DHerian%26aufirst%3DU.%26aulast%3DBartenschlager%26aufirst%3DR.%26atitle%3DBiochemical%2520properties%2520of%2520hepatitis%2520c%2520virus%2520ns5b%2520RNAdependent%2520RNA%2520polymerase%2520and%2520identification%2520of%2520amino%2520acid%2520sequence%2520motifs%2520essential%2520for%2520enzymatic%2520activity%26jtitle%3DJ.%2520Virol.%26date%3D1997%26volume%3D71%26spage%3D8416%26epage%3D8428" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Quinkert, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartenschlager, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lohmann, V.</span><span> </span><span class="NLM_article-title">Quantitative analysis of the hepatitis C virus replication complex</span> <span class="citation_source-journal">J. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">13594</span><span class="NLM_x">–</span> <span class="NLM_lpage">13605</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm201258k&amp;key=10.1128%2FJVI.79.21.13594-13605.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm201258k&amp;key=16227280" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm201258k&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFKjtr%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2005&pages=13594-13605&author=D.+Quinkertauthor=R.+Bartenschlagerauthor=V.+Lohmann&title=Quantitative+analysis+of+the+hepatitis+C+virus+replication+complex"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Quantitative analysis of the hepatitis C virus replication complex</span></div><div class="casAuthors">Quinkert, Doris; Bartenschlager, Ralf; Lohmann, Volker</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">13594-13605</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The hepatitis C virus (HCV) encodes a large polyprotein; therefore, all viral proteins are produced in equimolar amts. regardless of their function.  The aim of our study was to det. the ratio of nonstructural proteins to RNA that is required for HCV RNA replication.  We analyzed Huh-7 cells harboring full-length HCV genomes or subgenomic replicons and found in all cases a >1000-fold excess of HCV proteins over pos.- and neg.-strand RNA.  To examine whether all nonstructural protein copies are involved in RNA synthesis, we isolated active HCV replication complexes from replicon cells and examd. them for their content of viral RNA and proteins before and after treatment with protease and/or nuclease.  In vitro replicase activity, as well as almost the entire neg.- and pos.-strand RNA, was resistant to nuclease treatment, whereas <5% of the nonstructural proteins were protected from protease digest but accounted for the full in vitro replicase activity.  In consequence, only a minor fraction of the HCV nonstructural proteins was actively involved in RNA synthesis at a given time point but, due to the high amts. present in replicon cells, still representing a huge excess compared to the viral RNA.  Based on the comparison of nuclease-resistant viral RNA to protease-resistant viral proteins, we est. that an active HCV replicase complex consists of one neg.-strand RNA, two to ten pos.-strand RNAs, and several hundred nonstructural protein copies, which might be required as structural components of the vesicular compartments that are the site of HCV replication.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogSsRsSfAAvLVg90H21EOLACvtfcHk0lgYMDJtHdEB6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFKjtr%252FJ&md5=c5060858a84ac062a62d2bfa0a5ca926</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1128%2FJVI.79.21.13594-13605.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.79.21.13594-13605.2005%26sid%3Dliteratum%253Aachs%26aulast%3DQuinkert%26aufirst%3DD.%26aulast%3DBartenschlager%26aufirst%3DR.%26aulast%3DLohmann%26aufirst%3DV.%26atitle%3DQuantitative%2520analysis%2520of%2520the%2520hepatitis%2520C%2520virus%2520replication%2520complex%26jtitle%3DJ.%2520Virol.%26date%3D2005%26volume%3D79%26spage%3D13594%26epage%3D13605" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Lesburg, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cable, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrari, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mannarino, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, P. C.</span><span> </span><span class="NLM_article-title">Crystal structure of the RNA-dependent RNA polymerase from hepatitis C virus reveals a fully encircled active site</span> <span class="citation_source-journal">Nature Struct. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">937</span><span class="NLM_x">–</span> <span class="NLM_lpage">943</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=16&amp;doi=10.1021%2Fjm201258k&amp;key=10.1038%2F13305" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=8&amp;doi=10.1021%2Fjm201258k&amp;key=10504728" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=32&amp;doi=10.1021%2Fjm201258k&amp;key=1%3ACAS%3A528%3ADyaK1MXmslCktLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1999&pages=937-943&author=C.+A.+Lesburgauthor=M.+B.+Cableauthor=E.+Ferrariauthor=Z.+Hongauthor=A.+F.+Mannarinoauthor=P.+C.+Weber&title=Crystal+structure+of+the+RNA-dependent+RNA+polymerase+from+hepatitis+C+virus+reveals+a+fully+encircled+active+site"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11aR"><div class="casContent"><span class="casTitleNuber">11a</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of the RNA-dependent RNA polymerase from hepatitis C virus reveals a fully encircled active site</span></div><div class="casAuthors">Lesburg, Charles A.; Cable, Michael B.; Ferrari, Eric; Hong, Zhi; Mannarino, Anthony F.; Weber, Patricia C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural Biology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">937-943</span>CODEN:
                <span class="NLM_cas:coden">NSBIEW</span>;
        ISSN:<span class="NLM_cas:issn">1072-8368</span>.
    
            (<span class="NLM_cas:orgname">Nature America</span>)
        </div><div class="casAbstract">Various classes of nucleotidyl polymerases with different transcriptional roles contain a conserved core structure.  Less is known, however, about the distinguishing features of these enzymes, particularly those of the RNA-dependent RNA polymerase class.  The 1.9 Å resoln. crystal structure of hepatitis C virus (HCV) nonstructural protein 5B (NS5B) presented here provides the first complete and detailed view of an RNA-dependent RNA polymerase.  While canonical polymerase features exist in the structure, NS5B adopts a unique shape due to extensive interactions between the fingers and thumb polymerase subdomains that serve to encircle the enzyme active site.  Several insertions in the fingers subdomain account for intersubdomain linkages that include two extended loops and a pair of antiparallel α-helixes.  The HCV NS5B apoenzyme structure reported here can accommodate a template:primer duplex without global conformational changes, supporting the hypothesis that this structure is essentially preserved during the reaction pathway.  This NS5B template:primer model also allows identification of a new structural motif involved in stabilizing the nascent base pair.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnLsPABmT0XbVg90H21EOLACvtfcHk0lgYMDJtHdEB6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmslCktLo%253D&md5=210fd9e96e7ca8d342ed1ae87f0b4acc</span></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=10.1038%2F13305&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F13305%26sid%3Dliteratum%253Aachs%26aulast%3DLesburg%26aufirst%3DC.%2BA.%26aulast%3DCable%26aufirst%3DM.%2BB.%26aulast%3DFerrari%26aufirst%3DE.%26aulast%3DHong%26aufirst%3DZ.%26aulast%3DMannarino%26aufirst%3DA.%2BF.%26aulast%3DWeber%26aufirst%3DP.%2BC.%26atitle%3DCrystal%2520structure%2520of%2520the%2520RNA-dependent%2520RNA%2520polymerase%2520from%2520hepatitis%2520C%2520virus%2520reveals%2520a%2520fully%2520encircled%2520active%2520site%26jtitle%3DNature%2520Struct.%2520Biol.%26date%3D1999%26volume%3D6%26spage%3D937%26epage%3D943" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit11b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Ago, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adachi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Habuka, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yatsunami, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyano, M.</span><span> </span><span class="NLM_article-title">Crystal structure of the RNA-dependent RNA polymerase of hepatitis C virus</span> <span class="citation_source-journal">Structure</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1417</span><span class="NLM_x">–</span> <span class="NLM_lpage">1426</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=16&amp;doi=10.1021%2Fjm201258k&amp;key=10.1016%2FS0969-2126%2800%2980031-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=8&amp;doi=10.1021%2Fjm201258k&amp;key=10574802" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=32&amp;doi=10.1021%2Fjm201258k&amp;key=1%3ACAS%3A528%3ADyaK1MXnslOit7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1999&pages=1417-1426&author=H.+Agoauthor=T.+Adachiauthor=A.+Yoshidaauthor=M.+Yamamotoauthor=N.+Habukaauthor=K.+Yatsunamiauthor=M.+Miyano&title=Crystal+structure+of+the+RNA-dependent+RNA+polymerase+of+hepatitis+C+virus"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11bR"><div class="casContent"><span class="casTitleNuber">11b</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of the RNA-dependent RNA polymerase of hepatitis C virus</span></div><div class="casAuthors">Ago, Hideo; Adachi, Tsuyoshi; Yoshida, Atsuhito; Yamamoto, Masaki; Habuka, Noriyuki; Yatsunami, Kimio; Miyano, Masashi</div><div class="citationInfo"><span class="NLM_cas:title">Structure (London)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1417-1426</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Current Biology Publications</span>)
        </div><div class="casAbstract">Hepatitis C virus (HCV) is the major etiol. agent of hepatocellular carcinoma, and HCV RNA-dependent RNA polymerase (RNA replicase) (I) is one of the main potential targets for anti-HCV agents.  HCV I performs run-off copying replication in an RNA-selective manner for the template-primer duplex and the substrate, but the structural basis of this reaction mechanism has still to be elucidated.  Here, the 3-dimensional structure of HCV I was detd. by x-ray crystallog. at 2.5 Å resoln.  The compact HCV I structure resembled a right hand, but had more complicated fingers and thumb domains than those of the other known polymerases, with a novel α-helix-rich subdomain (α fingers) as an addn. to the fingers domain.  The other fingers subdomain (β fingers) was folded in the same manner as the fingers domain of HIV virus reverse transcriptase, another RNA-dependent polymerase.  The ribose-recognition site of HCV I was constructed of hydrophilic residues, unlike those of DNA polymerases.  The C-terminal region of HCV I occupied the putative RNA-duplex-binding cleft.  The structural basis of the RNA selectivity of HCV I was elucidated from its crystal structure.  The putative substrate-binding site with a shallow hydrophilic cavity should have ribonucleoside triphosphate as the preferred substrate.  The authors propose that the unique α fingers might represent a common structural discriminator of the template-primer duplex that distinguishes between RNA and DNA during the replication of pos. single-stranded RNA by viral I enzymes.  The C-terminal region might exert a regulatory function on the initiation and activity of HCV I.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKp1aOmXjMKLVg90H21EOLACvtfcHk0lhMiIkddI6jYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXnslOit7o%253D&md5=95fcc20ce2f28dab4d76d8dfac0aa4ee</span></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=10.1016%2FS0969-2126%2800%2980031-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0969-2126%252800%252980031-3%26sid%3Dliteratum%253Aachs%26aulast%3DAgo%26aufirst%3DH.%26aulast%3DAdachi%26aufirst%3DT.%26aulast%3DYoshida%26aufirst%3DA.%26aulast%3DYamamoto%26aufirst%3DM.%26aulast%3DHabuka%26aufirst%3DN.%26aulast%3DYatsunami%26aufirst%3DK.%26aulast%3DMiyano%26aufirst%3DM.%26atitle%3DCrystal%2520structure%2520of%2520the%2520RNA-dependent%2520RNA%2520polymerase%2520of%2520hepatitis%2520C%2520virus%26jtitle%3DStructure%26date%3D1999%26volume%3D7%26spage%3D1417%26epage%3D1426" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="note"><p class="first last">Reviews of non-nucleoside HCV NS5B polymerase inhibitors:</p></div><div class="NLM_citation" id="rightTab-cit12a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Liu, Y.; He, Y.; Molla, A.</span><span> </span><span class="NLM_article-title">Hepatitis C Virus Polymerase as a Target for Antiviral Drug Intervention: Non-Nucleoside Inhibitors</span>. In:  <span class="citation_source-book">Antiviral Research: Strategies in Antiviral Drug Discovery</span>; <span class="NLM_contrib-group">LaFemina, R. L.</span>, Ed.; <span class="NLM_publisher-name">ASM Press</span>: <span class="NLM_publisher-loc">Washington, DC</span>,<span class="NLM_x"> </span><span class="NLM_year">2009</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">137</span><span class="NLM_x">–</span> <span class="NLM_lpage">151</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=16&amp;doi=10.1021%2Fjm201258k&amp;key=10.1128%2F9781555815493.ch8" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&pages=137-151&author=Y.+Liu&author=Y.+He&author=A.+Mollaauthor=R.+L.+LaFemina&title=Antiviral+Research%3A+Strategies+in+Antiviral+Drug+Discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12a&amp;dbid=16384&amp;doi=10.1128%2F9781555815493.ch8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1128%252F9781555815493.ch8%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DY.%26atitle%3DHepatitis%2520C%2520Virus%2520Polymerase%2520as%2520a%2520Target%2520for%2520Antiviral%2520Drug%2520Intervention%253A%2520Non-Nucleoside%2520Inhibitors%26btitle%3DAntiviral%2520Research%253A%2520Strategies%2520in%2520Antiviral%2520Drug%2520Discovery%26aulast%3DLaFemina%26aufirst%3DR.%2BL.%26pub%3DASM%2520Press%26date%3D2009%26spage%3D137%26epage%3D151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Beaulieu, P. L.</span><span> </span><span class="NLM_article-title">Non-nucleoside inhibitors of the hcv ns5b polymerase: progress in the discovery and development of novel agents for the treatment of hcv infections</span> <span class="citation_source-journal">Curr. Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">614</span><span class="NLM_x">–</span> <span class="NLM_lpage">634</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2007&pages=614-634&author=P.+L.+Beaulieu&title=Non-nucleoside+inhibitors+of+the+hcv+ns5b+polymerase%3A+progress+in+the+discovery+and+development+of+novel+agents+for+the+treatment+of+hcv+infections"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBeaulieu%26aufirst%3DP.%2BL.%26atitle%3DNon-nucleoside%2520inhibitors%2520of%2520the%2520hcv%2520ns5b%2520polymerase%253A%2520progress%2520in%2520the%2520discovery%2520and%2520development%2520of%2520novel%2520agents%2520for%2520the%2520treatment%2520of%2520hcv%2520infections%26jtitle%3DCurr.%2520Opin.%2520Invest.%2520Drugs%26date%3D2007%26volume%3D8%26spage%3D614%26epage%3D634" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="note"><p class="first last">Reviews of HCV NS5B polymerase inhibitors:</p></div><div class="NLM_citation" id="rightTab-cit13a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Watkins, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ray, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chong, L. S.</span><span> </span><span class="NLM_article-title">HCV NS5B polymerase inhibitors</span> <span class="citation_source-journal">Curr. Opin. Drug Discovery Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">441</span><span class="NLM_x">–</span> <span class="NLM_lpage">465</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2010&pages=441-465&author=W.+J.+Watkinsauthor=A.+S.+Rayauthor=L.+S.+Chong&title=HCV+NS5B+polymerase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWatkins%26aufirst%3DW.%2BJ.%26aulast%3DRay%26aufirst%3DA.%2BS.%26aulast%3DChong%26aufirst%3DL.%2BS.%26atitle%3DHCV%2520NS5B%2520polymerase%2520inhibitors%26jtitle%3DCurr.%2520Opin.%2520Drug%2520Discovery%2520Dev.%26date%3D2010%26volume%3D13%26spage%3D441%26epage%3D465" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit13b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Legrand-Abravanel, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicot, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Izopet, J.</span><span> </span><span class="NLM_article-title">New NS5B polymerase inhibitors for hepatitis C</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">963</span><span class="NLM_x">–</span> <span class="NLM_lpage">975</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2010&pages=963-975&author=F.+Legrand-Abravanelauthor=F.+Nicotauthor=J.+Izopet&title=New+NS5B+polymerase+inhibitors+for+hepatitis+C"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLegrand-Abravanel%26aufirst%3DF.%26aulast%3DNicot%26aufirst%3DF.%26aulast%3DIzopet%26aufirst%3DJ.%26atitle%3DNew%2520NS5B%2520polymerase%2520inhibitors%2520for%2520hepatitis%2520C%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2010%26volume%3D19%26spage%3D963%26epage%3D975" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit13c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Beaulieu, P. L.</span><span> </span><span class="NLM_article-title">Recent advances in the development of NS5B polymerase inhibitors for the treatment of hepatitis C virus infection</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">145</span><span class="NLM_x">–</span> <span class="NLM_lpage">164</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13c&amp;dbid=16&amp;doi=10.1021%2Fjm201258k&amp;key=10.1517%2F13543770802672598" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13c&amp;dbid=32&amp;doi=10.1021%2Fjm201258k&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVCks74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=145-164&author=P.+L.+Beaulieu&title=Recent+advances+in+the+development+of+NS5B+polymerase+inhibitors+for+the+treatment+of+hepatitis+C+virus+infection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13cR"><div class="casContent"><span class="casTitleNuber">13c</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in the development of NS5B polymerase inhibitors for the treatment of hepatitis C virus infection</span></div><div class="casAuthors">Beaulieu, Pierre L.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">145-164</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  170 To 200 million people worldwide are believed to suffer from chronic hepatitis C virus (HCV) infection, a blood-born disease that targets the liver and progresses to organ cirrhosis and primary cancer in a significant proportion of patients.  The currently available treatment has limited efficacy and suffers from restricting side effects.  HCV infection is the principal cause of liver transplant in industrialized nations and between 8000 and 10,000 deaths result annually from the disease in the United States alone.  Virus-specific, more efficacious, and better-tolerated anti-HCV therapies are thus required to address the unmet medical need.  Objective: To review progress achieved since 2005 in the development of HCV NS5B polymerase inhibitors as potential therapy for the treatment of HCV infection with a primary focus on available patent and medical literature.  Results/conclusion: Several classes of small-mol. inhibitors of HCV NS5B have progressed into clin. development and demonstrated efficacy in reducing viral load in infected patients.  The results so far provide an encouraging foundation for the development of novel, more tolerable therapies and addressing emergence of resistance through combination of antiviral agents with complementary mechanisms of action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoo8VVFJs4oSbVg90H21EOLACvtfcHk0lhMiIkddI6jYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVCks74%253D&md5=64b78562e2b4e3e8a166fdabf14f7efe</span></div><a href="/servlet/linkout?suffix=cit13c&amp;dbid=16384&amp;doi=10.1517%2F13543770802672598&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543770802672598%26sid%3Dliteratum%253Aachs%26aulast%3DBeaulieu%26aufirst%3DP.%2BL.%26atitle%3DRecent%2520advances%2520in%2520the%2520development%2520of%2520NS5B%2520polymerase%2520inhibitors%2520for%2520the%2520treatment%2520of%2520hepatitis%2520C%2520virus%2520infection%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2009%26volume%3D19%26spage%3D145%26epage%3D164" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Ma, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leveque, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Witte, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hendricks, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clausen, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cammack, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klumpp, K.</span><span> </span><span class="NLM_article-title">Inhibition of native hepatitis C virus replicase by nucleotide and non-nucleoside inhibitors</span> <span class="citation_source-journal">Virology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">332</span><span class="NLM_x">, </span> <span class="NLM_fpage">8</span><span class="NLM_x">–</span> <span class="NLM_lpage">15</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=332&publication_year=2005&pages=8-15&author=H.+Maauthor=V.+Levequeauthor=A.+De+Witteauthor=W.+Liauthor=T.+Hendricksauthor=S.+M.+Clausenauthor=N.+Cammackauthor=K.+Klumpp&title=Inhibition+of+native+hepatitis+C+virus+replicase+by+nucleotide+and+non-nucleoside+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DH.%26aulast%3DLeveque%26aufirst%3DV.%26aulast%3DDe%2BWitte%26aufirst%3DA.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DHendricks%26aufirst%3DT.%26aulast%3DClausen%26aufirst%3DS.%2BM.%26aulast%3DCammack%26aufirst%3DN.%26aulast%3DKlumpp%26aufirst%3DK.%26atitle%3DInhibition%2520of%2520native%2520hepatitis%2520C%2520virus%2520replicase%2520by%2520nucleotide%2520and%2520non-nucleoside%2520inhibitors%26jtitle%3DVirology%26date%3D2005%26volume%3D332%26spage%3D8%26epage%3D15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Manns, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rockstroh, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeuzem, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zoulim, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houghton, M.</span><span> </span><span class="NLM_article-title">The way forward in hcv treatment—finding the right path</span> <span class="citation_source-journal">Nature Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">991</span><span class="NLM_x">–</span> <span class="NLM_lpage">1000</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=991-1000&author=M.+P.+Mannsauthor=G.+R.+Fosterauthor=J.+K.+Rockstrohauthor=S.+Zeuzemauthor=F.+Zoulimauthor=M.+Houghton&title=The+way+forward+in+hcv+treatment%E2%80%94finding+the+right+path"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DManns%26aufirst%3DM.%2BP.%26aulast%3DFoster%26aufirst%3DG.%2BR.%26aulast%3DRockstroh%26aufirst%3DJ.%2BK.%26aulast%3DZeuzem%26aufirst%3DS.%26aulast%3DZoulim%26aufirst%3DF.%26aulast%3DHoughton%26aufirst%3DM.%26atitle%3DThe%2520way%2520forward%2520in%2520hcv%2520treatment%25E2%2580%2594finding%2520the%2520right%2520path%26jtitle%3DNature%2520Rev.%2520Drug%2520Discovery%26date%3D2007%26volume%3D6%26spage%3D991%26epage%3D1000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Pierra, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amador, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benzaria, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cretton-Scott, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Amours, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathieu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moussa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridges, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Standring, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sammadossi, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Storer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gosselin, G.</span><span> </span><span class="NLM_article-title">Synthesis and Pharmacokinetics of Valopicitabine (NM283), an Efficient Prodrug of the Potent Anti-HCV Agent 20-C-Methylcytidine</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">6614</span><span class="NLM_x">–</span> <span class="NLM_lpage">6620</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0603623" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6614-6620&author=C.+Pierraauthor=A.+Amadorauthor=S.+Benzariaauthor=E.+Cretton-Scottauthor=M.+D%E2%80%99Amoursauthor=J.+Maoauthor=S.+Mathieuauthor=A.+Moussaauthor=E.+G.+Bridgesauthor=D.+M.+Standringauthor=J.-P.+Sammadossiauthor=R.+Storerauthor=G.+Gosselin&title=Synthesis+and+Pharmacokinetics+of+Valopicitabine+%28NM283%29%2C+an+Efficient+Prodrug+of+the+Potent+Anti-HCV+Agent+20-C-Methylcytidine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16a&amp;dbid=16384&amp;doi=10.1021%2Fjm0603623&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0603623%26sid%3Dliteratum%253Aachs%26aulast%3DPierra%26aufirst%3DC.%26aulast%3DAmador%26aufirst%3DA.%26aulast%3DBenzaria%26aufirst%3DS.%26aulast%3DCretton-Scott%26aufirst%3DE.%26aulast%3DD%25E2%2580%2599Amours%26aufirst%3DM.%26aulast%3DMao%26aufirst%3DJ.%26aulast%3DMathieu%26aufirst%3DS.%26aulast%3DMoussa%26aufirst%3DA.%26aulast%3DBridges%26aufirst%3DE.%2BG.%26aulast%3DStandring%26aufirst%3DD.%2BM.%26aulast%3DSammadossi%26aufirst%3DJ.-P.%26aulast%3DStorer%26aufirst%3DR.%26aulast%3DGosselin%26aufirst%3DG.%26atitle%3DSynthesis%2520and%2520Pharmacokinetics%2520of%2520Valopicitabine%2520%2528NM283%2529%252C%2520an%2520Efficient%2520Prodrug%2520of%2520the%2520Potent%2520Anti-HCV%2520Agent%252020-C-Methylcytidine%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6614%26epage%3D6620" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit16b"><span><span class="NLM_label">(b) </span><div class="note"><p class="first last">(R1626)</p></div><span class="NLM_contrib-group">Smith, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalayanov, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sund, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winqvist, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maltseva, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leveque, V. J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajyagurr, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Pogam, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Najer, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benkestock, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, X.-X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaiser, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maag, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cammack, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swallow, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johannsson, N. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klumpp, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, M.</span><span> </span><span class="NLM_article-title">The Design, Synthesis, and Antiviral Activity of Monofluoro and Difluoro Analogues of 40-Axidocytidine against Hepatitis C Virus Replication: The Discovery of 40-Azido-20-deoxy-20-fluorocytidine and 40-Azido-20-dideoxy-20,20-difuorocytidine</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">2971</span><span class="NLM_x">–</span> <span class="NLM_lpage">2978</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm801595c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=2971-2978&author=D.+B.+Smithauthor=G.+Kalayanovauthor=G.+Sundauthor=A.+Winqvistauthor=T.+Maltsevaauthor=V.+J.-P.+Levequeauthor=S.+Rajyagurrauthor=S.+Le+Pogamauthor=I.+Najerauthor=K.+Benkestockauthor=X.-X.+Zhouauthor=A.+C.+Kaiserauthor=H.+Maagauthor=N.+Cammackauthor=J.+A.+Martinauthor=S.+Swallowauthor=N.+G.+Johannssonauthor=K.+Klumppauthor=M.+Smith&title=The+Design%2C+Synthesis%2C+and+Antiviral+Activity+of+Monofluoro+and+Difluoro+Analogues+of+40-Axidocytidine+against+Hepatitis+C+Virus+Replication%3A+The+Discovery+of+40-Azido-20-deoxy-20-fluorocytidine+and+40-Azido-20-dideoxy-20%2C20-difuorocytidine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16b&amp;dbid=16384&amp;doi=10.1021%2Fjm801595c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801595c%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DD.%2BB.%26aulast%3DKalayanov%26aufirst%3DG.%26aulast%3DSund%26aufirst%3DG.%26aulast%3DWinqvist%26aufirst%3DA.%26aulast%3DMaltseva%26aufirst%3DT.%26aulast%3DLeveque%26aufirst%3DV.%2BJ.-P.%26aulast%3DRajyagurr%26aufirst%3DS.%26aulast%3DLe%2BPogam%26aufirst%3DS.%26aulast%3DNajer%26aufirst%3DI.%26aulast%3DBenkestock%26aufirst%3DK.%26aulast%3DZhou%26aufirst%3DX.-X.%26aulast%3DKaiser%26aufirst%3DA.%2BC.%26aulast%3DMaag%26aufirst%3DH.%26aulast%3DCammack%26aufirst%3DN.%26aulast%3DMartin%26aufirst%3DJ.%2BA.%26aulast%3DSwallow%26aufirst%3DS.%26aulast%3DJohannsson%26aufirst%3DN.%2BG.%26aulast%3DKlumpp%26aufirst%3DK.%26aulast%3DSmith%26aufirst%3DM.%26atitle%3DThe%2520Design%252C%2520Synthesis%252C%2520and%2520Antiviral%2520Activity%2520of%2520Monofluoro%2520and%2520Difluoro%2520Analogues%2520of%252040-Axidocytidine%2520against%2520Hepatitis%2520C%2520Virus%2520Replication%253A%2520The%2520Discovery%2520of%252040-Azido-20-deoxy-20-fluorocytidine%2520and%252040-Azido-20-dideoxy-20%252C20-difuorocytidine%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D2971%26epage%3D2978" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit16c"><span><span class="NLM_label">(c) </span><div class="note"><p class="first last">(PSI-6130)</p></div><span class="NLM_contrib-group">Clark, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollecker, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mason, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stuyver, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tharnish, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lostia, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McBrayer, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schinazi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otto, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furman, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stec, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patterson, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pankiewicz, K. W.</span><span> </span><span class="NLM_article-title">Design, Synthesis, and Antiviral Activity of 20-Deoxy-20-fluoro-20-C-methylcytidine, a Potent Inhibitor of Hepatitis C Virus Replication</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">5504</span><span class="NLM_x">–</span> <span class="NLM_lpage">5508</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0502788" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=5504-5508&author=J.+L.+Clarkauthor=L.+Holleckerauthor=J.+C.+Masonauthor=L.+J.+Stuyverauthor=P.+M.+Tharnishauthor=S.+Lostiaauthor=T.+R.+McBrayerauthor=R.+Schinaziauthor=K.+A.+Watanabeauthor=M.+J.+Ottoauthor=P.+A.+Furmanauthor=W.+J.+Stecauthor=S.+E.+Pattersonauthor=K.+W.+Pankiewicz&title=Design%2C+Synthesis%2C+and+Antiviral+Activity+of+20-Deoxy-20-fluoro-20-C-methylcytidine%2C+a+Potent+Inhibitor+of+Hepatitis+C+Virus+Replication"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16c&amp;dbid=16384&amp;doi=10.1021%2Fjm0502788&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0502788%26sid%3Dliteratum%253Aachs%26aulast%3DClark%26aufirst%3DJ.%2BL.%26aulast%3DHollecker%26aufirst%3DL.%26aulast%3DMason%26aufirst%3DJ.%2BC.%26aulast%3DStuyver%26aufirst%3DL.%2BJ.%26aulast%3DTharnish%26aufirst%3DP.%2BM.%26aulast%3DLostia%26aufirst%3DS.%26aulast%3DMcBrayer%26aufirst%3DT.%2BR.%26aulast%3DSchinazi%26aufirst%3DR.%26aulast%3DWatanabe%26aufirst%3DK.%2BA.%26aulast%3DOtto%26aufirst%3DM.%2BJ.%26aulast%3DFurman%26aufirst%3DP.%2BA.%26aulast%3DStec%26aufirst%3DW.%2BJ.%26aulast%3DPatterson%26aufirst%3DS.%2BE.%26aulast%3DPankiewicz%26aufirst%3DK.%2BW.%26atitle%3DDesign%252C%2520Synthesis%252C%2520and%2520Antiviral%2520Activity%2520of%252020-Deoxy-20-fluoro-20-C-methylcytidine%252C%2520a%2520Potent%2520Inhibitor%2520of%2520Hepatitis%2520C%2520Virus%2520Replication%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D5504%26epage%3D5508" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit16d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Sofia, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bao, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagarathnam, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rachakonda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bansal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Espiritu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keilman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steuer, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otto, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furman, P. A.</span><span> </span><span class="NLM_article-title">Discovery of a β-<span class="smallcaps smallerCapital">d</span>-2′-deoxy-2′-α-fluoro-2′-β-C-methyluridine nucleotide prodrug (PSI-7977) for the treatment of hepatitis C virus</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">7202</span><span class="NLM_x">–</span> <span class="NLM_lpage">7218</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm100863x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16d&amp;dbid=32&amp;doi=10.1021%2Fjm201258k&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFKmtb%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=7202-7218&author=M.+J.+Sofiaauthor=D.+Baoauthor=W.+Changauthor=J.+Duauthor=D.+Nagarathnamauthor=S.+Rachakondaauthor=P.+G.+Reddyauthor=B.+S.+Rossauthor=P.+Wangauthor=H.+R.+Zhangauthor=S.+Bansalauthor=C.+Espirituauthor=M.+Keilmanauthor=A.+M.+Lamauthor=H.+M.+Steuerauthor=C.+Niuauthor=M.+J.+Ottoauthor=P.+A.+Furman&title=Discovery+of+a+%CE%B2-d-2%E2%80%B2-deoxy-2%E2%80%B2-%CE%B1-fluoro-2%E2%80%B2-%CE%B2-C-methyluridine+nucleotide+prodrug+%28PSI-7977%29+for+the+treatment+of+hepatitis+C+virus"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16dR"><div class="casContent"><span class="casTitleNuber">16d</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a β-D-2'-Deoxy-2'-α-fluoro-2'-β-C-methyluridine Nucleotide Prodrug (PSI-7977) for the Treatment of Hepatitis C Virus</span></div><div class="casAuthors">Sofia, Michael J.; Bao, Donghui; Chang, Wonsuk; Du, Jinfa; Nagarathnam, Dhanapalan; Rachakonda, Suguna; Reddy, P. Ganapati; Ross, Bruce S.; Wang, Peiyuan; Zhang, Hai-Ren; Bansal, Shalini; Espiritu, Christine; Keilman, Meg; Lam, Angela M.; Steuer, Holly M. Micolochick; Niu, Congrong; Otto, Michael J.; Furman, Phillip A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">7202-7218</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Hepatitis C virus (HCV) is a global health problem requiring novel approaches for effective treatment of this disease.  The HCV NS5B polymerase has been demonstrated to be a viable target for the development of HCV therapies.  β-D-2'-Deoxy-2'-α-fluoro-2'-β-C-Me nucleosides are selective inhibitors of the HCV NS5B polymerase and have demonstrated potent activity in the clinic.  Phosphoramidate prodrugs of the 5'-phosphate deriv. of the β-D-2'-deoxy-2'-α-fluoro-2'-β-C-methyluridine nucleoside were prepd. and showed significant potency in the HCV subgenomic replicon assay (<1 μM) and produced high levels of triphosphate 6 in primary hepatocytes and in the livers of rats, dogs, and monkeys when administered in vivo.  The single diastereomer 51 of diastereomeric mixt. 14 was crystd., and an X-ray structure was detd. establishing the phosphoramidate stereochem. as Sp, thus correlating for the first time the stereochem. of a phosphoramidate prodrug with biol. activity.  51 (PSI-7977) was selected as a clin. development candidate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWAkLi9-odWbVg90H21EOLACvtfcHk0ljR4kewvto6rQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFKmtb%252FO&md5=33d371e557e9d70562a326f97798f45c</span></div><a href="/servlet/linkout?suffix=cit16d&amp;dbid=16384&amp;doi=10.1021%2Fjm100863x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100863x%26sid%3Dliteratum%253Aachs%26aulast%3DSofia%26aufirst%3DM.%2BJ.%26aulast%3DBao%26aufirst%3DD.%26aulast%3DChang%26aufirst%3DW.%26aulast%3DDu%26aufirst%3DJ.%26aulast%3DNagarathnam%26aufirst%3DD.%26aulast%3DRachakonda%26aufirst%3DS.%26aulast%3DReddy%26aufirst%3DP.%2BG.%26aulast%3DRoss%26aufirst%3DB.%2BS.%26aulast%3DWang%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DH.%2BR.%26aulast%3DBansal%26aufirst%3DS.%26aulast%3DEspiritu%26aufirst%3DC.%26aulast%3DKeilman%26aufirst%3DM.%26aulast%3DLam%26aufirst%3DA.%2BM.%26aulast%3DSteuer%26aufirst%3DH.%2BM.%26aulast%3DNiu%26aufirst%3DC.%26aulast%3DOtto%26aufirst%3DM.%2BJ.%26aulast%3DFurman%26aufirst%3DP.%2BA.%26atitle%3DDiscovery%2520of%2520a%2520%25CE%25B2-d-2%25E2%2580%25B2-deoxy-2%25E2%2580%25B2-%25CE%25B1-fluoro-2%25E2%2580%25B2-%25CE%25B2-C-methyluridine%2520nucleotide%2520prodrug%2520%2528PSI-7977%2529%2520for%2520the%2520treatment%2520of%2520hepatitis%2520C%2520virus%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D7202%26epage%3D7218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit16e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Reddy, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bao, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chun, B.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagarathnam, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rachakonda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.-R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bansal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Espiritu, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keilman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steuer, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furman, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otto, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sofia, M. J.</span><span> </span><span class="NLM_article-title">20-Deoxy-20-a-fluoro-20-b-C-methyl 30,50-cyclic phosphate nucleotide prodrug analogs as inhibitors of HCV NS5B polymerase: discovery of PSI-352938</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">7376</span><span class="NLM_x">–</span> <span class="NLM_lpage">7380</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=7376-7380&author=P.+G.+Reddyauthor=D.+Baoauthor=W.+Changauthor=B.-K.+Chunauthor=J.+Duauthor=D.+Nagarathnamauthor=S.+Rachakondaauthor=B.+S.+Rossauthor=H.-R.+Zhangauthor=S.+Bansalauthor=C.+L.+Espirituauthor=M.+Keilmanauthor=A.+M.+Lamauthor=C.+Niuauthor=H.+M.+Steuerauthor=P.+A.+Furmanauthor=M.+J.+Ottoauthor=M.+J.+Sofia&title=20-Deoxy-20-a-fluoro-20-b-C-methyl+30%2C50-cyclic+phosphate+nucleotide+prodrug+analogs+as+inhibitors+of+HCV+NS5B+polymerase%3A+discovery+of+PSI-352938"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DReddy%26aufirst%3DP.%2BG.%26aulast%3DBao%26aufirst%3DD.%26aulast%3DChang%26aufirst%3DW.%26aulast%3DChun%26aufirst%3DB.-K.%26aulast%3DDu%26aufirst%3DJ.%26aulast%3DNagarathnam%26aufirst%3DD.%26aulast%3DRachakonda%26aufirst%3DS.%26aulast%3DRoss%26aufirst%3DB.%2BS.%26aulast%3DZhang%26aufirst%3DH.-R.%26aulast%3DBansal%26aufirst%3DS.%26aulast%3DEspiritu%26aufirst%3DC.%2BL.%26aulast%3DKeilman%26aufirst%3DM.%26aulast%3DLam%26aufirst%3DA.%2BM.%26aulast%3DNiu%26aufirst%3DC.%26aulast%3DSteuer%26aufirst%3DH.%2BM.%26aulast%3DFurman%26aufirst%3DP.%2BA.%26aulast%3DOtto%26aufirst%3DM.%2BJ.%26aulast%3DSofia%26aufirst%3DM.%2BJ.%26atitle%3D20-Deoxy-20-a-fluoro-20-b-C-methyl%252030%252C50-cyclic%2520phosphate%2520nucleotide%2520prodrug%2520analogs%2520as%2520inhibitors%2520of%2520HCV%2520NS5B%2520polymerase%253A%2520discovery%2520of%2520PSI-352938%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D7376%26epage%3D7380" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit16f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Cretton-Scott, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perigaud, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peyrottes, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Licklider, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camire, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larsson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La Colla, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hildebrand, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lallos, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bilello, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarville, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seifer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liuzzi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pierra, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Badaroux, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gosselin, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surleraux, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Standring, D. N.</span><span> </span><span class="NLM_article-title">In vitro antiviral activity and pharmacology of IDX184, a novel and potent inhibitor of HCV replication</span> <span class="citation_source-journal">J. Hepatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">S220</span><span class="NLM_x">–</span> <span class="NLM_lpage">S225</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2008&pages=S220-S225&author=E.+Cretton-Scottauthor=C.+Perigaudauthor=S.+Peyrottesauthor=L.+Lickliderauthor=M.+Camireauthor=M.+Larssonauthor=M.+La+Collaauthor=E.+Hildebrandauthor=L.+Lallosauthor=J.+Bilelloauthor=J.+McCarvilleauthor=M.+Seiferauthor=M.+Liuzziauthor=C.+Pierraauthor=E.+Badarouxauthor=G.+Gosselinauthor=D.+Surlerauxauthor=D.+N.+Standring&title=In+vitro+antiviral+activity+and+pharmacology+of+IDX184%2C+a+novel+and+potent+inhibitor+of+HCV+replication"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16f&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCretton-Scott%26aufirst%3DE.%26aulast%3DPerigaud%26aufirst%3DC.%26aulast%3DPeyrottes%26aufirst%3DS.%26aulast%3DLicklider%26aufirst%3DL.%26aulast%3DCamire%26aufirst%3DM.%26aulast%3DLarsson%26aufirst%3DM.%26aulast%3DLa%2BColla%26aufirst%3DM.%26aulast%3DHildebrand%26aufirst%3DE.%26aulast%3DLallos%26aufirst%3DL.%26aulast%3DBilello%26aufirst%3DJ.%26aulast%3DMcCarville%26aufirst%3DJ.%26aulast%3DSeifer%26aufirst%3DM.%26aulast%3DLiuzzi%26aufirst%3DM.%26aulast%3DPierra%26aufirst%3DC.%26aulast%3DBadaroux%26aufirst%3DE.%26aulast%3DGosselin%26aufirst%3DG.%26aulast%3DSurleraux%26aufirst%3DD.%26aulast%3DStandring%26aufirst%3DD.%2BN.%26atitle%3DIn%2520vitro%2520antiviral%2520activity%2520and%2520pharmacology%2520of%2520IDX184%252C%2520a%2520novel%2520and%2520potent%2520inhibitor%2520of%2520HCV%2520replication%26jtitle%3DJ.%2520Hepatol.%26date%3D2008%26volume%3D48%26spage%3DS220%26epage%3DS225" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit16g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">McGuigan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madela, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aljarah, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilles, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brancale, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zonta, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chamberlain, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vernachio, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutchins, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ames, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorovits, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganguly, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolykhalov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muhammadb, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patti, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henson, G.</span><span> </span><span class="NLM_article-title">Design, synthesis and evaluation of a novel double pro-drug: INX-08189. A new clinical candidate for hepatitis C virus</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">4850</span><span class="NLM_x">–</span> <span class="NLM_lpage">4854</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16g&amp;dbid=16&amp;doi=10.1021%2Fjm201258k&amp;key=10.1016%2Fj.bmcl.2010.06.094" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16g&amp;dbid=8&amp;doi=10.1021%2Fjm201258k&amp;key=20637609" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16g&amp;dbid=32&amp;doi=10.1021%2Fjm201258k&amp;key=1%3ACAS%3A528%3ADC%252BC3cXptlagurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=4850-4854&author=C.+McGuiganauthor=K.+Madelaauthor=M.+Aljarahauthor=A.+Gillesauthor=A.+Brancaleauthor=N.+Zontaauthor=S.+Chamberlainauthor=J.+Vernachioauthor=J.+Hutchinsauthor=A.+Hallauthor=B.+Amesauthor=E.+Gorovitsauthor=B.+Gangulyauthor=A.+Kolykhalovauthor=J.+Wangauthor=J.+Muhammadbauthor=J.+M.+Pattiauthor=G.+Henson&title=Design%2C+synthesis+and+evaluation+of+a+novel+double+pro-drug%3A+INX-08189.+A+new+clinical+candidate+for+hepatitis+C+virus"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16gR"><div class="casContent"><span class="casTitleNuber">16g</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis and evaluation of a novel double prodrug: INX-08189. A new clinical candidate for hepatitis C virus</span></div><div class="casAuthors">McGuigan, Christopher; Madela, Karolina; Aljarah, Mohamed; Gilles, Arnaud; Brancale, Andrea; Zonta, Nicola; Chamberlain, Stanley; Vernachio, John; Hutchins, Jeff; Hall, Andrea; Ames, Brenda; Gorovits, Elena; Ganguly, Babita; Kolykhalov, Alexander; Wang, Jin; Muhammad, Jerry; Patti, Joseph M.; Henson, Geoffrey</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">4850-4854</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We herein report a novel double prodrug approach applied to the anti-HCV agent 2'-β-C-Me guanosine.  A phosphoramidate ProTide motif and a 6-O-methoxy base prodrug moiety are combined to generate lipophilic prodrugs of the monophosphate of the guanine nucleoside.  Modification of the ester and amino acid moieties lead to a compd. INX-08189 that exhibits 10 nM potency in the HCV genotype 1b sub-genomic replicon, thus being 500 times more potent than the parent nucleoside.  The potency of the lead compd. INX-08189 was shown to be consistent with intracellular 2'-C-Me guanosine triphosphate levels in primary human hepatocytes.  The sepd. diastereomers of INX-08189 were shown to have similar activity in the replicon assay and were also shown to be similar substrates for enzyme processing.  INX-08189 has completed investigational new drug enabling studies and has been progressed into human clin. trials for the treatment of chronic HCV infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRKJa0VtEVwrVg90H21EOLACvtfcHk0lgFuaiNIK-vLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXptlagurs%253D&md5=20d10847a850ddf681fe8accc4ed49db</span></div><a href="/servlet/linkout?suffix=cit16g&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.06.094&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.06.094%26sid%3Dliteratum%253Aachs%26aulast%3DMcGuigan%26aufirst%3DC.%26aulast%3DMadela%26aufirst%3DK.%26aulast%3DAljarah%26aufirst%3DM.%26aulast%3DGilles%26aufirst%3DA.%26aulast%3DBrancale%26aufirst%3DA.%26aulast%3DZonta%26aufirst%3DN.%26aulast%3DChamberlain%26aufirst%3DS.%26aulast%3DVernachio%26aufirst%3DJ.%26aulast%3DHutchins%26aufirst%3DJ.%26aulast%3DHall%26aufirst%3DA.%26aulast%3DAmes%26aufirst%3DB.%26aulast%3DGorovits%26aufirst%3DE.%26aulast%3DGanguly%26aufirst%3DB.%26aulast%3DKolykhalov%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DMuhammadb%26aufirst%3DJ.%26aulast%3DPatti%26aufirst%3DJ.%2BM.%26aulast%3DHenson%26aufirst%3DG.%26atitle%3DDesign%252C%2520synthesis%2520and%2520evaluation%2520of%2520a%2520novel%2520double%2520pro-drug%253A%2520INX-08189.%2520A%2520new%2520clinical%2520candidate%2520for%2520hepatitis%2520C%2520virus%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D4850%26epage%3D4854" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Kneteman, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howe, A. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pevear, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lund, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Douglas, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercer, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tyrrell, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Immermann, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaudhary, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Speth, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villano, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connell, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collett, M.</span><span> </span><span class="NLM_article-title">HCV796: A selective nonstructural protein 5B polymerase inhibitor with potent anti-hepatitis C virus activity in vitro, in mice with chimeric human livers, and in humans infected with hepatitis C virus</span> <span class="citation_source-journal">Hepatology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">745</span><span class="NLM_x">–</span> <span class="NLM_lpage">752</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm201258k&amp;key=10.1002%2Fhep.22717" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm201258k&amp;key=19072827" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm201258k&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjvFOnu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2009&pages=745-752&author=N.+M.+Knetemanauthor=A.+Y.+Howeauthor=T.+Gaoauthor=J.+Lewisauthor=D.+Pevearauthor=G.+Lundauthor=D.+Douglasauthor=D.+F.+Mercerauthor=D.+L.+Tyrrellauthor=F.+Immermannauthor=I.+Chaudharyauthor=J.+Spethauthor=S.+A.+Villanoauthor=J.+O%E2%80%99Connellauthor=M.+Collett&title=HCV796%3A+A+selective+nonstructural+protein+5B+polymerase+inhibitor+with+potent+anti-hepatitis+C+virus+activity+in+vitro%2C+in+mice+with+chimeric+human+livers%2C+and+in+humans+infected+with+hepatitis+C+virus"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">HCCV796: a selective nonstructural protein 5B polymerase inhibitor with potent anti-hepatitis C virus activity in vitro, in mice with chimeric human livers, and in humans infected with hepatitis C virus</span></div><div class="casAuthors">Kneteman, Norman M.; Howe, Anita Y. M.; Gao, Tiejun; Lewis, Jamie; Pevear, Dan; Lund, Gary; Douglas, Donna; Mercer, David F.; Tyrrell, D. Lorne J.; Immermann, Frederick; Chaudhary, Inder; Speth, John; Villano, Stephen A.; O'Connell, John; Collett, Marc</div><div class="citationInfo"><span class="NLM_cas:title">Hepatology (Hoboken, NJ, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">745-752</span>CODEN:
                <span class="NLM_cas:coden">HPTLD9</span>;
        ISSN:<span class="NLM_cas:issn">0270-9139</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Anti-hepatitis C virus (HCV) drug development has been challenged by a lack of experience with inhibitors inclusive of in vitro, animal model, and clin. study.  This manuscript outlines activity and correlation across such a spectrum of models and into clin. trials with a novel selective nonstructural protein 5B (NS5B) polymerase inhibitor, HCV796.  Enzyme assays yielded median inhibitory concn. (IC50) values of 0.01 to 0.14 μM for genotype 1, with half maximal effective concn. (EC50s) of 5 nM and 9 nM against genotype 1a and 1b replicons.  In the chimeric mouse model, a 2.02 ± 0.55 log redn. in HCV titer was seen with monotherapy, whereas a suboptimal dose of 30 mg/kg three times per day in combination with interferon demonstrated a 2.44 log redn. (P = 0.001 vs. interferon alone) Clin. outcomes in combination with pegylated interferon and ribavirin have revealed additive efficacy in treatment naive patients.  Abnormal liver function test results were obsd. in 8% of HCV-796 patients treated for over 8 wk, resulting in suspension of further trial activity.  Conclusion: The RNA-dependent RNA polymerase inhibitor HCV796 demonstrated potent anti-HCV activity consistently through enzyme inhibition assays, subgenomic replicon, and chimeric mouse studies.  Strong correlations of outcomes in the mouse model were seen with subsequent clin. trials, including a plateau in dose-related antiviral activity and additive impact from combination therapy with interferon.  These outcomes demonstrate the utility of the range of in vitro and in vivo models now available for anti-HCV drug development and support the potential utility of polymerase inhibitors in future combination therapies for HCV treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7ZCtNeI0RLLVg90H21EOLACvtfcHk0lgFuaiNIK-vLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjvFOnu70%253D&md5=0dcebc9c1e93051ad46eae43b352e7cf</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1002%2Fhep.22717&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhep.22717%26sid%3Dliteratum%253Aachs%26aulast%3DKneteman%26aufirst%3DN.%2BM.%26aulast%3DHowe%26aufirst%3DA.%2BY.%26aulast%3DGao%26aufirst%3DT.%26aulast%3DLewis%26aufirst%3DJ.%26aulast%3DPevear%26aufirst%3DD.%26aulast%3DLund%26aufirst%3DG.%26aulast%3DDouglas%26aufirst%3DD.%26aulast%3DMercer%26aufirst%3DD.%2BF.%26aulast%3DTyrrell%26aufirst%3DD.%2BL.%26aulast%3DImmermann%26aufirst%3DF.%26aulast%3DChaudhary%26aufirst%3DI.%26aulast%3DSpeth%26aufirst%3DJ.%26aulast%3DVillano%26aufirst%3DS.%2BA.%26aulast%3DO%25E2%2580%2599Connell%26aufirst%3DJ.%26aulast%3DCollett%26aufirst%3DM.%26atitle%3DHCV796%253A%2520A%2520selective%2520nonstructural%2520protein%25205B%2520polymerase%2520inhibitor%2520with%2520potent%2520anti-hepatitis%2520C%2520virus%2520activity%2520in%2520vitro%252C%2520in%2520mice%2520with%2520chimeric%2520human%2520livers%252C%2520and%2520in%2520humans%2520infected%2520with%2520hepatitis%2520C%2520virus%26jtitle%3DHepatology%26date%3D2009%26volume%3D49%26spage%3D745%26epage%3D752" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Li, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tatlock, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linton, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jewell, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ludlum, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drowns, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahavendran, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skor, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunter, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herlihy, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parge, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickey, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chau, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nonomiya, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, C.</span><span> </span><span class="NLM_article-title">Discovery of (<i>R</i>)-6-Cyclopentyl-6-(2-(2,6-diethylpyridin-4-yl)ethyl)-3-((5,7-dimethyl-[1,2,4]triazolo[1,5-<i>a</i>]pyrimidin-2-yl)methyl)-4-hydroxy-5,6-dihydro-pyran-2-one (PF-00868554) as a Potent and Orally Available Hepatitis C Virus Polymerase Inhibitor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">1255</span><span class="NLM_x">–</span> <span class="NLM_lpage">1258</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm8014537" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=1255-1258&author=H.+Liauthor=J.+Tatlockauthor=A.+Lintonauthor=J.+Gonzalezauthor=T.+Jewellauthor=L.+Patelauthor=S.+Ludlumauthor=M.+Drownsauthor=S.+V.+Rahavendranauthor=H.+Skorauthor=R.+Hunterauthor=S.+T.+Shiauthor=K.+J.+Herlihyauthor=H.+Pargeauthor=M.+Hickeyauthor=X.+Yuauthor=F.+Chauauthor=J.+Nonomiyaauthor=C.+Lewis&title=Discovery+of+%28R%29-6-Cyclopentyl-6-%282-%282%2C6-diethylpyridin-4-yl%29ethyl%29-3-%28%285%2C7-dimethyl-%5B1%2C2%2C4%5Dtriazolo%5B1%2C5-a%5Dpyrimidin-2-yl%29methyl%29-4-hydroxy-5%2C6-dihydro-pyran-2-one+%28PF-00868554%29+as+a+Potent+and+Orally+Available+Hepatitis+C+Virus+Polymerase+Inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm8014537&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8014537%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DH.%26aulast%3DTatlock%26aufirst%3DJ.%26aulast%3DLinton%26aufirst%3DA.%26aulast%3DGonzalez%26aufirst%3DJ.%26aulast%3DJewell%26aufirst%3DT.%26aulast%3DPatel%26aufirst%3DL.%26aulast%3DLudlum%26aufirst%3DS.%26aulast%3DDrowns%26aufirst%3DM.%26aulast%3DRahavendran%26aufirst%3DS.%2BV.%26aulast%3DSkor%26aufirst%3DH.%26aulast%3DHunter%26aufirst%3DR.%26aulast%3DShi%26aufirst%3DS.%2BT.%26aulast%3DHerlihy%26aufirst%3DK.%2BJ.%26aulast%3DParge%26aufirst%3DH.%26aulast%3DHickey%26aufirst%3DM.%26aulast%3DYu%26aufirst%3DX.%26aulast%3DChau%26aufirst%3DF.%26aulast%3DNonomiya%26aufirst%3DJ.%26aulast%3DLewis%26aufirst%3DC.%26atitle%3DDiscovery%2520of%2520%2528R%2529-6-Cyclopentyl-6-%25282-%25282%252C6-diethylpyridin-4-yl%2529ethyl%2529-3-%2528%25285%252C7-dimethyl-%255B1%252C2%252C4%255Dtriazolo%255B1%252C5-a%255Dpyrimidin-2-yl%2529methyl%2529-4-hydroxy-5%252C6-dihydro-pyran-2-one%2520%2528PF-00868554%2529%2520as%2520a%2520Potent%2520and%2520Orally%2520Available%2520Hepatitis%2520C%2520Virus%2520Polymerase%2520Inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D1255%26epage%3D1258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Rodriguez-Torres, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawitz, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conway, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaita, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheikh, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghalib, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adrover, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silva, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosario, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourgault, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proulx, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McHutchison, J. G.</span><span> </span><span class="NLM_article-title">Safety and antiviral activity of the non-nucleoside polymerase inhibitor VX-222 in treatment naïve genotype 1 HCV infected patients</span> <span class="citation_source-journal">J. Hepatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">S14</span><span class="NLM_x">–</span> <span class="NLM_lpage">S18</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2010&pages=S14-S18&author=M.+Rodriguez-Torresauthor=E.+Lawitzauthor=B.+Conwayauthor=K.+Kaitaauthor=A.+M.+Sheikhauthor=R.+Ghalibauthor=R.+Adroverauthor=C.+Cooperauthor=M.+Silvaauthor=M.+Rosarioauthor=B.+Bourgaultauthor=L.+Proulxauthor=J.+G.+McHutchison&title=Safety+and+antiviral+activity+of+the+non-nucleoside+polymerase+inhibitor+VX-222+in+treatment+na%C3%AFve+genotype+1+HCV+infected+patients"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRodriguez-Torres%26aufirst%3DM.%26aulast%3DLawitz%26aufirst%3DE.%26aulast%3DConway%26aufirst%3DB.%26aulast%3DKaita%26aufirst%3DK.%26aulast%3DSheikh%26aufirst%3DA.%2BM.%26aulast%3DGhalib%26aufirst%3DR.%26aulast%3DAdrover%26aufirst%3DR.%26aulast%3DCooper%26aufirst%3DC.%26aulast%3DSilva%26aufirst%3DM.%26aulast%3DRosario%26aufirst%3DM.%26aulast%3DBourgault%26aufirst%3DB.%26aulast%3DProulx%26aufirst%3DL.%26aulast%3DMcHutchison%26aufirst%3DJ.%2BG.%26atitle%3DSafety%2520and%2520antiviral%2520activity%2520of%2520the%2520non-nucleoside%2520polymerase%2520inhibitor%2520VX-222%2520in%2520treatment%2520na%25C3%25AFve%2520genotype%25201%2520HCV%2520infected%2520patients%26jtitle%3DJ.%2520Hepatol.%26date%3D2010%26volume%3D52%26spage%3DS14%26epage%3DS18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Lawitz, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodrigues-Torres, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeMicco, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Godofsky, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Appleman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahimy, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crowley, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freddo, J.</span><span> </span><span class="NLM_article-title">Antiviral activity of ANA598, a potent non-nucleoside polymerase inhibitor, in chronic hepatitis C patients</span> <span class="citation_source-journal">J. Hepatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">S384</span><span class="NLM_x">–</span> <span class="NLM_lpage">S387</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2009&pages=S384-S387&author=E.+Lawitzauthor=M.+Rodrigues-Torresauthor=T.+DeMiccoauthor=T.+Nguyenauthor=E.+Godofskyauthor=J.+Applemanauthor=M.+Rahimyauthor=C.+Crowleyauthor=J.+Freddo&title=Antiviral+activity+of+ANA598%2C+a+potent+non-nucleoside+polymerase+inhibitor%2C+in+chronic+hepatitis+C+patients"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLawitz%26aufirst%3DE.%26aulast%3DRodrigues-Torres%26aufirst%3DM.%26aulast%3DDeMicco%26aufirst%3DT.%26aulast%3DNguyen%26aufirst%3DT.%26aulast%3DGodofsky%26aufirst%3DE.%26aulast%3DAppleman%26aufirst%3DJ.%26aulast%3DRahimy%26aufirst%3DM.%26aulast%3DCrowley%26aufirst%3DC.%26aulast%3DFreddo%26aufirst%3DJ.%26atitle%3DAntiviral%2520activity%2520of%2520ANA598%252C%2520a%2520potent%2520non-nucleoside%2520polymerase%2520inhibitor%252C%2520in%2520chronic%2520hepatitis%2520C%2520patients%26jtitle%3DJ.%2520Hepatol.%26date%3D2009%26volume%3D50%26spage%3DS384%26epage%3DS387" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Larrey, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benhamou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lohse, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trepo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moelleken, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bronowicki, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heim, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arastéh, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zarski, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourlière, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiest, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calleja, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Enríquez, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erhardt, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wedemeyer, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerlach, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berg, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stern, J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abdallah, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nehmiz, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boecher, W. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steffgen, J.</span><span> </span><span class="NLM_article-title">BI 207127 is a potent HCV RNA polymerase inhibitor during 5 days monotherapy in patients with chronic hepatitis C</span> <span class="citation_source-journal">Hepatology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">1044A</span><span class="NLM_x">–</span> <span class="NLM_lpage">1046A</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2009&pages=1044A-1046A&author=D.+Larreyauthor=Y.+Benhamouauthor=A.+W.+Lohseauthor=C.+Trepoauthor=C.+Moellekenauthor=J.-P.+Bronowickiauthor=M.+H.+Heimauthor=K.+Arast%C3%A9hauthor=J.-P.+Zarskiauthor=M.+Bourli%C3%A8reauthor=R.+Wiestauthor=J.+L.+Callejaauthor=J.+Enr%C3%ADquezauthor=A.+Erhardtauthor=H.+Wedemeyerauthor=T.+Gerlachauthor=T.+Bergauthor=J.+O.+Sternauthor=K.+Wuauthor=N.+Abdallahauthor=G.+Nehmizauthor=W.+O.+Boecherauthor=F.+M.+Bergerauthor=J.+Steffgen&title=BI+207127+is+a+potent+HCV+RNA+polymerase+inhibitor+during+5+days+monotherapy+in+patients+with+chronic+hepatitis+C"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLarrey%26aufirst%3DD.%26aulast%3DBenhamou%26aufirst%3DY.%26aulast%3DLohse%26aufirst%3DA.%2BW.%26aulast%3DTrepo%26aufirst%3DC.%26aulast%3DMoelleken%26aufirst%3DC.%26aulast%3DBronowicki%26aufirst%3DJ.-P.%26aulast%3DHeim%26aufirst%3DM.%2BH.%26aulast%3DArast%25C3%25A9h%26aufirst%3DK.%26aulast%3DZarski%26aufirst%3DJ.-P.%26aulast%3DBourli%25C3%25A8re%26aufirst%3DM.%26aulast%3DWiest%26aufirst%3DR.%26aulast%3DCalleja%26aufirst%3DJ.%2BL.%26aulast%3DEnr%25C3%25ADquez%26aufirst%3DJ.%26aulast%3DErhardt%26aufirst%3DA.%26aulast%3DWedemeyer%26aufirst%3DH.%26aulast%3DGerlach%26aufirst%3DT.%26aulast%3DBerg%26aufirst%3DT.%26aulast%3DStern%26aufirst%3DJ.%2BO.%26aulast%3DWu%26aufirst%3DK.%26aulast%3DAbdallah%26aufirst%3DN.%26aulast%3DNehmiz%26aufirst%3DG.%26aulast%3DBoecher%26aufirst%3DW.%2BO.%26aulast%3DBerger%26aufirst%3DF.%2BM.%26aulast%3DSteffgen%26aufirst%3DJ.%26atitle%3DBI%2520207127%2520is%2520a%2520potent%2520HCV%2520RNA%2520polymerase%2520inhibitor%2520during%25205%2520days%2520monotherapy%2520in%2520patients%2520with%2520chronic%2520hepatitis%2520C%26jtitle%3DHepatology%26date%3D2009%26volume%3D50%26spage%3D1044A%26epage%3D1046A" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span>BMS-791325 from Bristol-Myers Squibb Has Been Advanced to Phase II Clinical Trials; <a href="http://clinicaltrials.gov/ct2/show/NCT01193361?term=bms-791325&amp;rank=4" class="extLink">http://clinicaltrials.gov/ct2/show/NCT01193361?term=bms-791325&rank=4</a><span class="NLM_access-date"> (Accessed January 5, 2012)</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=BMS-791325+from+Bristol-Myers+Squibb+Has+Been+Advanced+to+Phase+II+Clinical+Trials%3B+http%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT01193361%3Fterm%3Dbms-791325%26rank%3D4+%28Accessed+January+5%2C+2012%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26jtitle%3DBMS-791325%2520from%2520Bristol-Myers%2520Squibb%2520Has%2520Been%2520Advanced%2520to%2520Phase%2520II%2520Clinical%2520Trials" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Ferrari, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palermo, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, H. C.</span><span> </span><span class="NLM_article-title">Hepatitis C Virus NS5B Polymerase Exhibits Distinct Nucleotide Requirements for Initiation and Elongation</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x">, </span> <span class="NLM_fpage">33893</span><span class="NLM_x">–</span> <span class="NLM_lpage">33901</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2008&pages=33893-33901&author=E.+Ferrariauthor=Z.+Heauthor=R.+E.+Palermoauthor=H.+C.+Huang&title=Hepatitis+C+Virus+NS5B+Polymerase+Exhibits+Distinct+Nucleotide+Requirements+for+Initiation+and+Elongation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFerrari%26aufirst%3DE.%26aulast%3DHe%26aufirst%3DZ.%26aulast%3DPalermo%26aufirst%3DR.%2BE.%26aulast%3DHuang%26aufirst%3DH.%2BC.%26atitle%3DHepatitis%2520C%2520Virus%2520NS5B%2520Polymerase%2520Exhibits%2520Distinct%2520Nucleotide%2520Requirements%2520for%2520Initiation%2520and%2520Elongation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2008%26volume%3D283%26spage%3D33893%26epage%3D33901" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Lohmann, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Körner, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, J.-O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herian, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Theilmann, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartenschlager, R.</span><span> </span><span class="NLM_article-title">Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">285</span><span class="NLM_x">, </span> <span class="NLM_fpage">110</span><span class="NLM_x">–</span> <span class="NLM_lpage">113</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm201258k&amp;key=10.1126%2Fscience.285.5424.110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm201258k&amp;key=10390360" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm201258k&amp;key=1%3ACAS%3A528%3ADyaK1MXksVCqurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=1999&pages=110-113&author=V.+Lohmannauthor=F.+K%C3%B6rnerauthor=J.-O.+Kochauthor=U.+Herianauthor=L.+Theilmannauthor=R.+Bartenschlager&title=Replication+of+subgenomic+hepatitis+C+virus+RNAs+in+a+hepatoma+cell+line"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line</span></div><div class="casAuthors">Lohmann, V.; Korner, F.; Koch, J.-O.; Herian, U.; Theilmann, L.; Bartenschlager, R.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">285</span>
        (<span class="NLM_cas:issue">5424</span>),
    <span class="NLM_cas:pages">110-113</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">An estd. 170 million persons worldwide are infected with hepatitis C virus (HCV), a major cause of chronic liver disease.  Despite increasing knowledge of genome structure and individual viral proteins, studies on virus replication and pathogenesis have been hampered by the lack of reliable and efficient cell culture systems.  A full-length consensus genome was cloned from viral RNA isolated from an infected human liver and used to construct subgenomic selectable replicons.  Upon transfection into a human hepatoma cell line, these RNAs replicated to high levels, permitting metabolic radiolabeling of viral RNA and proteins.  This work defines the structure of HCV replicons functional in cell culture and provides the basis for a long-sought cellular system that should allow detailed mol. studies of HCV and the development of antiviral drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7X754RT8y1LVg90H21EOLACvtfcHk0ljUTDv6pcW1BQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXksVCqurk%253D&md5=b075621b316209ecf4498c9b5b33e4b5</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1126%2Fscience.285.5424.110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.285.5424.110%26sid%3Dliteratum%253Aachs%26aulast%3DLohmann%26aufirst%3DV.%26aulast%3DK%25C3%25B6rner%26aufirst%3DF.%26aulast%3DKoch%26aufirst%3DJ.-O.%26aulast%3DHerian%26aufirst%3DU.%26aulast%3DTheilmann%26aufirst%3DL.%26aulast%3DBartenschlager%26aufirst%3DR.%26atitle%3DReplication%2520of%2520subgenomic%2520hepatitis%2520C%2520virus%2520RNAs%2520in%2520a%2520hepatoma%2520cell%2520line%26jtitle%3DScience%26date%3D1999%26volume%3D285%26spage%3D110%26epage%3D113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Anilkumar, G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lesburg, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selyutin, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenblum, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, T.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaccaro, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duca, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gavalas, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinto, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sannigrahi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velazquez, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venkatraman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vibulbhan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agrawal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butkiewicz, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feld, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrari, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, C.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palermo, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mcmonagle, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, H.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shih, N.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Njoroge, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozlowski, J. A.</span><span> </span><span class="NLM_article-title">I. Novel HCV NS5B Polymerase Inhibitors: Discovery of Indole 2-Carboxylic Acids with C-3-Heterocycles</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">5336</span><span class="NLM_x">–</span> <span class="NLM_lpage">5341</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=5336-5341&author=G.+N.+Anilkumarauthor=C.+A.+Lesburgauthor=O.+Selyutinauthor=S.+B.+Rosenblumauthor=Q.+Zengauthor=Y.+Jiangauthor=T.-Y.+Chanauthor=H.+Puauthor=H.+Vaccaroauthor=L.+Wangauthor=F.+Bennettauthor=K.+X.+Chenauthor=J.+Ducaauthor=S.+Gavalasauthor=Y.+Huangauthor=P.+Pintoauthor=M.+Sannigrahiauthor=F.+Velazquezauthor=S.+Venkatramanauthor=B.+Vibulbhanauthor=S.+Agrawalauthor=N.+Butkiewiczauthor=B.+Feldauthor=E.+Ferrariauthor=Z.+Heauthor=C.-K.+Jiangauthor=R.+E.+Palermoauthor=P.+Mcmonagleauthor=H.-C.+Huangauthor=N.-Y.+Shihauthor=G.+Njorogeauthor=J.+A.+Kozlowski&title=I.+Novel+HCV+NS5B+Polymerase+Inhibitors%3A+Discovery+of+Indole+2-Carboxylic+Acids+with+C-3-Heterocycles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAnilkumar%26aufirst%3DG.%2BN.%26aulast%3DLesburg%26aufirst%3DC.%2BA.%26aulast%3DSelyutin%26aufirst%3DO.%26aulast%3DRosenblum%26aufirst%3DS.%2BB.%26aulast%3DZeng%26aufirst%3DQ.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DChan%26aufirst%3DT.-Y.%26aulast%3DPu%26aufirst%3DH.%26aulast%3DVaccaro%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DBennett%26aufirst%3DF.%26aulast%3DChen%26aufirst%3DK.%2BX.%26aulast%3DDuca%26aufirst%3DJ.%26aulast%3DGavalas%26aufirst%3DS.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DPinto%26aufirst%3DP.%26aulast%3DSannigrahi%26aufirst%3DM.%26aulast%3DVelazquez%26aufirst%3DF.%26aulast%3DVenkatraman%26aufirst%3DS.%26aulast%3DVibulbhan%26aufirst%3DB.%26aulast%3DAgrawal%26aufirst%3DS.%26aulast%3DButkiewicz%26aufirst%3DN.%26aulast%3DFeld%26aufirst%3DB.%26aulast%3DFerrari%26aufirst%3DE.%26aulast%3DHe%26aufirst%3DZ.%26aulast%3DJiang%26aufirst%3DC.-K.%26aulast%3DPalermo%26aufirst%3DR.%2BE.%26aulast%3DMcmonagle%26aufirst%3DP.%26aulast%3DHuang%26aufirst%3DH.-C.%26aulast%3DShih%26aufirst%3DN.-Y.%26aulast%3DNjoroge%26aufirst%3DG.%26aulast%3DKozlowski%26aufirst%3DJ.%2BA.%26atitle%3DI.%2520Novel%2520HCV%2520NS5B%2520Polymerase%2520Inhibitors%253A%2520Discovery%2520of%2520Indole%25202-Carboxylic%2520Acids%2520with%2520C-3-Heterocycles%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D5336%26epage%3D5341" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Ishiyama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murata, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyaura, N.</span><span> </span><span class="NLM_article-title">Palladium(0)-Catalyzed Cross-Coupling Reaction of Alkoxydiboron with Haloarenes: A Direct Procedure for Arylboronic Esters</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">7508</span><span class="NLM_x">–</span> <span class="NLM_lpage">7510</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo00128a024" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm201258k&amp;key=1%3ACAS%3A528%3ADyaK2MXovFSku7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=1995&pages=7508-7510&author=T.+Ishiyamaauthor=M.+Murataauthor=N.+Miyaura&title=Palladium%280%29-Catalyzed+Cross-Coupling+Reaction+of+Alkoxydiboron+with+Haloarenes%3A+A+Direct+Procedure+for+Arylboronic+Esters"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Palladium(0)-Catalyzed Cross-Coupling Reaction of Alkoxydiboron with Haloarenes: A Direct Procedure for Arylboronic Esters</span></div><div class="casAuthors">Ishiyama, Tatsuo; Murata, Miki; Miyaura, Norio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">7508-10</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The palladium-catalyzed cross-coupling reaction of the pinacol ester of diboronic acid I with haloarenes gave a direct procedure for arylboronic esters II (Ar = aryl) from aryl halides in a range of 60-98%.  The reaction was catalyzed by PdCl2(dppf) (3 mol %) at 80° in the presence of KOAc (3 equiv) in DMSO and available with various functional groups such as nitrile, cyanide, ester, and carbonyl groups.  The trans-ArPd(II)(OAc)(PPh3)2 intermediate was isolated and characterized to propose the catalytic cycle involving the transmetalation between the phenylpalladium(II) acetate complex and I.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobehJBGFjDH7Vg90H21EOLACvtfcHk0ljUTDv6pcW1BQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXovFSku7g%253D&md5=2666902270ec1efc5742480b133f1255</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjo00128a024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00128a024%26sid%3Dliteratum%253Aachs%26aulast%3DIshiyama%26aufirst%3DT.%26aulast%3DMurata%26aufirst%3DM.%26aulast%3DMiyaura%26aufirst%3DN.%26atitle%3DPalladium%25280%2529-Catalyzed%2520Cross-Coupling%2520Reaction%2520of%2520Alkoxydiboron%2520with%2520Haloarenes%253A%2520A%2520Direct%2520Procedure%2520for%2520Arylboronic%2520Esters%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1995%26volume%3D60%26spage%3D7508%26epage%3D7510" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Jansen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dannhardt, G.</span><span> </span><span class="NLM_article-title">Variations of acidic functions at position 2 and substituents at positions 4, 5 and 6 of the indole moiety and their effect on NMDA–glycine site affinity</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">855</span><span class="NLM_x">–</span> <span class="NLM_lpage">865</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2003&pages=855-865&author=M.+Jansenauthor=G.+Dannhardt&title=Variations+of+acidic+functions+at+position+2+and+substituents+at+positions+4%2C+5+and+6+of+the+indole+moiety+and+their+effect+on+NMDA%E2%80%93glycine+site+affinity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJansen%26aufirst%3DM.%26aulast%3DDannhardt%26aufirst%3DG.%26atitle%3DVariations%2520of%2520acidic%2520functions%2520at%2520position%25202%2520and%2520substituents%2520at%2520positions%25204%252C%25205%2520and%25206%2520of%2520the%2520indole%2520moiety%2520and%2520their%2520effect%2520on%2520NMDA%25E2%2580%2593glycine%2520site%2520affinity%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2003%26volume%3D38%26spage%3D855%26epage%3D865" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="note"><p class="first last">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a> was generated using the program PyMOL (The PyMOL Molecular Graphics System, version 1.2r1, Schrödinger, LLC.).</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="note"><p class="first last">X-Ray crystal structure data of HCV NS5B in complex with <b>56</b> have been deposited in the Protein Data Bank with access code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3TYV">3TYV</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3TYV" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3TYV','PDB','3TYV'); return false;">PDB: 3TYV</a></li></ul></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm201258k&amp;pbContext=%3Barticle%3Aarticle%3A10.1021%2Fjm201258k%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2012.55.issue-2%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm201258k" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                1MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679a567bfc2b1949","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
